#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Connectivity maps based analysis of EEG for the advanced diagnosis of schizophrenia attributes
#Text=This article presents a novel connectivity analysis method that is suitable for multi-node networks such as EEG, MEG or EcOG electrode recordings.
1-1	0-12	Connectivity	_
1-2	13-17	maps	_
1-3	18-23	based	_
1-4	24-32	analysis	_
1-5	33-35	of	_
1-6	36-39	EEG	_
1-7	40-43	for	_
1-8	44-47	the	_
1-9	48-56	advanced	_
1-10	57-66	diagnosis	_
1-11	67-69	of	_
1-12	70-83	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-13	84-94	attributes	_
1-14	95-99	This	_
1-15	100-107	article	_
1-16	108-116	presents	_
1-17	117-118	a	_
1-18	119-124	novel	_
1-19	125-137	connectivity	_
1-20	138-146	analysis	_
1-21	147-153	method	_
1-22	154-158	that	_
1-23	159-161	is	_
1-24	162-170	suitable	_
1-25	171-174	for	_
1-26	175-185	multi-node	_
1-27	186-194	networks	_
1-28	195-199	such	_
1-29	200-202	as	_
1-30	203-206	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
1-31	206-207	,	_
1-32	208-211	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
1-33	212-214	or	_
1-34	215-219	EcOG	http://maven.renci.org/NeuroBridge/neurobridge#Electrocorticogram
1-35	220-229	electrode	_
1-36	230-240	recordings	_
1-37	240-241	.	_

#Text=Its diagnostic power and ability to interpret brain states in schizophrenia is demonstrated on a set of 50 subjects that constituted of 25 healthy and 25 diagnosed with schizophrenia and treated with medication.
2-1	242-245	Its	_
2-2	246-256	diagnostic	_
2-3	257-262	power	_
2-4	263-266	and	_
2-5	267-274	ability	_
2-6	275-277	to	_
2-7	278-287	interpret	_
2-8	288-293	brain	_
2-9	294-300	states	_
2-10	301-303	in	_
2-11	304-317	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-12	318-320	is	_
2-13	321-333	demonstrated	_
2-14	334-336	on	_
2-15	337-338	a	_
2-16	339-342	set	_
2-17	343-345	of	_
2-18	346-348	50	_
2-19	349-357	subjects	_
2-20	358-362	that	_
2-21	363-374	constituted	_
2-22	375-377	of	_
2-23	378-380	25	_
2-24	381-388	healthy	_
2-25	389-392	and	_
2-26	393-395	25	_
2-27	396-405	diagnosed	_
2-28	406-410	with	_
2-29	411-424	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-30	425-428	and	_
2-31	429-436	treated	_
2-32	437-441	with	_
2-33	442-452	medication	_
2-34	452-453	.	_

#Text=The method can also be used for the automatic detection of schizophrenia; it exhibits higher sensitivity than state-of-the-art methods with no false positives.
3-1	454-457	The	_
3-2	458-464	method	_
3-3	465-468	can	_
3-4	469-473	also	_
3-5	474-476	be	_
3-6	477-481	used	_
3-7	482-485	for	_
3-8	486-489	the	_
3-9	490-499	automatic	_
3-10	500-509	detection	_
3-11	510-512	of	_
3-12	513-526	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-13	526-527	;	_
3-14	528-530	it	_
3-15	531-539	exhibits	_
3-16	540-546	higher	_
3-17	547-558	sensitivity	_
3-18	559-563	than	_
3-19	564-580	state-of-the-art	_
3-20	581-588	methods	_
3-21	589-593	with	_
3-22	594-596	no	_
3-23	597-602	false	_
3-24	603-612	positives	_
3-25	612-613	.	_

#Text=The detection is based on an analysis from a minute long pattern-recognition computer task.
4-1	614-617	The	_
4-2	618-627	detection	_
4-3	628-630	is	_
4-4	631-636	based	_
4-5	637-639	on	_
4-6	640-642	an	_
4-7	643-651	analysis	_
4-8	652-656	from	_
4-9	657-658	a	_
4-10	659-665	minute	_
4-11	666-670	long	_
4-12	671-690	pattern-recognition	_
4-13	691-699	computer	_
4-14	700-704	task	_
4-15	704-705	.	_

#Text=Moreover, this connectivity analysis leads naturally to an optimal choice of electrodes and hence to highly statistically significant results that are based on data from only 3–5 electrodes.
5-1	706-714	Moreover	_
5-2	714-715	,	_
5-3	716-720	this	_
5-4	721-733	connectivity	_
5-5	734-742	analysis	_
5-6	743-748	leads	_
5-7	749-758	naturally	_
5-8	759-761	to	_
5-9	762-764	an	_
5-10	765-772	optimal	_
5-11	773-779	choice	_
5-12	780-782	of	_
5-13	783-793	electrodes	_
5-14	794-797	and	_
5-15	798-803	hence	_
5-16	804-806	to	_
5-17	807-813	highly	_
5-18	814-827	statistically	_
5-19	828-839	significant	_
5-20	840-847	results	_
5-21	848-852	that	_
5-22	853-856	are	_
5-23	857-862	based	_
5-24	863-865	on	_
5-25	866-870	data	_
5-26	871-875	from	_
5-27	876-880	only	_
5-28	881-882	3	_
5-29	882-883	–	_
5-30	883-884	5	_
5-31	885-895	electrodes	_
5-32	895-896	.	_

#Text=The method is general and can be used for the diagnosis of other psychiatric conditions, provided an appropriate computer task is devised.
#Text=1.
6-1	897-900	The	_
6-2	901-907	method	_
6-3	908-910	is	_
6-4	911-918	general	_
6-5	919-922	and	_
6-6	923-926	can	_
6-7	927-929	be	_
6-8	930-934	used	_
6-9	935-938	for	_
6-10	939-942	the	_
6-11	943-952	diagnosis	_
6-12	953-955	of	_
6-13	956-961	other	_
6-14	962-973	psychiatric	_
6-15	974-984	conditions	_
6-16	984-985	,	_
6-17	986-994	provided	_
6-18	995-997	an	_
6-19	998-1009	appropriate	_
6-20	1010-1018	computer	_
6-21	1019-1023	task	_
6-22	1024-1026	is	_
6-23	1027-1034	devised	_
6-24	1034-1035	.	_
6-25	1036-1037	1	_
6-26	1037-1038	.	_

#Text=Introduction
#Text=Electroencephalography (EEG) has become a preferred tool for general brain state interpretations, despite its low spatial resolution.
7-1	1039-1051	Introduction	_
7-2	1052-1074	Electroencephalography	_
7-3	1075-1076	(	_
7-4	1076-1079	EEG	_
7-5	1079-1080	)	_
7-6	1081-1084	has	_
7-7	1085-1091	become	_
7-8	1092-1093	a	_
7-9	1094-1103	preferred	_
7-10	1104-1108	tool	_
7-11	1109-1112	for	_
7-12	1113-1120	general	_
7-13	1121-1126	brain	_
7-14	1127-1132	state	_
7-15	1133-1148	interpretations	_
7-16	1148-1149	,	_
7-17	1150-1157	despite	_
7-18	1158-1161	its	_
7-19	1162-1165	low	_
7-20	1166-1173	spatial	_
7-21	1174-1184	resolution	_
7-22	1184-1185	.	_

#Text=The main alternative to the EEG for recording and analyzing brain activity is the MRI (or functional MRI), a high-resolution tool based on magnetic resonance.
8-1	1186-1189	The	_
8-2	1190-1194	main	_
8-3	1195-1206	alternative	_
8-4	1207-1209	to	_
8-5	1210-1213	the	_
8-6	1214-1217	EEG	_
8-7	1218-1221	for	_
8-8	1222-1231	recording	_
8-9	1232-1235	and	_
8-10	1236-1245	analyzing	_
8-11	1246-1251	brain	_
8-12	1252-1260	activity	_
8-13	1261-1263	is	_
8-14	1264-1267	the	_
8-15	1268-1271	MRI	_
8-16	1272-1273	(	_
8-17	1273-1275	or	_
8-18	1276-1286	functional	_
8-19	1287-1290	MRI	_
8-20	1290-1291	)	_
8-21	1291-1292	,	_
8-22	1293-1294	a	_
8-23	1295-1310	high-resolution	_
8-24	1311-1315	tool	_
8-25	1316-1321	based	_
8-26	1322-1324	on	_
8-27	1325-1333	magnetic	_
8-28	1334-1343	resonance	_
8-29	1343-1344	.	_

#Text=Although superior to the EEG in spatial resolution, fMRI-based recordings have poor temporal resolution (compared to EEG recordings), and the acquisition device is several thousand times more expensive.
9-1	1345-1353	Although	_
9-2	1354-1362	superior	_
9-3	1363-1365	to	_
9-4	1366-1369	the	_
9-5	1370-1373	EEG	_
9-6	1374-1376	in	_
9-7	1377-1384	spatial	_
9-8	1385-1395	resolution	_
9-9	1395-1396	,	_
9-10	1397-1407	fMRI-based	_
9-11	1408-1418	recordings	_
9-12	1419-1423	have	_
9-13	1424-1428	poor	_
9-14	1429-1437	temporal	_
9-15	1438-1448	resolution	_
9-16	1449-1450	(	_
9-17	1450-1458	compared	_
9-18	1459-1461	to	_
9-19	1462-1465	EEG	_
9-20	1466-1476	recordings	_
9-21	1476-1477	)	_
9-22	1477-1478	,	_
9-23	1479-1482	and	_
9-24	1483-1486	the	_
9-25	1487-1498	acquisition	_
9-26	1499-1505	device	_
9-27	1506-1508	is	_
9-28	1509-1516	several	_
9-29	1517-1525	thousand	_
9-30	1526-1531	times	_
9-31	1532-1536	more	_
9-32	1537-1546	expensive	_
9-33	1546-1547	.	_

#Text=It can only be used in clinical settings, is sensitive to the subjects’ movement and cannot be used for continuous brain state monitoring.
10-1	1548-1550	It	_
10-2	1551-1554	can	_
10-3	1555-1559	only	_
10-4	1560-1562	be	_
10-5	1563-1567	used	_
10-6	1568-1570	in	_
10-7	1571-1579	clinical	_
10-8	1580-1588	settings	_
10-9	1588-1589	,	_
10-10	1590-1592	is	_
10-11	1593-1602	sensitive	_
10-12	1603-1605	to	_
10-13	1606-1609	the	_
10-14	1610-1618	subjects	_
10-15	1618-1619	’	_
10-16	1620-1628	movement	_
10-17	1629-1632	and	_
10-18	1633-1639	cannot	_
10-19	1640-1642	be	_
10-20	1643-1647	used	_
10-21	1648-1651	for	_
10-22	1652-1662	continuous	_
10-23	1663-1668	brain	_
10-24	1669-1674	state	_
10-25	1675-1685	monitoring	_
10-26	1685-1686	.	_

#Text=Thus, analyses based on EEG recordings offer significant advantages and enable many applications.
11-1	1687-1691	Thus	_
11-2	1691-1692	,	_
11-3	1693-1701	analyses	_
11-4	1702-1707	based	_
11-5	1708-1710	on	_
11-6	1711-1714	EEG	_
11-7	1715-1725	recordings	_
11-8	1726-1731	offer	_
11-9	1732-1743	significant	_
11-10	1744-1754	advantages	_
11-11	1755-1758	and	_
11-12	1759-1765	enable	_
11-13	1766-1770	many	_
11-14	1771-1783	applications	_
11-15	1783-1784	.	_

#Text=Therefore, while analyses of network connectivity conducted to gain a broader knowledge of clinically relevant physiological attributes of mental disorders have largely been performed based on fMRI, using EEG data could be of tremendous use in medicine and research.
12-1	1785-1794	Therefore	_
12-2	1794-1795	,	_
12-3	1796-1801	while	_
12-4	1802-1810	analyses	_
12-5	1811-1813	of	_
12-6	1814-1821	network	_
12-7	1822-1834	connectivity	_
12-8	1835-1844	conducted	_
12-9	1845-1847	to	_
12-10	1848-1852	gain	_
12-11	1853-1854	a	_
12-12	1855-1862	broader	_
12-13	1863-1872	knowledge	_
12-14	1873-1875	of	_
12-15	1876-1886	clinically	_
12-16	1887-1895	relevant	_
12-17	1896-1909	physiological	_
12-18	1910-1920	attributes	_
12-19	1921-1923	of	_
12-20	1924-1930	mental	_
12-21	1931-1940	disorders	_
12-22	1941-1945	have	_
12-23	1946-1953	largely	_
12-24	1954-1958	been	_
12-25	1959-1968	performed	_
12-26	1969-1974	based	_
12-27	1975-1977	on	_
12-28	1978-1982	fMRI	_
12-29	1982-1983	,	_
12-30	1984-1989	using	_
12-31	1990-1993	EEG	_
12-32	1994-1998	data	_
12-33	1999-2004	could	_
12-34	2005-2007	be	_
12-35	2008-2010	of	_
12-36	2011-2021	tremendous	_
12-37	2022-2025	use	_
12-38	2026-2028	in	_
12-39	2029-2037	medicine	_
12-40	2038-2041	and	_
12-41	2042-2050	research	_
12-42	2050-2051	.	_

#Text=EEG data have primarily been regarded as complementary to fMRI data, , but more recently, the EEG has been used as a tool for the early detection of changes in general cognitive activity, for example, in emotional states , cognitive states , analysis of epileptic seizures  and autism .
13-1	2052-2055	EEG	_
13-2	2056-2060	data	_
13-3	2061-2065	have	_
13-4	2066-2075	primarily	_
13-5	2076-2080	been	_
13-6	2081-2089	regarded	_
13-7	2090-2092	as	_
13-8	2093-2106	complementary	_
13-9	2107-2109	to	_
13-10	2110-2114	fMRI	_
13-11	2115-2119	data	_
13-12	2119-2120	,	_
13-13	2121-2122	,	_
13-14	2123-2126	but	_
13-15	2127-2131	more	_
13-16	2132-2140	recently	_
13-17	2140-2141	,	_
13-18	2142-2145	the	_
13-19	2146-2149	EEG	_
13-20	2150-2153	has	_
13-21	2154-2158	been	_
13-22	2159-2163	used	_
13-23	2164-2166	as	_
13-24	2167-2168	a	_
13-25	2169-2173	tool	_
13-26	2174-2177	for	_
13-27	2178-2181	the	_
13-28	2182-2187	early	_
13-29	2188-2197	detection	_
13-30	2198-2200	of	_
13-31	2201-2208	changes	_
13-32	2209-2211	in	_
13-33	2212-2219	general	_
13-34	2220-2229	cognitive	_
13-35	2230-2238	activity	_
13-36	2238-2239	,	_
13-37	2240-2243	for	_
13-38	2244-2251	example	_
13-39	2251-2252	,	_
13-40	2253-2255	in	_
13-41	2256-2265	emotional	_
13-42	2266-2272	states	_
13-43	2273-2274	,	_
13-44	2275-2284	cognitive	_
13-45	2285-2291	states	_
13-46	2292-2293	,	_
13-47	2294-2302	analysis	_
13-48	2303-2305	of	_
13-49	2306-2315	epileptic	_
13-50	2316-2324	seizures	_
13-51	2326-2329	and	_
13-52	2330-2336	autism	_
13-53	2337-2338	.	_

#Text=Other recent EEG applications have been in the area of brain-machine interfaces .
14-1	2339-2344	Other	_
14-2	2345-2351	recent	_
14-3	2352-2355	EEG	_
14-4	2356-2368	applications	_
14-5	2369-2373	have	_
14-6	2374-2378	been	_
14-7	2379-2381	in	_
14-8	2382-2385	the	_
14-9	2386-2390	area	_
14-10	2391-2393	of	_
14-11	2394-2407	brain-machine	_
14-12	2408-2418	interfaces	_
14-13	2419-2420	.	_

#Text=EEG studies have suggested that changes in functional connectivity occur in schizophrenia patients , and a significant difference in theta-frequency activity has been found, as well .
15-1	2421-2424	EEG	_
15-2	2425-2432	studies	_
15-3	2433-2437	have	_
15-4	2438-2447	suggested	_
15-5	2448-2452	that	_
15-6	2453-2460	changes	_
15-7	2461-2463	in	_
15-8	2464-2474	functional	_
15-9	2475-2487	connectivity	_
15-10	2488-2493	occur	_
15-11	2494-2496	in	_
15-12	2497-2510	schizophrenia	_
15-13	2511-2519	patients	_
15-14	2520-2521	,	_
15-15	2522-2525	and	_
15-16	2526-2527	a	_
15-17	2528-2539	significant	_
15-18	2540-2550	difference	_
15-19	2551-2553	in	_
15-20	2554-2569	theta-frequency	_
15-21	2570-2578	activity	_
15-22	2579-2582	has	_
15-23	2583-2587	been	_
15-24	2588-2593	found	_
15-25	2593-2594	,	_
15-26	2595-2597	as	_
15-27	2598-2602	well	_
15-28	2603-2604	.	_

#Text=Recent studies suggest that a single- or few- electrode approach may be used to classify changes in schizophrenia  and that single trial-based analysis may be used to characterize emotional states .
16-1	2605-2611	Recent	_
16-2	2612-2619	studies	_
16-3	2620-2627	suggest	_
16-4	2628-2632	that	_
16-5	2633-2634	a	_
16-6	2635-2641	single	_
16-7	2641-2642	-	_
16-8	2643-2645	or	_
16-9	2646-2649	few	_
16-10	2649-2650	-	_
16-11	2651-2660	electrode	_
16-12	2661-2669	approach	_
16-13	2670-2673	may	_
16-14	2674-2676	be	_
16-15	2677-2681	used	_
16-16	2682-2684	to	_
16-17	2685-2693	classify	_
16-18	2694-2701	changes	_
16-19	2702-2704	in	_
16-20	2705-2718	schizophrenia	_
16-21	2720-2723	and	_
16-22	2724-2728	that	_
16-23	2729-2735	single	_
16-24	2736-2747	trial-based	_
16-25	2748-2756	analysis	_
16-26	2757-2760	may	_
16-27	2761-2763	be	_
16-28	2764-2768	used	_
16-29	2769-2771	to	_
16-30	2772-2784	characterize	_
16-31	2785-2794	emotional	_
16-32	2795-2801	states	_
16-33	2802-2803	.	_

#Text=As connectivity research using fMRI has become common in analyzing mental pathologies  including resting state schizophrenia demonstrating strong discrimination , it has inspired the study of EEG-based connectivity analysis.
17-1	2804-2806	As	_
17-2	2807-2819	connectivity	_
17-3	2820-2828	research	_
17-4	2829-2834	using	_
17-5	2835-2839	fMRI	_
17-6	2840-2843	has	_
17-7	2844-2850	become	_
17-8	2851-2857	common	_
17-9	2858-2860	in	_
17-10	2861-2870	analyzing	_
17-11	2871-2877	mental	_
17-12	2878-2889	pathologies	_
17-13	2891-2900	including	_
17-14	2901-2908	resting	_
17-15	2909-2914	state	_
17-16	2915-2928	schizophrenia	_
17-17	2929-2942	demonstrating	_
17-18	2943-2949	strong	_
17-19	2950-2964	discrimination	_
17-20	2965-2966	,	_
17-21	2967-2969	it	_
17-22	2970-2973	has	_
17-23	2974-2982	inspired	_
17-24	2983-2986	the	_
17-25	2987-2992	study	_
17-26	2993-2995	of	_
17-27	2996-3005	EEG-based	_
17-28	3006-3018	connectivity	_
17-29	3019-3027	analysis	_
17-30	3027-3028	.	_

#Text=In particular, EEG enables finer temporal connectivity analysis.
18-1	3029-3031	In	_
18-2	3032-3042	particular	_
18-3	3042-3043	,	_
18-4	3044-3047	EEG	_
18-5	3048-3055	enables	_
18-6	3056-3061	finer	_
18-7	3062-3070	temporal	_
18-8	3071-3083	connectivity	_
18-9	3084-3092	analysis	_
18-10	3092-3093	.	_

#Text=Motivated by fMRI, multiple-electrode methodologies tend to look for the most relevant connections based on a dense configuration .
19-1	3094-3103	Motivated	_
19-2	3104-3106	by	_
19-3	3107-3111	fMRI	_
19-4	3111-3112	,	_
19-5	3113-3131	multiple-electrode	_
19-6	3132-3145	methodologies	_
19-7	3146-3150	tend	_
19-8	3151-3153	to	_
19-9	3154-3158	look	_
19-10	3159-3162	for	_
19-11	3163-3166	the	_
19-12	3167-3171	most	_
19-13	3172-3180	relevant	_
19-14	3181-3192	connections	_
19-15	3193-3198	based	_
19-16	3199-3201	on	_
19-17	3202-3203	a	_
19-18	3204-3209	dense	_
19-19	3210-3223	configuration	_
19-20	3224-3225	.	_

#Text=More recent work has attempted to examine all possible direct connections between electrodes to enable real-time clinical diagnosis .
20-1	3226-3230	More	_
20-2	3231-3237	recent	_
20-3	3238-3242	work	_
20-4	3243-3246	has	_
20-5	3247-3256	attempted	_
20-6	3257-3259	to	_
20-7	3260-3267	examine	_
20-8	3268-3271	all	_
20-9	3272-3280	possible	_
20-10	3281-3287	direct	_
20-11	3288-3299	connections	_
20-12	3300-3307	between	_
20-13	3308-3318	electrodes	_
20-14	3319-3321	to	_
20-15	3322-3328	enable	_
20-16	3329-3338	real-time	_
20-17	3339-3347	clinical	_
20-18	3348-3357	diagnosis	_
20-19	3358-3359	.	_

#Text=A recent connectivity study of resting EEG networks successfully demonstrated the ability to discriminate between Psychogenic non-epileptic seizures (PNES) and Epilepsy .
21-1	3360-3361	A	_
21-2	3362-3368	recent	_
21-3	3369-3381	connectivity	_
21-4	3382-3387	study	_
21-5	3388-3390	of	_
21-6	3391-3398	resting	_
21-7	3399-3402	EEG	_
21-8	3403-3411	networks	_
21-9	3412-3424	successfully	_
21-10	3425-3437	demonstrated	_
21-11	3438-3441	the	_
21-12	3442-3449	ability	_
21-13	3450-3452	to	_
21-14	3453-3465	discriminate	_
21-15	3466-3473	between	_
21-16	3474-3485	Psychogenic	_
21-17	3486-3499	non-epileptic	_
21-18	3500-3508	seizures	_
21-19	3509-3510	(	_
21-20	3510-3514	PNES	_
21-21	3514-3515	)	_
21-22	3516-3519	and	_
21-23	3520-3528	Epilepsy	_
21-24	3529-3530	.	_

#Text=The present study is inspired by feature-connectivity research that is based solely on EEG recordings.
22-1	3531-3534	The	_
22-2	3535-3542	present	_
22-3	3543-3548	study	_
22-4	3549-3551	is	_
22-5	3552-3560	inspired	_
22-6	3561-3563	by	_
22-7	3564-3584	feature-connectivity	_
22-8	3585-3593	research	_
22-9	3594-3598	that	_
22-10	3599-3601	is	_
22-11	3602-3607	based	_
22-12	3608-3614	solely	_
22-13	3615-3617	on	_
22-14	3618-3621	EEG	_
22-15	3622-3632	recordings	_
22-16	3632-3633	.	_

#Text=We describe a novel connectivity analysis tool—Connectivity Maps—for the analysis of connectivity between nodes.
23-1	3634-3636	We	_
23-2	3637-3645	describe	_
23-3	3646-3647	a	_
23-4	3648-3653	novel	_
23-5	3654-3666	connectivity	_
23-6	3667-3675	analysis	_
23-7	3676-3693	tool—Connectivity	_
23-8	3694-3702	Maps—for	_
23-9	3703-3706	the	_
23-10	3707-3715	analysis	_
23-11	3716-3718	of	_
23-12	3719-3731	connectivity	_
23-13	3732-3739	between	_
23-14	3740-3745	nodes	_
23-15	3745-3746	.	_

#Text=The main difference between this method and conventional connectivity analysis  is that the connectivity between nodes is measured in terms of the connectivity between each node and a third, reference node.
24-1	3747-3750	The	_
24-2	3751-3755	main	_
24-3	3756-3766	difference	_
24-4	3767-3774	between	_
24-5	3775-3779	this	_
24-6	3780-3786	method	_
24-7	3787-3790	and	_
24-8	3791-3803	conventional	_
24-9	3804-3816	connectivity	_
24-10	3817-3825	analysis	_
24-11	3827-3829	is	_
24-12	3830-3834	that	_
24-13	3835-3838	the	_
24-14	3839-3851	connectivity	_
24-15	3852-3859	between	_
24-16	3860-3865	nodes	_
24-17	3866-3868	is	_
24-18	3869-3877	measured	_
24-19	3878-3880	in	_
24-20	3881-3886	terms	_
24-21	3887-3889	of	_
24-22	3890-3893	the	_
24-23	3894-3906	connectivity	_
24-24	3907-3914	between	_
24-25	3915-3919	each	_
24-26	3920-3924	node	_
24-27	3925-3928	and	_
24-28	3929-3930	a	_
24-29	3931-3936	third	_
24-30	3936-3937	,	_
24-31	3938-3947	reference	_
24-32	3948-3952	node	_
24-33	3952-3953	.	_

#Text=In connectivity analysis, a total of n2 maps are created (n from each source electrode), and the largest changes between each pair of electrodes are determined.
25-1	3954-3956	In	_
25-2	3957-3969	connectivity	_
25-3	3970-3978	analysis	_
25-4	3978-3979	,	_
25-5	3980-3981	a	_
25-6	3982-3987	total	_
25-7	3988-3990	of	_
25-8	3991-3993	n2	_
25-9	3994-3998	maps	_
25-10	3999-4002	are	_
25-11	4003-4010	created	_
25-12	4011-4012	(	_
25-13	4012-4013	n	_
25-14	4014-4018	from	_
25-15	4019-4023	each	_
25-16	4024-4030	source	_
25-17	4031-4040	electrode	_
25-18	4040-4041	)	_
25-19	4041-4042	,	_
25-20	4043-4046	and	_
25-21	4047-4050	the	_
25-22	4051-4058	largest	_
25-23	4059-4066	changes	_
25-24	4067-4074	between	_
25-25	4075-4079	each	_
25-26	4080-4084	pair	_
25-27	4085-4087	of	_
25-28	4088-4098	electrodes	_
25-29	4099-4102	are	_
25-30	4103-4113	determined	_
25-31	4113-4114	.	_

#Text=Thus, the properties obtained using such an approach enrich the current direct perception of connectivity.
26-1	4115-4119	Thus	_
26-2	4119-4120	,	_
26-3	4121-4124	the	_
26-4	4125-4135	properties	_
26-5	4136-4144	obtained	_
26-6	4145-4150	using	_
26-7	4151-4155	such	_
26-8	4156-4158	an	_
26-9	4159-4167	approach	_
26-10	4168-4174	enrich	_
26-11	4175-4178	the	_
26-12	4179-4186	current	_
26-13	4187-4193	direct	_
26-14	4194-4204	perception	_
26-15	4205-4207	of	_
26-16	4208-4220	connectivity	_
26-17	4220-4221	.	_

#Text=This methodology is demonstrated using data from schizophrenia patients that has been examined previously .
27-1	4222-4226	This	_
27-2	4227-4238	methodology	_
27-3	4239-4241	is	_
27-4	4242-4254	demonstrated	_
27-5	4255-4260	using	_
27-6	4261-4265	data	_
27-7	4266-4270	from	_
27-8	4271-4284	schizophrenia	_
27-9	4285-4293	patients	_
27-10	4294-4298	that	_
27-11	4299-4302	has	_
27-12	4303-4307	been	_
27-13	4308-4316	examined	_
27-14	4317-4327	previously	_
27-15	4328-4329	.	_

#Text=Applying the proposed methodology to this data set improved the ability to discriminate between patients and healthy controls and provided insight into physiological aspects of this disease.
#Text=2 Methodology – A novel measure of connectivity
#Text=2.1 –Connectivity maps
#Text=The motivation for the proposed connectivity analysis is best explained by the following analysis of airline traffic.
28-1	4330-4338	Applying	_
28-2	4339-4342	the	_
28-3	4343-4351	proposed	_
28-4	4352-4363	methodology	_
28-5	4364-4366	to	_
28-6	4367-4371	this	_
28-7	4372-4376	data	_
28-8	4377-4380	set	_
28-9	4381-4389	improved	_
28-10	4390-4393	the	_
28-11	4394-4401	ability	_
28-12	4402-4404	to	_
28-13	4405-4417	discriminate	_
28-14	4418-4425	between	_
28-15	4426-4434	patients	_
28-16	4435-4438	and	_
28-17	4439-4446	healthy	_
28-18	4447-4455	controls	_
28-19	4456-4459	and	_
28-20	4460-4468	provided	_
28-21	4469-4476	insight	_
28-22	4477-4481	into	_
28-23	4482-4495	physiological	_
28-24	4496-4503	aspects	_
28-25	4504-4506	of	_
28-26	4507-4511	this	_
28-27	4512-4519	disease	_
28-28	4519-4520	.	_
28-29	4521-4522	2	_
28-30	4523-4534	Methodology	http://www.case.edu/ProvCaRe/provcare#StudyMethod
28-31	4535-4536	–	_
28-32	4537-4538	A	_
28-33	4539-4544	novel	_
28-34	4545-4552	measure	_
28-35	4553-4555	of	_
28-36	4556-4568	connectivity	_
28-37	4569-4572	2.1	_
28-38	4573-4574	–	_
28-39	4574-4586	Connectivity	_
28-40	4587-4591	maps	_
28-41	4592-4595	The	_
28-42	4596-4606	motivation	_
28-43	4607-4610	for	_
28-44	4611-4614	the	_
28-45	4615-4623	proposed	_
28-46	4624-4636	connectivity	_
28-47	4637-4645	analysis	_
28-48	4646-4648	is	_
28-49	4649-4653	best	_
28-50	4654-4663	explained	_
28-51	4664-4666	by	_
28-52	4667-4670	the	_
28-53	4671-4680	following	_
28-54	4681-4689	analysis	_
28-55	4690-4692	of	_
28-56	4693-4700	airline	_
28-57	4701-4708	traffic	_
28-58	4708-4709	.	_

#Text=Consider the air traffic from BOS to ATL and BOS to DEN.
29-1	4710-4718	Consider	_
29-2	4719-4722	the	_
29-3	4723-4726	air	_
29-4	4727-4734	traffic	_
29-5	4735-4739	from	_
29-6	4740-4743	BOS	_
29-7	4744-4746	to	_
29-8	4747-4750	ATL	_
29-9	4751-4754	and	_
29-10	4755-4758	BOS	_
29-11	4759-4761	to	_
29-12	4762-4765	DEN	_
29-13	4765-4766	.	_

#Text=A classical connectivity analysis of the nodes ATL and DEN would examine the connection between these two cities.
30-1	4767-4768	A	_
30-2	4769-4778	classical	_
30-3	4779-4791	connectivity	_
30-4	4792-4800	analysis	_
30-5	4801-4803	of	_
30-6	4804-4807	the	_
30-7	4808-4813	nodes	_
30-8	4814-4817	ATL	_
30-9	4818-4821	and	_
30-10	4822-4825	DEN	_
30-11	4826-4831	would	_
30-12	4832-4839	examine	_
30-13	4840-4843	the	_
30-14	4844-4854	connection	_
30-15	4855-4862	between	_
30-16	4863-4868	these	_
30-17	4869-4872	two	_
30-18	4873-4879	cities	_
30-19	4879-4880	.	_

#Text=For the sake of argument, let us assume that all the flights of a certain airline from BOS to DEN go through ATL.
31-1	4881-4884	For	_
31-2	4885-4888	the	_
31-3	4889-4893	sake	_
31-4	4894-4896	of	_
31-5	4897-4905	argument	_
31-6	4905-4906	,	_
31-7	4907-4910	let	_
31-8	4911-4913	us	_
31-9	4914-4920	assume	_
31-10	4921-4925	that	_
31-11	4926-4929	all	_
31-12	4930-4933	the	_
31-13	4934-4941	flights	_
31-14	4942-4944	of	_
31-15	4945-4946	a	_
31-16	4947-4954	certain	_
31-17	4955-4962	airline	_
31-18	4963-4967	from	_
31-19	4968-4971	BOS	_
31-20	4972-4974	to	_
31-21	4975-4978	DEN	_
31-22	4979-4981	go	_
31-23	4982-4989	through	_
31-24	4990-4993	ATL	_
31-25	4993-4994	.	_

#Text=We consider a more refined, high dimensional notion of connectivity by analyzing the changes in connectivity between ATL and DEN with reference to flights that emanated from other locations, such as BOS.
32-1	4995-4997	We	_
32-2	4998-5006	consider	_
32-3	5007-5008	a	_
32-4	5009-5013	more	_
32-5	5014-5021	refined	_
32-6	5021-5022	,	_
32-7	5023-5027	high	_
32-8	5028-5039	dimensional	_
32-9	5040-5046	notion	_
32-10	5047-5049	of	_
32-11	5050-5062	connectivity	_
32-12	5063-5065	by	_
32-13	5066-5075	analyzing	_
32-14	5076-5079	the	_
32-15	5080-5087	changes	_
32-16	5088-5090	in	_
32-17	5091-5103	connectivity	_
32-18	5104-5111	between	_
32-19	5112-5115	ATL	_
32-20	5116-5119	and	_
32-21	5120-5123	DEN	_
32-22	5124-5128	with	_
32-23	5129-5138	reference	_
32-24	5139-5141	to	_
32-25	5142-5149	flights	_
32-26	5150-5154	that	_
32-27	5155-5163	emanated	_
32-28	5164-5168	from	_
32-29	5169-5174	other	_
32-30	5175-5184	locations	_
32-31	5184-5185	,	_
32-32	5186-5190	such	_
32-33	5191-5193	as	_
32-34	5194-5197	BOS	_
32-35	5197-5198	.	_

#Text=By observing that there was a reduction in connectivity between BOS and DEN but no change in or even an increase in connectivity between BOS and ATL.
33-1	5199-5201	By	_
33-2	5202-5211	observing	_
33-3	5212-5216	that	_
33-4	5217-5222	there	_
33-5	5223-5226	was	_
33-6	5227-5228	a	_
33-7	5229-5238	reduction	_
33-8	5239-5241	in	_
33-9	5242-5254	connectivity	_
33-10	5255-5262	between	_
33-11	5263-5266	BOS	_
33-12	5267-5270	and	_
33-13	5271-5274	DEN	_
33-14	5275-5278	but	_
33-15	5279-5281	no	_
33-16	5282-5288	change	_
33-17	5289-5291	in	_
33-18	5292-5294	or	_
33-19	5295-5299	even	_
33-20	5300-5302	an	_
33-21	5303-5311	increase	_
33-22	5312-5314	in	_
33-23	5315-5327	connectivity	_
33-24	5328-5335	between	_
33-25	5336-5339	BOS	_
33-26	5340-5343	and	_
33-27	5344-5347	ATL	_
33-28	5347-5348	.	_

#Text=In other words, we may observe that when the flights of one airline company that flies from BOS to DEN via ATL are canceled, it is possible that those passengers book alternative flights with another carrier due to the cancellations.
34-1	5349-5351	In	_
34-2	5352-5357	other	_
34-3	5358-5363	words	_
34-4	5363-5364	,	_
34-5	5365-5367	we	_
34-6	5368-5371	may	_
34-7	5372-5379	observe	_
34-8	5380-5384	that	_
34-9	5385-5389	when	_
34-10	5390-5393	the	_
34-11	5394-5401	flights	_
34-12	5402-5404	of	_
34-13	5405-5408	one	_
34-14	5409-5416	airline	_
34-15	5417-5424	company	_
34-16	5425-5429	that	_
34-17	5430-5435	flies	_
34-18	5436-5440	from	_
34-19	5441-5444	BOS	_
34-20	5445-5447	to	_
34-21	5448-5451	DEN	_
34-22	5452-5455	via	_
34-23	5456-5459	ATL	_
34-24	5460-5463	are	_
34-25	5464-5472	canceled	_
34-26	5472-5473	,	_
34-27	5474-5476	it	_
34-28	5477-5479	is	_
34-29	5480-5488	possible	_
34-30	5489-5493	that	_
34-31	5494-5499	those	_
34-32	5500-5510	passengers	_
34-33	5511-5515	book	_
34-34	5516-5527	alternative	_
34-35	5528-5535	flights	_
34-36	5536-5540	with	_
34-37	5541-5548	another	_
34-38	5549-5556	carrier	_
34-39	5557-5560	due	_
34-40	5561-5563	to	_
34-41	5564-5567	the	_
34-42	5568-5581	cancellations	_
34-43	5581-5582	.	_

#Text=Note that the traffic between ATL and DEN includes flights by all other carriers; thus, it would be difficult to observe the reduction in traffic due to cancellations by a single carrier.
35-1	5583-5587	Note	_
35-2	5588-5592	that	_
35-3	5593-5596	the	_
35-4	5597-5604	traffic	_
35-5	5605-5612	between	_
35-6	5613-5616	ATL	_
35-7	5617-5620	and	_
35-8	5621-5624	DEN	_
35-9	5625-5633	includes	_
35-10	5634-5641	flights	_
35-11	5642-5644	by	_
35-12	5645-5648	all	_
35-13	5649-5654	other	_
35-14	5655-5663	carriers	_
35-15	5663-5664	;	_
35-16	5665-5669	thus	_
35-17	5669-5670	,	_
35-18	5671-5673	it	_
35-19	5674-5679	would	_
35-20	5680-5682	be	_
35-21	5683-5692	difficult	_
35-22	5693-5695	to	_
35-23	5696-5703	observe	_
35-24	5704-5707	the	_
35-25	5708-5717	reduction	_
35-26	5718-5720	in	_
35-27	5721-5728	traffic	_
35-28	5729-5732	due	_
35-29	5733-5735	to	_
35-30	5736-5749	cancellations	_
35-31	5750-5752	by	_
35-32	5753-5754	a	_
35-33	5755-5761	single	_
35-34	5762-5769	carrier	_
35-35	5769-5770	.	_

#Text=By finding a city, BOS, from which a given carrier’s flights to DEN only go through ATL, a cancellation becomes more apparent.
36-1	5771-5773	By	_
36-2	5774-5781	finding	_
36-3	5782-5783	a	_
36-4	5784-5788	city	_
36-5	5788-5789	,	_
36-6	5790-5793	BOS	_
36-7	5793-5794	,	_
36-8	5795-5799	from	_
36-9	5800-5805	which	_
36-10	5806-5807	a	_
36-11	5808-5813	given	_
36-12	5814-5821	carrier	_
36-13	5821-5822	’	_
36-14	5822-5823	s	_
36-15	5824-5831	flights	_
36-16	5832-5834	to	_
36-17	5835-5838	DEN	_
36-18	5839-5843	only	_
36-19	5844-5846	go	_
36-20	5847-5854	through	_
36-21	5855-5858	ATL	_
36-22	5858-5859	,	_
36-23	5860-5861	a	_
36-24	5862-5874	cancellation	_
36-25	5875-5882	becomes	_
36-26	5883-5887	more	_
36-27	5888-5896	apparent	_
36-28	5896-5897	.	_

#Text=In Electroencephalography, such technique may reveal the same type of significant insights, while the nodes in this case are simply the electrodes placed on the scalp and a reference-based connectivity function is required to measure the relationships between them.
37-1	5898-5900	In	_
37-2	5901-5923	Electroencephalography	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
37-3	5923-5924	,	_
37-4	5925-5929	such	_
37-5	5930-5939	technique	_
37-6	5940-5943	may	_
37-7	5944-5950	reveal	_
37-8	5951-5954	the	_
37-9	5955-5959	same	_
37-10	5960-5964	type	_
37-11	5965-5967	of	_
37-12	5968-5979	significant	_
37-13	5980-5988	insights	_
37-14	5988-5989	,	_
37-15	5990-5995	while	_
37-16	5996-5999	the	_
37-17	6000-6005	nodes	_
37-18	6006-6008	in	_
37-19	6009-6013	this	_
37-20	6014-6018	case	_
37-21	6019-6022	are	_
37-22	6023-6029	simply	_
37-23	6030-6033	the	_
37-24	6034-6044	electrodes	_
37-25	6045-6051	placed	_
37-26	6052-6054	on	_
37-27	6055-6058	the	_
37-28	6059-6064	scalp	_
37-29	6065-6068	and	_
37-30	6069-6070	a	_
37-31	6071-6086	reference-based	_
37-32	6087-6099	connectivity	_
37-33	6100-6108	function	_
37-34	6109-6111	is	_
37-35	6112-6120	required	_
37-36	6121-6123	to	_
37-37	6124-6131	measure	_
37-38	6132-6135	the	_
37-39	6136-6149	relationships	_
37-40	6150-6157	between	_
37-41	6158-6162	them	_
37-42	6162-6163	.	_

#Text=Therefore, in the same way, we analyze the connectivity between electrodes A and B (Fig 1) by examining either the direct connectivity or information transfer between A and B (left panel) or the induced change in connectivity between A and B, as seen by the change in the information transfer between reference electrode C and A with respect to the information transfer between C and B.
38-1	6164-6173	Therefore	_
38-2	6173-6174	,	_
38-3	6175-6177	in	_
38-4	6178-6181	the	_
38-5	6182-6186	same	_
38-6	6187-6190	way	_
38-7	6190-6191	,	_
38-8	6192-6194	we	_
38-9	6195-6202	analyze	_
38-10	6203-6206	the	_
38-11	6207-6219	connectivity	_
38-12	6220-6227	between	_
38-13	6228-6238	electrodes	_
38-14	6239-6240	A	_
38-15	6241-6244	and	_
38-16	6245-6246	B	_
38-17	6247-6248	(	_
38-18	6248-6251	Fig	_
38-19	6252-6253	1	_
38-20	6253-6254	)	_
38-21	6255-6257	by	_
38-22	6258-6267	examining	_
38-23	6268-6274	either	_
38-24	6275-6278	the	_
38-25	6279-6285	direct	_
38-26	6286-6298	connectivity	_
38-27	6299-6301	or	_
38-28	6302-6313	information	_
38-29	6314-6322	transfer	_
38-30	6323-6330	between	_
38-31	6331-6332	A	_
38-32	6333-6336	and	_
38-33	6337-6338	B	_
38-34	6339-6340	(	_
38-35	6340-6344	left	_
38-36	6345-6350	panel	_
38-37	6350-6351	)	_
38-38	6352-6354	or	_
38-39	6355-6358	the	_
38-40	6359-6366	induced	_
38-41	6367-6373	change	_
38-42	6374-6376	in	_
38-43	6377-6389	connectivity	_
38-44	6390-6397	between	_
38-45	6398-6399	A	_
38-46	6400-6403	and	_
38-47	6404-6405	B	_
38-48	6405-6406	,	_
38-49	6407-6409	as	_
38-50	6410-6414	seen	_
38-51	6415-6417	by	_
38-52	6418-6421	the	_
38-53	6422-6428	change	_
38-54	6429-6431	in	_
38-55	6432-6435	the	_
38-56	6436-6447	information	_
38-57	6448-6456	transfer	_
38-58	6457-6464	between	_
38-59	6465-6474	reference	_
38-60	6475-6484	electrode	_
38-61	6485-6486	C	_
38-62	6487-6490	and	_
38-63	6491-6492	A	_
38-64	6493-6497	with	_
38-65	6498-6505	respect	_
38-66	6506-6508	to	_
38-67	6509-6512	the	_
38-68	6513-6524	information	_
38-69	6525-6533	transfer	_
38-70	6534-6541	between	_
38-71	6542-6543	C	_
38-72	6544-6547	and	_
38-73	6548-6549	B	_
38-74	6549-6550	.	_

#Text=In addition to the direct connectivity approach (left panel), the connectivity maps approach brings features involving a reference electrode when addressing bi-electrode connectivity.
39-1	6551-6553	In	_
39-2	6554-6562	addition	_
39-3	6563-6565	to	_
39-4	6566-6569	the	_
39-5	6570-6576	direct	_
39-6	6577-6589	connectivity	_
39-7	6590-6598	approach	_
39-8	6599-6600	(	_
39-9	6600-6604	left	_
39-10	6605-6610	panel	_
39-11	6610-6611	)	_
39-12	6611-6612	,	_
39-13	6613-6616	the	_
39-14	6617-6629	connectivity	_
39-15	6630-6634	maps	_
39-16	6635-6643	approach	_
39-17	6644-6650	brings	_
39-18	6651-6659	features	_
39-19	6660-6669	involving	_
39-20	6670-6671	a	_
39-21	6672-6681	reference	_
39-22	6682-6691	electrode	_
39-23	6692-6696	when	_
39-24	6697-6707	addressing	_
39-25	6708-6720	bi-electrode	_
39-26	6721-6733	connectivity	_
39-27	6733-6734	.	_

#Text=Adding such an electrode expands the connectivity approach, as the relative changes in connectivity are uncovered.
40-1	6735-6741	Adding	_
40-2	6742-6746	such	_
40-3	6747-6749	an	_
40-4	6750-6759	electrode	_
40-5	6760-6767	expands	_
40-6	6768-6771	the	_
40-7	6772-6784	connectivity	_
40-8	6785-6793	approach	_
40-9	6793-6794	,	_
40-10	6795-6797	as	_
40-11	6798-6801	the	_
40-12	6802-6810	relative	_
40-13	6811-6818	changes	_
40-14	6819-6821	in	_
40-15	6822-6834	connectivity	_
40-16	6835-6838	are	_
40-17	6839-6848	uncovered	_
40-18	6848-6849	.	_

#Text=Our proposed discrimination and classification mechanism is based on a novel connectivity analysis tool that we term “Connectivity Maps”.
41-1	6850-6853	Our	_
41-2	6854-6862	proposed	_
41-3	6863-6877	discrimination	_
41-4	6878-6881	and	_
41-5	6882-6896	classification	_
41-6	6897-6906	mechanism	_
41-7	6907-6909	is	_
41-8	6910-6915	based	_
41-9	6916-6918	on	_
41-10	6919-6920	a	_
41-11	6921-6926	novel	_
41-12	6927-6939	connectivity	_
41-13	6940-6948	analysis	_
41-14	6949-6953	tool	_
41-15	6954-6958	that	_
41-16	6959-6961	we	_
41-17	6962-6966	term	_
41-18	6967-6968	“	_
41-19	6968-6980	Connectivity	_
41-20	6981-6985	Maps	_
41-21	6985-6986	”	_
41-22	6986-6987	.	_

#Text=These maps are generated in a relatively simple process that consists of the following 6 steps:
#Text=Several preprocessing tasks are performed, and the raw signals are broken into relevant intervals.
42-1	6988-6993	These	_
42-2	6994-6998	maps	_
42-3	6999-7002	are	_
42-4	7003-7012	generated	_
42-5	7013-7015	in	_
42-6	7016-7017	a	_
42-7	7018-7028	relatively	_
42-8	7029-7035	simple	_
42-9	7036-7043	process	_
42-10	7044-7048	that	_
42-11	7049-7057	consists	_
42-12	7058-7060	of	_
42-13	7061-7064	the	_
42-14	7065-7074	following	_
42-15	7075-7076	6	_
42-16	7077-7082	steps	_
42-17	7082-7083	:	_
42-18	7084-7091	Several	_
42-19	7092-7105	preprocessing	_
42-20	7106-7111	tasks	_
42-21	7112-7115	are	_
42-22	7116-7125	performed	_
42-23	7125-7126	,	_
42-24	7127-7130	and	_
42-25	7131-7134	the	_
42-26	7135-7138	raw	_
42-27	7139-7146	signals	_
42-28	7147-7150	are	_
42-29	7151-7157	broken	_
42-30	7158-7162	into	_
42-31	7163-7171	relevant	_
42-32	7172-7181	intervals	_
42-33	7181-7182	.	_

#Text=Technical description of the preprocessing phase is detailed below under “Experimental Setup”.
43-1	7183-7192	Technical	_
43-2	7193-7204	description	_
43-3	7205-7207	of	_
43-4	7208-7211	the	_
43-5	7212-7225	preprocessing	_
43-6	7226-7231	phase	_
43-7	7232-7234	is	_
43-8	7235-7243	detailed	_
43-9	7244-7249	below	_
43-10	7250-7255	under	_
43-11	7256-7257	“	_
43-12	7257-7269	Experimental	_
43-13	7270-7275	Setup	_
43-14	7275-7276	”	_
43-15	7276-7277	.	_

#Text=The signal in several frequency bands is decomposed and reconstructed, and then time windows that maximize the correlation between electrodes are sought.
44-1	7278-7281	The	_
44-2	7282-7288	signal	_
44-3	7289-7291	in	_
44-4	7292-7299	several	_
44-5	7300-7309	frequency	_
44-6	7310-7315	bands	_
44-7	7316-7318	is	_
44-8	7319-7329	decomposed	_
44-9	7330-7333	and	_
44-10	7334-7347	reconstructed	_
44-11	7347-7348	,	_
44-12	7349-7352	and	_
44-13	7353-7357	then	_
44-14	7358-7362	time	_
44-15	7363-7370	windows	_
44-16	7371-7375	that	_
44-17	7376-7384	maximize	_
44-18	7385-7388	the	_
44-19	7389-7400	correlation	_
44-20	7401-7408	between	_
44-21	7409-7419	electrodes	_
44-22	7420-7423	are	_
44-23	7424-7430	sought	_
44-24	7430-7431	.	_

#Text=A network of correlations with respect to different base or reference electrodes is constructed.
45-1	7432-7433	A	_
45-2	7434-7441	network	_
45-3	7442-7444	of	_
45-4	7445-7457	correlations	_
45-5	7458-7462	with	_
45-6	7463-7470	respect	_
45-7	7471-7473	to	_
45-8	7474-7483	different	_
45-9	7484-7488	base	_
45-10	7489-7491	or	_
45-11	7492-7501	reference	_
45-12	7502-7512	electrodes	_
45-13	7513-7515	is	_
45-14	7516-7527	constructed	_
45-15	7527-7528	.	_

#Text=Fisher-based feature extraction (See below definitions for Fisher and Relative Fisher matrices) from the set of connectivity maps obtained for the different reference electrodes is performed.
46-1	7529-7541	Fisher-based	_
46-2	7542-7549	feature	_
46-3	7550-7560	extraction	_
46-4	7561-7562	(	_
46-5	7562-7565	See	_
46-6	7566-7571	below	_
46-7	7572-7583	definitions	_
46-8	7584-7587	for	_
46-9	7588-7594	Fisher	_
46-10	7595-7598	and	_
46-11	7599-7607	Relative	_
46-12	7608-7614	Fisher	_
46-13	7615-7623	matrices	_
46-14	7623-7624	)	_
46-15	7625-7629	from	_
46-16	7630-7633	the	_
46-17	7634-7637	set	_
46-18	7638-7640	of	_
46-19	7641-7653	connectivity	_
46-20	7654-7658	maps	_
46-21	7659-7667	obtained	_
46-22	7668-7671	for	_
46-23	7672-7675	the	_
46-24	7676-7685	different	_
46-25	7686-7695	reference	_
46-26	7696-7706	electrodes	_
46-27	7707-7709	is	_
46-28	7710-7719	performed	_
46-29	7719-7720	.	_

#Text=An optimization analysis is conducted based on the chronological presence of stimuli.
47-1	7721-7723	An	_
47-2	7724-7736	optimization	_
47-3	7737-7745	analysis	_
47-4	7746-7748	is	_
47-5	7749-7758	conducted	_
47-6	7759-7764	based	_
47-7	7765-7767	on	_
47-8	7768-7771	the	_
47-9	7772-7785	chronological	_
47-10	7786-7794	presence	_
47-11	7795-7797	of	_
47-12	7798-7805	stimuli	_
47-13	7805-7806	.	_

#Text=Post analysis and processing of the results is performed, including discrimination between the correlation matrix and Fisher-based features of the healthy subjects and those of the schizophrenia patients.
48-1	7807-7811	Post	_
48-2	7812-7820	analysis	_
48-3	7821-7824	and	_
48-4	7825-7835	processing	_
48-5	7836-7838	of	_
48-6	7839-7842	the	_
48-7	7843-7850	results	_
48-8	7851-7853	is	_
48-9	7854-7863	performed	_
48-10	7863-7864	,	_
48-11	7865-7874	including	_
48-12	7875-7889	discrimination	_
48-13	7890-7897	between	_
48-14	7898-7901	the	_
48-15	7902-7913	correlation	_
48-16	7914-7920	matrix	_
48-17	7921-7924	and	_
48-18	7925-7937	Fisher-based	_
48-19	7938-7946	features	_
48-20	7947-7949	of	_
48-21	7950-7953	the	_
48-22	7954-7961	healthy	_
48-23	7962-7970	subjects	_
48-24	7971-7974	and	_
48-25	7975-7980	those	_
48-26	7981-7983	of	_
48-27	7984-7987	the	_
48-28	7988-8001	schizophrenia	_
48-29	8002-8010	patients	_
48-30	8010-8011	.	_

#Text=In addition to the resulted parameters, this step is also performed under different constraints, such as specific time frames or following specific stimuli, for a broader statistical analysis.
49-1	8012-8014	In	_
49-2	8015-8023	addition	_
49-3	8024-8026	to	_
49-4	8027-8030	the	_
49-5	8031-8039	resulted	_
49-6	8040-8050	parameters	_
49-7	8050-8051	,	_
49-8	8052-8056	this	_
49-9	8057-8061	step	_
49-10	8062-8064	is	_
49-11	8065-8069	also	_
49-12	8070-8079	performed	_
49-13	8080-8085	under	_
49-14	8086-8095	different	_
49-15	8096-8107	constraints	_
49-16	8107-8108	,	_
49-17	8109-8113	such	_
49-18	8114-8116	as	_
49-19	8117-8125	specific	_
49-20	8126-8130	time	_
49-21	8131-8137	frames	_
49-22	8138-8140	or	_
49-23	8141-8150	following	_
49-24	8151-8159	specific	_
49-25	8160-8167	stimuli	_
49-26	8167-8168	,	_
49-27	8169-8172	for	_
49-28	8173-8174	a	_
49-29	8175-8182	broader	_
49-30	8183-8194	statistical	_
49-31	8195-8203	analysis	_
49-32	8203-8204	.	_

#Text=These steps are shown in Fig 2 below.
50-1	8205-8210	These	_
50-2	8211-8216	steps	_
50-3	8217-8220	are	_
50-4	8221-8226	shown	_
50-5	8227-8229	in	_
50-6	8230-8233	Fig	_
50-7	8234-8235	2	_
50-8	8236-8241	below	_
50-9	8241-8242	.	_

#Text=Phases of the connectivity maps methodology.
51-1	8243-8249	Phases	_
51-2	8250-8252	of	_
51-3	8253-8256	the	_
51-4	8257-8269	connectivity	_
51-5	8270-8274	maps	_
51-6	8275-8286	methodology	_
51-7	8286-8287	.	_

#Text=Given a window size W, a maximum phase φ and a number of trials i ∈ {1..t} for an electrode, let us define a connectivity function Fconn between two electrodes, such as a cross correlation, as
#Text=Fconn can be replaced with any other metric of bi-electrode connectivity.
52-1	8288-8293	Given	_
52-2	8294-8295	a	_
52-3	8296-8302	window	_
52-4	8303-8307	size	_
52-5	8308-8309	W	_
52-6	8309-8310	,	_
52-7	8311-8312	a	_
52-8	8313-8320	maximum	_
52-9	8321-8326	phase	_
52-10	8327-8328	φ	_
52-11	8329-8332	and	_
52-12	8333-8334	a	_
52-13	8335-8341	number	_
52-14	8342-8344	of	_
52-15	8345-8351	trials	_
52-16	8352-8353	i	_
52-17	8354-8355	∈	_
52-18	8356-8357	{	_
52-19	8357-8358	1	_
52-20	8358-8359	.	_
52-21	8359-8360	.	_
52-22	8360-8361	t	_
52-23	8361-8362	}	_
52-24	8363-8366	for	_
52-25	8367-8369	an	_
52-26	8370-8379	electrode	_
52-27	8379-8380	,	_
52-28	8381-8384	let	_
52-29	8385-8387	us	_
52-30	8388-8394	define	_
52-31	8395-8396	a	_
52-32	8397-8409	connectivity	_
52-33	8410-8418	function	_
52-34	8419-8424	Fconn	_
52-35	8425-8432	between	_
52-36	8433-8436	two	_
52-37	8437-8447	electrodes	_
52-38	8447-8448	,	_
52-39	8449-8453	such	_
52-40	8454-8456	as	_
52-41	8457-8458	a	_
52-42	8459-8464	cross	_
52-43	8465-8476	correlation	_
52-44	8476-8477	,	_
52-45	8478-8480	as	_
52-46	8483-8488	Fconn	_
52-47	8489-8492	can	_
52-48	8493-8495	be	_
52-49	8496-8504	replaced	_
52-50	8505-8509	with	_
52-51	8510-8513	any	_
52-52	8514-8519	other	_
52-53	8520-8526	metric	_
52-54	8527-8529	of	_
52-55	8530-8542	bi-electrode	_
52-56	8543-8555	connectivity	_
52-57	8555-8556	.	_

#Text=For example, the average-over-trials function could be replaced with the corresponding max or median function.
53-1	8557-8560	For	_
53-2	8561-8568	example	_
53-3	8568-8569	,	_
53-4	8570-8573	the	_
53-5	8574-8593	average-over-trials	_
53-6	8594-8602	function	_
53-7	8603-8608	could	_
53-8	8609-8611	be	_
53-9	8612-8620	replaced	_
53-10	8621-8625	with	_
53-11	8626-8629	the	_
53-12	8630-8643	corresponding	_
53-13	8644-8647	max	_
53-14	8648-8650	or	_
53-15	8651-8657	median	_
53-16	8658-8666	function	_
53-17	8666-8667	.	_

#Text=For each electrode, two initial connectivity maps are created and presented using matrices.
54-1	8668-8671	For	_
54-2	8672-8676	each	_
54-3	8677-8686	electrode	_
54-4	8686-8687	,	_
54-5	8688-8691	two	_
54-6	8692-8699	initial	_
54-7	8700-8712	connectivity	_
54-8	8713-8717	maps	_
54-9	8718-8721	are	_
54-10	8722-8729	created	_
54-11	8730-8733	and	_
54-12	8734-8743	presented	_
54-13	8744-8749	using	_
54-14	8750-8758	matrices	_
54-15	8758-8759	.	_

#Text=The correlation connectivity map for electrode A is defined by  where N is the total number of subjects and W ∈ {50 ms, 100 ms, 150 ms, 200 ms}.
55-1	8760-8763	The	_
55-2	8764-8775	correlation	_
55-3	8776-8788	connectivity	_
55-4	8789-8792	map	_
55-5	8793-8796	for	_
55-6	8797-8806	electrode	_
55-7	8807-8808	A	_
55-8	8809-8811	is	_
55-9	8812-8819	defined	_
55-10	8820-8822	by	_
55-11	8824-8829	where	_
55-12	8830-8831	N	_
55-13	8832-8834	is	_
55-14	8835-8838	the	_
55-15	8839-8844	total	_
55-16	8845-8851	number	_
55-17	8852-8854	of	_
55-18	8855-8863	subjects	_
55-19	8864-8867	and	_
55-20	8868-8869	W	_
55-21	8870-8871	∈	_
55-22	8872-8873	{	_
55-23	8873-8875	50	_
55-24	8876-8878	ms	_
55-25	8878-8879	,	_
55-26	8880-8883	100	_
55-27	8884-8886	ms	_
55-28	8886-8887	,	_
55-29	8888-8891	150	_
55-30	8892-8894	ms	_
55-31	8894-8895	,	_
55-32	8896-8899	200	_
55-33	8900-8902	ms	_
55-34	8902-8903	}	_
55-35	8903-8904	.	_

#Text=Such a cross-correlation function with different possible window sizes alongside a small phase limit φ can be efficient in detecting synchronization of the flow of information in a system.
56-1	8905-8909	Such	_
56-2	8910-8911	a	_
56-3	8912-8929	cross-correlation	_
56-4	8930-8938	function	_
56-5	8939-8943	with	_
56-6	8944-8953	different	_
56-7	8954-8962	possible	_
56-8	8963-8969	window	_
56-9	8970-8975	sizes	_
56-10	8976-8985	alongside	_
56-11	8986-8987	a	_
56-12	8988-8993	small	_
56-13	8994-8999	phase	_
56-14	9000-9005	limit	_
56-15	9006-9007	φ	_
56-16	9008-9011	can	_
56-17	9012-9014	be	_
56-18	9015-9024	efficient	_
56-19	9025-9027	in	_
56-20	9028-9037	detecting	_
56-21	9038-9053	synchronization	_
56-22	9054-9056	of	_
56-23	9057-9060	the	_
56-24	9061-9065	flow	_
56-25	9066-9068	of	_
56-26	9069-9080	information	_
56-27	9081-9083	in	_
56-28	9084-9085	a	_
56-29	9086-9092	system	_
56-30	9092-9093	.	_

#Text=In a similar way, a standard deviation matrix map can be defined as follows:
#Text=CM_STDA(B) = StdsubjectFConn(A,B).
57-1	9094-9096	In	_
57-2	9097-9098	a	_
57-3	9099-9106	similar	_
57-4	9107-9110	way	_
57-5	9110-9111	,	_
57-6	9112-9113	a	_
57-7	9114-9122	standard	_
57-8	9123-9132	deviation	_
57-9	9133-9139	matrix	_
57-10	9140-9143	map	_
57-11	9144-9147	can	_
57-12	9148-9150	be	_
57-13	9151-9158	defined	_
57-14	9159-9161	as	_
57-15	9162-9169	follows	_
57-16	9169-9170	:	_
57-17	9171-9178	CM_STDA	_
57-18	9178-9179	(	_
57-19	9179-9180	B	_
57-20	9180-9181	)	_
57-21	9182-9183	=	_
57-22	9184-9199	StdsubjectFConn	_
57-23	9199-9200	(	_
57-24	9200-9201	A	_
57-25	9201-9202	,	_
57-26	9202-9203	B	_
57-27	9203-9204	)	_
57-28	9204-9205	.	_

#Text=A healthy-schizophrenia patients Fisher-score matrix can then be created using the following equation:
#Text=Feature matrices are then created for additional features, for prediction and classification.
58-1	9206-9207	A	_
58-2	9208-9229	healthy-schizophrenia	_
58-3	9230-9238	patients	_
58-4	9239-9251	Fisher-score	_
58-5	9252-9258	matrix	_
58-6	9259-9262	can	_
58-7	9263-9267	then	_
58-8	9268-9270	be	_
58-9	9271-9278	created	_
58-10	9279-9284	using	_
58-11	9285-9288	the	_
58-12	9289-9298	following	_
58-13	9299-9307	equation	_
58-14	9307-9308	:	_
58-15	9310-9317	Feature	_
58-16	9318-9326	matrices	_
58-17	9327-9330	are	_
58-18	9331-9335	then	_
58-19	9336-9343	created	_
58-20	9344-9347	for	_
58-21	9348-9358	additional	_
58-22	9359-9367	features	_
58-23	9367-9368	,	_
58-24	9369-9372	for	_
58-25	9373-9383	prediction	_
58-26	9384-9387	and	_
58-27	9388-9402	classification	_
58-28	9402-9403	.	_

#Text=Three characteristics were used to create these additional features: 1.
59-1	9404-9409	Three	_
59-2	9410-9425	characteristics	_
59-3	9426-9430	were	_
59-4	9431-9435	used	_
59-5	9436-9438	to	_
59-6	9439-9445	create	_
59-7	9446-9451	these	_
59-8	9452-9462	additional	_
59-9	9463-9471	features	_
59-10	9471-9472	:	_
59-11	9473-9474	1	_
59-12	9474-9475	.	_

#Text=Relative distances: the differences in the direct connectivity map are computed with respect to the reference electrode (see Fig 1).
60-1	9476-9484	Relative	_
60-2	9485-9494	distances	_
60-3	9494-9495	:	_
60-4	9496-9499	the	_
60-5	9500-9511	differences	_
60-6	9512-9514	in	_
60-7	9515-9518	the	_
60-8	9519-9525	direct	_
60-9	9526-9538	connectivity	_
60-10	9539-9542	map	_
60-11	9543-9546	are	_
60-12	9547-9555	computed	_
60-13	9556-9560	with	_
60-14	9561-9568	respect	_
60-15	9569-9571	to	_
60-16	9572-9575	the	_
60-17	9576-9585	reference	_
60-18	9586-9595	electrode	_
60-19	9596-9597	(	_
60-20	9597-9600	see	_
60-21	9601-9604	Fig	_
60-22	9605-9606	1	_
60-23	9606-9607	)	_
60-24	9607-9608	.	_

#Text=The relative distances are defined by
#Text=2.
61-1	9609-9612	The	_
61-2	9613-9621	relative	_
61-3	9622-9631	distances	_
61-4	9632-9635	are	_
61-5	9636-9643	defined	_
61-6	9644-9646	by	_
61-7	9648-9649	2	_
61-8	9649-9650	.	_

#Text=Feature multiplication: Multiplication elements that are extensions of the relative distances are defined.
62-1	9651-9658	Feature	_
62-2	9659-9673	multiplication	_
62-3	9673-9674	:	_
62-4	9675-9689	Multiplication	_
62-5	9690-9698	elements	_
62-6	9699-9703	that	_
62-7	9704-9707	are	_
62-8	9708-9718	extensions	_
62-9	9719-9721	of	_
62-10	9722-9725	the	_
62-11	9726-9734	relative	_
62-12	9735-9744	distances	_
62-13	9745-9748	are	_
62-14	9749-9756	defined	_
62-15	9756-9757	.	_

#Text=As reference electrode is shared by both elements of each multiplication matrix, these features amplify contribution of such successful, “multi-purpose” reference points.
63-1	9758-9760	As	_
63-2	9761-9770	reference	_
63-3	9771-9780	electrode	_
63-4	9781-9783	is	_
63-5	9784-9790	shared	_
63-6	9791-9793	by	_
63-7	9794-9798	both	_
63-8	9799-9807	elements	_
63-9	9808-9810	of	_
63-10	9811-9815	each	_
63-11	9816-9830	multiplication	_
63-12	9831-9837	matrix	_
63-13	9837-9838	,	_
63-14	9839-9844	these	_
63-15	9845-9853	features	_
63-16	9854-9861	amplify	_
63-17	9862-9874	contribution	_
63-18	9875-9877	of	_
63-19	9878-9882	such	_
63-20	9883-9893	successful	_
63-21	9893-9894	,	_
63-22	9895-9896	“	_
63-23	9896-9909	multi-purpose	_
63-24	9909-9910	”	_
63-25	9911-9920	reference	_
63-26	9921-9927	points	_
63-27	9927-9928	.	_

#Text=For each pair of relative elements, as defined above, a multiplication element is created, defined as follows:
#Text=3.
64-1	9929-9932	For	_
64-2	9933-9937	each	_
64-3	9938-9942	pair	_
64-4	9943-9945	of	_
64-5	9946-9954	relative	_
64-6	9955-9963	elements	_
64-7	9963-9964	,	_
64-8	9965-9967	as	_
64-9	9968-9975	defined	_
64-10	9976-9981	above	_
64-11	9981-9982	,	_
64-12	9983-9984	a	_
64-13	9985-9999	multiplication	_
64-14	10000-10007	element	_
64-15	10008-10010	is	_
64-16	10011-10018	created	_
64-17	10018-10019	,	_
64-18	10020-10027	defined	_
64-19	10028-10030	as	_
64-20	10031-10038	follows	_
64-21	10038-10039	:	_
64-22	10041-10042	3	_
64-23	10042-10043	.	_

#Text=Fisher relative score features matrix: This matrix is defined by
#Text=The feature classification procedure collects only the most statistically significant discriminating features rather than the holistic network connectivity level.
65-1	10044-10050	Fisher	_
65-2	10051-10059	relative	_
65-3	10060-10065	score	_
65-4	10066-10074	features	_
65-5	10075-10081	matrix	_
65-6	10081-10082	:	_
65-7	10083-10087	This	_
65-8	10088-10094	matrix	_
65-9	10095-10097	is	_
65-10	10098-10105	defined	_
65-11	10106-10108	by	_
65-12	10110-10113	The	_
65-13	10114-10121	feature	_
65-14	10122-10136	classification	_
65-15	10137-10146	procedure	_
65-16	10147-10155	collects	_
65-17	10156-10160	only	_
65-18	10161-10164	the	_
65-19	10165-10169	most	_
65-20	10170-10183	statistically	_
65-21	10184-10195	significant	_
65-22	10196-10210	discriminating	_
65-23	10211-10219	features	_
65-24	10220-10226	rather	_
65-25	10227-10231	than	_
65-26	10232-10235	the	_
65-27	10236-10244	holistic	_
65-28	10245-10252	network	_
65-29	10253-10265	connectivity	_
65-30	10266-10271	level	_
65-31	10271-10272	.	_

#Text=The procedure is as follows:
#Text=Set the parameters K1, K2 with the goal of limiting the number of electrodes involved in the process of interest.
66-1	10273-10276	The	_
66-2	10277-10286	procedure	_
66-3	10287-10289	is	_
66-4	10290-10292	as	_
66-5	10293-10300	follows	_
66-6	10300-10301	:	_
66-7	10302-10305	Set	_
66-8	10306-10309	the	_
66-9	10310-10320	parameters	_
66-10	10321-10323	K1	_
66-11	10323-10324	,	_
66-12	10325-10327	K2	_
66-13	10328-10332	with	_
66-14	10333-10336	the	_
66-15	10337-10341	goal	_
66-16	10342-10344	of	_
66-17	10345-10353	limiting	_
66-18	10354-10357	the	_
66-19	10358-10364	number	_
66-20	10365-10367	of	_
66-21	10368-10378	electrodes	_
66-22	10379-10387	involved	_
66-23	10388-10390	in	_
66-24	10391-10394	the	_
66-25	10395-10402	process	_
66-26	10403-10405	of	_
66-27	10406-10414	interest	_
66-28	10414-10415	.	_

#Text=Construct a feature matrix F of size K1 electrodes x K2 features by letting each row Fi represent the source electrode i and its derived features.
67-1	10416-10425	Construct	_
67-2	10426-10427	a	_
67-3	10428-10435	feature	_
67-4	10436-10442	matrix	_
67-5	10443-10444	F	_
67-6	10445-10447	of	_
67-7	10448-10452	size	_
67-8	10453-10455	K1	_
67-9	10456-10466	electrodes	_
67-10	10467-10468	x	_
67-11	10469-10471	K2	_
67-12	10472-10480	features	_
67-13	10481-10483	by	_
67-14	10484-10491	letting	_
67-15	10492-10496	each	_
67-16	10497-10500	row	_
67-17	10501-10503	Fi	_
67-18	10504-10513	represent	_
67-19	10514-10517	the	_
67-20	10518-10524	source	_
67-21	10525-10534	electrode	_
67-22	10535-10536	i	_
67-23	10537-10540	and	_
67-24	10541-10544	its	_
67-25	10545-10552	derived	_
67-26	10553-10561	features	_
67-27	10561-10562	.	_

#Text=Steps 2–6 were tested with K1 chosen from {0.1N, 0.2N,.., N}, and K2 from {5%,10%}.
68-1	10563-10568	Steps	_
68-2	10569-10570	2	_
68-3	10570-10571	–	_
68-4	10571-10572	6	_
68-5	10573-10577	were	_
68-6	10578-10584	tested	_
68-7	10585-10589	with	_
68-8	10590-10592	K1	_
68-9	10593-10599	chosen	_
68-10	10600-10604	from	_
68-11	10605-10606	{	_
68-12	10606-10610	0.1N	_
68-13	10610-10611	,	_
68-14	10612-10616	0.2N	_
68-15	10616-10617	,	_
68-16	10617-10618	.	_
68-17	10618-10619	.	_
68-18	10619-10620	,	_
68-19	10621-10622	N	_
68-20	10622-10623	}	_
68-21	10623-10624	,	_
68-22	10625-10628	and	_
68-23	10629-10631	K2	_
68-24	10632-10636	from	_
68-25	10637-10638	{	_
68-26	10638-10640	5%	_
68-27	10640-10641	,	_
68-28	10641-10644	10%	_
68-29	10644-10645	}	_
68-30	10645-10646	.	_

#Text=The elements of row i of the feature matrix are all features obtained from electrode i, as defined above: .
69-1	10647-10650	The	_
69-2	10651-10659	elements	_
69-3	10660-10662	of	_
69-4	10663-10666	row	_
69-5	10667-10668	i	_
69-6	10669-10671	of	_
69-7	10672-10675	the	_
69-8	10676-10683	feature	_
69-9	10684-10690	matrix	_
69-10	10691-10694	are	_
69-11	10695-10698	all	_
69-12	10699-10707	features	_
69-13	10708-10716	obtained	_
69-14	10717-10721	from	_
69-15	10722-10731	electrode	_
69-16	10732-10733	i	_
69-17	10733-10734	,	_
69-18	10735-10737	as	_
69-19	10738-10745	defined	_
69-20	10746-10751	above	_
69-21	10751-10752	:	_
69-22	10753-10754	.	_

#Text=To increase the clarity of the maps, only the top 10% of features in terms of healthy-schizophrenia patients variance were retained .
70-1	10755-10757	To	_
70-2	10758-10766	increase	_
70-3	10767-10770	the	_
70-4	10771-10778	clarity	_
70-5	10779-10781	of	_
70-6	10782-10785	the	_
70-7	10786-10790	maps	_
70-8	10790-10791	,	_
70-9	10792-10796	only	_
70-10	10797-10800	the	_
70-11	10801-10804	top	_
70-12	10805-10808	10%	_
70-13	10809-10811	of	_
70-14	10812-10820	features	_
70-15	10821-10823	in	_
70-16	10824-10829	terms	_
70-17	10830-10832	of	_
70-18	10833-10854	healthy-schizophrenia	_
70-19	10855-10863	patients	_
70-20	10864-10872	variance	_
70-21	10873-10877	were	_
70-22	10878-10886	retained	_
70-23	10887-10888	.	_

#Text=For each row, calculate the average of the maximal K1 elements.
71-1	10889-10892	For	_
71-2	10893-10897	each	_
71-3	10898-10901	row	_
71-4	10901-10902	,	_
71-5	10903-10912	calculate	_
71-6	10913-10916	the	_
71-7	10917-10924	average	_
71-8	10925-10927	of	_
71-9	10928-10931	the	_
71-10	10932-10939	maximal	_
71-11	10940-10942	K1	_
71-12	10943-10951	elements	_
71-13	10951-10952	.	_

#Text=Choose the K2 features that have maximal scores.
72-1	10953-10959	Choose	_
72-2	10960-10963	the	_
72-3	10964-10966	K2	_
72-4	10967-10975	features	_
72-5	10976-10980	that	_
72-6	10981-10985	have	_
72-7	10986-10993	maximal	_
72-8	10994-11000	scores	_
72-9	11000-11001	.	_

#Text=Use Laplacian regularization for feature scoring.
73-1	11002-11005	Use	_
73-2	11006-11015	Laplacian	_
73-3	11016-11030	regularization	_
73-4	11031-11034	for	_
73-5	11035-11042	feature	_
73-6	11043-11050	scoring	_
73-7	11050-11051	.	_

#Text=Alternatively, another feature scoring method may also be used .
74-1	11052-11065	Alternatively	_
74-2	11065-11066	,	_
74-3	11067-11074	another	_
74-4	11075-11082	feature	_
74-5	11083-11090	scoring	_
74-6	11091-11097	method	_
74-7	11098-11101	may	_
74-8	11102-11106	also	_
74-9	11107-11109	be	_
74-10	11110-11114	used	_
74-11	11115-11116	.	_

#Text=Analyze the projected results for new segments of acquired data using a statistical model that features 2 states or models; compare the likelihood of each model (healthy individuals or schizophrenia patient) using Chi-squared tests followed by model comparison .
75-1	11117-11124	Analyze	_
75-2	11125-11128	the	_
75-3	11129-11138	projected	_
75-4	11139-11146	results	_
75-5	11147-11150	for	_
75-6	11151-11154	new	_
75-7	11155-11163	segments	_
75-8	11164-11166	of	_
75-9	11167-11175	acquired	_
75-10	11176-11180	data	_
75-11	11181-11186	using	_
75-12	11187-11188	a	_
75-13	11189-11200	statistical	_
75-14	11201-11206	model	_
75-15	11207-11211	that	_
75-16	11212-11220	features	_
75-17	11221-11222	2	_
75-18	11223-11229	states	_
75-19	11230-11232	or	_
75-20	11233-11239	models	_
75-21	11239-11240	;	_
75-22	11241-11248	compare	_
75-23	11249-11252	the	_
75-24	11253-11263	likelihood	_
75-25	11264-11266	of	_
75-26	11267-11271	each	_
75-27	11272-11277	model	_
75-28	11278-11279	(	_
75-29	11279-11286	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[1]
75-30	11287-11298	individuals	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[1]
75-31	11299-11301	or	_
75-32	11302-11315	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
75-33	11316-11323	patient	_
75-34	11323-11324	)	_
75-35	11325-11330	using	_
75-36	11331-11342	Chi-squared	_
75-37	11343-11348	tests	_
75-38	11349-11357	followed	_
75-39	11358-11360	by	_
75-40	11361-11366	model	_
75-41	11367-11377	comparison	_
75-42	11378-11379	.	_

#Text=Classify the feature set according to the likelihoods of the two models.
76-1	11380-11388	Classify	_
76-2	11389-11392	the	_
76-3	11393-11400	feature	_
76-4	11401-11404	set	_
76-5	11405-11414	according	_
76-6	11415-11417	to	_
76-7	11418-11421	the	_
76-8	11422-11433	likelihoods	_
76-9	11434-11436	of	_
76-10	11437-11440	the	_
76-11	11441-11444	two	_
76-12	11445-11451	models	_
76-13	11451-11452	.	_

#Text=Post-procedure validation: Perform cross-validation between patients’ data using the ‘leave one out’ method .
77-1	11453-11467	Post-procedure	_
77-2	11468-11478	validation	_
77-3	11478-11479	:	_
77-4	11480-11487	Perform	_
77-5	11488-11504	cross-validation	_
77-6	11505-11512	between	_
77-7	11513-11521	patients	_
77-8	11521-11522	’	_
77-9	11523-11527	data	_
77-10	11528-11533	using	_
77-11	11534-11537	the	_
77-12	11538-11539	‘	_
77-13	11539-11544	leave	_
77-14	11545-11548	one	_
77-15	11549-11552	out	_
77-16	11552-11553	’	_
77-17	11554-11560	method	_
77-18	11561-11562	.	_

#Text=In each phase, one subject’s data is left out of the training set, and all properties are computed without using this data.
78-1	11563-11565	In	_
78-2	11566-11570	each	_
78-3	11571-11576	phase	_
78-4	11576-11577	,	_
78-5	11578-11581	one	_
78-6	11582-11589	subject	_
78-7	11589-11590	’	_
78-8	11590-11591	s	_
78-9	11592-11596	data	_
78-10	11597-11599	is	_
78-11	11600-11604	left	_
78-12	11605-11608	out	_
78-13	11609-11611	of	_
78-14	11612-11615	the	_
78-15	11616-11624	training	_
78-16	11625-11628	set	_
78-17	11628-11629	,	_
78-18	11630-11633	and	_
78-19	11634-11637	all	_
78-20	11638-11648	properties	_
78-21	11649-11652	are	_
78-22	11653-11661	computed	_
78-23	11662-11669	without	_
78-24	11670-11675	using	_
78-25	11676-11680	this	_
78-26	11681-11685	data	_
78-27	11685-11686	.	_

#Text=Testing and predictions are then conducted with the data that was left out, treating this data as a fresh, newly acquired dataset.
#Text=2.2 –Experimental setup
#Text=We demonstrate an analysis of EEG data from a previously reported study ; this data provided evidence for contextual processing deficits in patients with schizophrenia by demonstrating alterations in the neural correlates of local contextual processing.
79-1	11687-11694	Testing	_
79-2	11695-11698	and	_
79-3	11699-11710	predictions	_
79-4	11711-11714	are	_
79-5	11715-11719	then	_
79-6	11720-11729	conducted	_
79-7	11730-11734	with	_
79-8	11735-11738	the	_
79-9	11739-11743	data	_
79-10	11744-11748	that	_
79-11	11749-11752	was	_
79-12	11753-11757	left	_
79-13	11758-11761	out	_
79-14	11761-11762	,	_
79-15	11763-11771	treating	_
79-16	11772-11776	this	_
79-17	11777-11781	data	_
79-18	11782-11784	as	_
79-19	11785-11786	a	_
79-20	11787-11792	fresh	_
79-21	11792-11793	,	_
79-22	11794-11799	newly	_
79-23	11800-11808	acquired	_
79-24	11809-11816	dataset	_
79-25	11816-11817	.	_
79-26	11818-11821	2.2	_
79-27	11822-11823	–	_
79-28	11823-11835	Experimental	_
79-29	11836-11841	setup	_
79-30	11842-11844	We	_
79-31	11845-11856	demonstrate	_
79-32	11857-11859	an	_
79-33	11860-11868	analysis	_
79-34	11869-11871	of	_
79-35	11872-11875	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
79-36	11876-11880	data	_
79-37	11881-11885	from	_
79-38	11886-11887	a	_
79-39	11888-11898	previously	_
79-40	11899-11907	reported	_
79-41	11908-11913	study	_
79-42	11914-11915	;	_
79-43	11916-11920	this	_
79-44	11921-11925	data	_
79-45	11926-11934	provided	_
79-46	11935-11943	evidence	_
79-47	11944-11947	for	_
79-48	11948-11958	contextual	_
79-49	11959-11969	processing	_
79-50	11970-11978	deficits	_
79-51	11979-11981	in	_
79-52	11982-11990	patients	_
79-53	11991-11995	with	_
79-54	11996-12009	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
79-55	12010-12012	by	_
79-56	12013-12026	demonstrating	_
79-57	12027-12038	alterations	_
79-58	12039-12041	in	_
79-59	12042-12045	the	_
79-60	12046-12052	neural	_
79-61	12053-12063	correlates	_
79-62	12064-12066	of	_
79-63	12067-12072	local	_
79-64	12073-12083	contextual	_
79-65	12084-12094	processing	_
79-66	12094-12095	.	_

#Text=This experimental data was acquired while the subjects played a computer simulation game.
80-1	12096-12100	This	_
80-2	12101-12113	experimental	_
80-3	12114-12118	data	_
80-4	12119-12122	was	_
80-5	12123-12131	acquired	_
80-6	12132-12137	while	_
80-7	12138-12141	the	_
80-8	12142-12150	subjects	_
80-9	12151-12157	played	_
80-10	12158-12159	a	_
80-11	12160-12168	computer	_
80-12	12169-12179	simulation	_
80-13	12180-12184	game	_
80-14	12184-12185	.	_

#Text=The game featured a basic visual-stimuli identification-response task.
81-1	12186-12189	The	_
81-2	12190-12194	game	_
81-3	12195-12203	featured	_
81-4	12204-12205	a	_
81-5	12206-12211	basic	_
81-6	12212-12226	visual-stimuli	_
81-7	12227-12250	identification-response	_
81-8	12251-12255	task	_
81-9	12255-12256	.	_

#Text=Three different triangles were presented, each pointing in a different direction, with different patterns of recurrence.
82-1	12257-12262	Three	_
82-2	12263-12272	different	_
82-3	12273-12282	triangles	_
82-4	12283-12287	were	_
82-5	12288-12297	presented	_
82-6	12297-12298	,	_
82-7	12299-12303	each	_
82-8	12304-12312	pointing	_
82-9	12313-12315	in	_
82-10	12316-12317	a	_
82-11	12318-12327	different	_
82-12	12328-12337	direction	_
82-13	12337-12338	,	_
82-14	12339-12343	with	_
82-15	12344-12353	different	_
82-16	12354-12362	patterns	_
82-17	12363-12365	of	_
82-18	12366-12376	recurrence	_
82-19	12376-12377	.	_

#Text=One of the shapes (‘P’ stimulus type) had a recurrence pattern that created a higher level of cognitive activity (“anticipation”) among the subjects in comparison to the other two; we focused on the EEG data that was recorded while responding to this specific stimulus.
83-1	12378-12381	One	_
83-2	12382-12384	of	_
83-3	12385-12388	the	_
83-4	12389-12395	shapes	_
83-5	12396-12397	(	_
83-6	12397-12398	‘	_
83-7	12398-12399	P	_
83-8	12399-12400	’	_
83-9	12401-12409	stimulus	_
83-10	12410-12414	type	_
83-11	12414-12415	)	_
83-12	12416-12419	had	_
83-13	12420-12421	a	_
83-14	12422-12432	recurrence	_
83-15	12433-12440	pattern	_
83-16	12441-12445	that	_
83-17	12446-12453	created	_
83-18	12454-12455	a	_
83-19	12456-12462	higher	_
83-20	12463-12468	level	_
83-21	12469-12471	of	_
83-22	12472-12481	cognitive	_
83-23	12482-12490	activity	_
83-24	12491-12492	(	_
83-25	12492-12493	“	_
83-26	12493-12505	anticipation	_
83-27	12505-12506	”	_
83-28	12506-12507	)	_
83-29	12508-12513	among	_
83-30	12514-12517	the	_
83-31	12518-12526	subjects	_
83-32	12527-12529	in	_
83-33	12530-12540	comparison	_
83-34	12541-12543	to	_
83-35	12544-12547	the	_
83-36	12548-12553	other	_
83-37	12554-12557	two	_
83-38	12557-12558	;	_
83-39	12559-12561	we	_
83-40	12562-12569	focused	_
83-41	12570-12572	on	_
83-42	12573-12576	the	_
83-43	12577-12580	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
83-44	12581-12585	data	_
83-45	12586-12590	that	_
83-46	12591-12594	was	_
83-47	12595-12603	recorded	_
83-48	12604-12609	while	_
83-49	12610-12620	responding	_
83-50	12621-12623	to	_
83-51	12624-12628	this	_
83-52	12629-12637	specific	_
83-53	12638-12646	stimulus	_
83-54	12646-12647	.	_

#Text=EEG data was recorded from a 64-electrode array using the ActiveTwo system (Biosemi, The Netherlands).
84-1	12648-12651	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
84-2	12652-12656	data	_
84-3	12657-12660	was	_
84-4	12661-12669	recorded	_
84-5	12670-12674	from	_
84-6	12675-12676	a	_
84-7	12677-12679	64	_
84-8	12679-12680	-	_
84-9	12680-12689	electrode	_
84-10	12690-12695	array	_
84-11	12696-12701	using	_
84-12	12702-12705	the	_
84-13	12706-12715	ActiveTwo	_
84-14	12716-12722	system	_
84-15	12723-12724	(	_
84-16	12724-12731	Biosemi	_
84-17	12731-12732	,	_
84-18	12733-12736	The	_
84-19	12737-12748	Netherlands	_
84-20	12748-12749	)	_
84-21	12749-12750	.	_

#Text=External electrodes above and below the right eye monitored vertical eye movements, and electrodes placed laterally to the left and right eyes monitored horizontal eye movements.
85-1	12751-12759	External	_
85-2	12760-12770	electrodes	_
85-3	12771-12776	above	_
85-4	12777-12780	and	_
85-5	12781-12786	below	_
85-6	12787-12790	the	_
85-7	12791-12796	right	_
85-8	12797-12800	eye	_
85-9	12801-12810	monitored	_
85-10	12811-12819	vertical	_
85-11	12820-12823	eye	_
85-12	12824-12833	movements	_
85-13	12833-12834	,	_
85-14	12835-12838	and	_
85-15	12839-12849	electrodes	_
85-16	12850-12856	placed	_
85-17	12857-12866	laterally	_
85-18	12867-12869	to	_
85-19	12870-12873	the	_
85-20	12874-12878	left	_
85-21	12879-12882	and	_
85-22	12883-12888	right	_
85-23	12889-12893	eyes	_
85-24	12894-12903	monitored	_
85-25	12904-12914	horizontal	_
85-26	12915-12918	eye	_
85-27	12919-12928	movements	_
85-28	12928-12929	.	_

#Text=Signals were sampled at 512 Hz.
86-1	12930-12937	Signals	_
86-2	12938-12942	were	_
86-3	12943-12950	sampled	_
86-4	12951-12953	at	_
86-5	12954-12957	512	_
86-6	12958-12960	Hz	_
86-7	12960-12961	.	_

#Text=The stimuli consisted of black triangles on a gray background (triangles pointing to the left, upwards and to the right, in 90-degree increments).
87-1	12962-12965	The	_
87-2	12966-12973	stimuli	_
87-3	12974-12983	consisted	_
87-4	12984-12986	of	_
87-5	12987-12992	black	_
87-6	12993-13002	triangles	_
87-7	13003-13005	on	_
87-8	13006-13007	a	_
87-9	13008-13012	gray	_
87-10	13013-13023	background	_
87-11	13024-13025	(	_
87-12	13025-13034	triangles	_
87-13	13035-13043	pointing	_
87-14	13044-13046	to	_
87-15	13047-13050	the	_
87-16	13051-13055	left	_
87-17	13055-13056	,	_
87-18	13057-13064	upwards	_
87-19	13065-13068	and	_
87-20	13069-13071	to	_
87-21	13072-13075	the	_
87-22	13076-13081	right	_
87-23	13081-13082	,	_
87-24	13083-13085	in	_
87-25	13086-13088	90	_
87-26	13088-13089	-	_
87-27	13089-13095	degree	_
87-28	13096-13106	increments	_
87-29	13106-13107	)	_
87-30	13107-13108	.	_

#Text=In each block, a total of 78 stimuli were presented for 150 ms each with an inter-stimulus interval (ISI) of 1 s.
88-1	13109-13111	In	_
88-2	13112-13116	each	_
88-3	13117-13122	block	_
88-4	13122-13123	,	_
88-5	13124-13125	a	_
88-6	13126-13131	total	_
88-7	13132-13134	of	_
88-8	13135-13137	78	_
88-9	13138-13145	stimuli	_
88-10	13146-13150	were	_
88-11	13151-13160	presented	_
88-12	13161-13164	for	_
88-13	13165-13168	150	_
88-14	13169-13171	ms	_
88-15	13172-13176	each	_
88-16	13177-13181	with	_
88-17	13182-13184	an	_
88-18	13185-13199	inter-stimulus	_
88-19	13200-13208	interval	_
88-20	13209-13210	(	_
88-21	13210-13213	ISI	_
88-22	13213-13214	)	_
88-23	13215-13217	of	_
88-24	13218-13219	1	_
88-25	13220-13221	s	_
88-26	13221-13222	.	_

#Text=The stimuli blocks were a mixture of randomized sequences of standards and sequences including a three-standard predictive sequence.
89-1	13223-13226	The	_
89-2	13227-13234	stimuli	_
89-3	13235-13241	blocks	_
89-4	13242-13246	were	_
89-5	13247-13248	a	_
89-6	13249-13256	mixture	_
89-7	13257-13259	of	_
89-8	13260-13270	randomized	_
89-9	13271-13280	sequences	_
89-10	13281-13283	of	_
89-11	13284-13293	standards	_
89-12	13294-13297	and	_
89-13	13298-13307	sequences	_
89-14	13308-13317	including	_
89-15	13318-13319	a	_
89-16	13320-13334	three-standard	_
89-17	13335-13345	predictive	_
89-18	13346-13354	sequence	_
89-19	13354-13355	.	_

#Text=The predictive sequence always consisted of the three triangles facing to the left, up and to the right, always in that order.
90-1	13356-13359	The	_
90-2	13360-13370	predictive	_
90-3	13371-13379	sequence	_
90-4	13380-13386	always	_
90-5	13387-13396	consisted	_
90-6	13397-13399	of	_
90-7	13400-13403	the	_
90-8	13404-13409	three	_
90-9	13410-13419	triangles	_
90-10	13420-13426	facing	_
90-11	13427-13429	to	_
90-12	13430-13433	the	_
90-13	13434-13438	left	_
90-14	13438-13439	,	_
90-15	13440-13442	up	_
90-16	13443-13446	and	_
90-17	13447-13449	to	_
90-18	13450-13453	the	_
90-19	13454-13459	right	_
90-20	13459-13460	,	_
90-21	13461-13467	always	_
90-22	13468-13470	in	_
90-23	13471-13475	that	_
90-24	13476-13481	order	_
90-25	13481-13482	.	_

#Text=We focused our analysis on the response to the predictive sequences (“P” stimuli), as these are considered to be significant indicators of schizophrenia .
91-1	13483-13485	We	_
91-2	13486-13493	focused	_
91-3	13494-13497	our	_
91-4	13498-13506	analysis	_
91-5	13507-13509	on	_
91-6	13510-13513	the	_
91-7	13514-13522	response	_
91-8	13523-13525	to	_
91-9	13526-13529	the	_
91-10	13530-13540	predictive	_
91-11	13541-13550	sequences	_
91-12	13551-13552	(	_
91-13	13552-13553	“	_
91-14	13553-13554	P	_
91-15	13554-13555	”	_
91-16	13556-13563	stimuli	_
91-17	13563-13564	)	_
91-18	13564-13565	,	_
91-19	13566-13568	as	_
91-20	13569-13574	these	_
91-21	13575-13578	are	_
91-22	13579-13589	considered	_
91-23	13590-13592	to	_
91-24	13593-13595	be	_
91-25	13596-13607	significant	_
91-26	13608-13618	indicators	_
91-27	13619-13621	of	_
91-28	13622-13635	schizophrenia	_
91-29	13636-13637	.	_

#Text=In the preprocessing phase, a band-pass filter was implemented to pass frequencies in the interval of 0.1 Hz-30 Hz (excluding the gamma-1 and gamma-2 bands), and the filtered data were normalized by the standard deviation .
92-1	13638-13640	In	_
92-2	13641-13644	the	_
92-3	13645-13658	preprocessing	_
92-4	13659-13664	phase	_
92-5	13664-13665	,	_
92-6	13666-13667	a	_
92-7	13668-13677	band-pass	_
92-8	13678-13684	filter	_
92-9	13685-13688	was	_
92-10	13689-13700	implemented	_
92-11	13701-13703	to	_
92-12	13704-13708	pass	_
92-13	13709-13720	frequencies	_
92-14	13721-13723	in	_
92-15	13724-13727	the	_
92-16	13728-13736	interval	_
92-17	13737-13739	of	_
92-18	13740-13743	0.1	_
92-19	13744-13746	Hz	_
92-20	13746-13747	-	_
92-21	13747-13749	30	_
92-22	13750-13752	Hz	_
92-23	13753-13754	(	_
92-24	13754-13763	excluding	_
92-25	13764-13767	the	_
92-26	13768-13773	gamma	_
92-27	13773-13774	-	_
92-28	13774-13775	1	_
92-29	13776-13779	and	_
92-30	13780-13785	gamma	_
92-31	13785-13786	-	_
92-32	13786-13787	2	_
92-33	13788-13793	bands	_
92-34	13793-13794	)	_
92-35	13794-13795	,	_
92-36	13796-13799	and	_
92-37	13800-13803	the	_
92-38	13804-13812	filtered	_
92-39	13813-13817	data	_
92-40	13818-13822	were	_
92-41	13823-13833	normalized	_
92-42	13834-13836	by	_
92-43	13837-13840	the	_
92-44	13841-13849	standard	_
92-45	13850-13859	deviation	_
92-46	13860-13861	.	_

#Text=The data were analyzed in 1.2-s epochs that began 200 ms prior to the appearance of the ‘P’ stimulus.
93-1	13862-13865	The	_
93-2	13866-13870	data	_
93-3	13871-13875	were	_
93-4	13876-13884	analyzed	_
93-5	13885-13887	in	_
93-6	13888-13891	1.2	_
93-7	13891-13892	-	_
93-8	13892-13893	s	_
93-9	13894-13900	epochs	_
93-10	13901-13905	that	_
93-11	13906-13911	began	_
93-12	13912-13915	200	_
93-13	13916-13918	ms	_
93-14	13919-13924	prior	_
93-15	13925-13927	to	_
93-16	13928-13931	the	_
93-17	13932-13942	appearance	_
93-18	13943-13945	of	_
93-19	13946-13949	the	_
93-20	13950-13951	‘	_
93-21	13951-13952	P	_
93-22	13952-13953	’	_
93-23	13954-13962	stimulus	_
93-24	13962-13963	.	_

#Text=Eye blinks were removed using ICA .
94-1	13964-13967	Eye	_
94-2	13968-13974	blinks	_
94-3	13975-13979	were	_
94-4	13980-13987	removed	_
94-5	13988-13993	using	_
94-6	13994-13997	ICA	_
94-7	13998-13999	.	_

#Text=Epochs containing misses (no button press 150–1150 ms post stimulus onset) and eye saccades were excluded from further analysis.
95-1	14000-14006	Epochs	_
95-2	14007-14017	containing	_
95-3	14018-14024	misses	_
95-4	14025-14026	(	_
95-5	14026-14028	no	_
95-6	14029-14035	button	_
95-7	14036-14041	press	_
95-8	14042-14045	150	_
95-9	14045-14046	–	_
95-10	14046-14050	1150	_
95-11	14051-14053	ms	_
95-12	14054-14058	post	_
95-13	14059-14067	stimulus	_
95-14	14068-14073	onset	_
95-15	14073-14074	)	_
95-16	14075-14078	and	_
95-17	14079-14082	eye	_
95-18	14083-14091	saccades	_
95-19	14092-14096	were	_
95-20	14097-14105	excluded	_
95-21	14106-14110	from	_
95-22	14111-14118	further	_
95-23	14119-14127	analysis	_
95-24	14127-14128	.	_

#Text=EEG epochs with amplitudes of more than 75 μV at any electrode were excluded.
96-1	14129-14132	EEG	_
96-2	14133-14139	epochs	_
96-3	14140-14144	with	_
96-4	14145-14155	amplitudes	_
96-5	14156-14158	of	_
96-6	14159-14163	more	_
96-7	14164-14168	than	_
96-8	14169-14171	75	_
96-9	14172-14174	μV	_
96-10	14175-14177	at	_
96-11	14178-14181	any	_
96-12	14182-14191	electrode	_
96-13	14192-14196	were	_
96-14	14197-14205	excluded	_
96-15	14205-14206	.	_

#Text=The parameters used for preprocessing and arguments for repetition analysis and optimization were the same as those used in a recent study that analyzed the same data set .
97-1	14207-14210	The	_
97-2	14211-14221	parameters	_
97-3	14222-14226	used	_
97-4	14227-14230	for	_
97-5	14231-14244	preprocessing	_
97-6	14245-14248	and	_
97-7	14249-14258	arguments	_
97-8	14259-14262	for	_
97-9	14263-14273	repetition	_
97-10	14274-14282	analysis	_
97-11	14283-14286	and	_
97-12	14287-14299	optimization	_
97-13	14300-14304	were	_
97-14	14305-14308	the	_
97-15	14309-14313	same	_
97-16	14314-14316	as	_
97-17	14317-14322	those	_
97-18	14323-14327	used	_
97-19	14328-14330	in	_
97-20	14331-14332	a	_
97-21	14333-14339	recent	_
97-22	14340-14345	study	_
97-23	14346-14350	that	_
97-24	14351-14359	analyzed	_
97-25	14360-14363	the	_
97-26	14364-14368	same	_
97-27	14369-14373	data	_
97-28	14374-14377	set	_
97-29	14378-14379	.	_

#Text=The process described above was applied using a set of time windows separated into different frequency bands.
98-1	14380-14383	The	_
98-2	14384-14391	process	_
98-3	14392-14401	described	_
98-4	14402-14407	above	_
98-5	14408-14411	was	_
98-6	14412-14419	applied	_
98-7	14420-14425	using	_
98-8	14426-14427	a	_
98-9	14428-14431	set	_
98-10	14432-14434	of	_
98-11	14435-14439	time	_
98-12	14440-14447	windows	_
98-13	14448-14457	separated	_
98-14	14458-14462	into	_
98-15	14463-14472	different	_
98-16	14473-14482	frequency	_
98-17	14483-14488	bands	_
98-18	14488-14489	.	_

#Text=Windows were created to overlap 90% of the 1.2-s epochs starting 200 ms before the stimulus and ending 1000 ms post stimulus.
99-1	14490-14497	Windows	_
99-2	14498-14502	were	_
99-3	14503-14510	created	_
99-4	14511-14513	to	_
99-5	14514-14521	overlap	_
99-6	14522-14525	90%	_
99-7	14526-14528	of	_
99-8	14529-14532	the	_
99-9	14533-14536	1.2	_
99-10	14536-14537	-	_
99-11	14537-14538	s	_
99-12	14539-14545	epochs	_
99-13	14546-14554	starting	_
99-14	14555-14558	200	_
99-15	14559-14561	ms	_
99-16	14562-14568	before	_
99-17	14569-14572	the	_
99-18	14573-14581	stimulus	_
99-19	14582-14585	and	_
99-20	14586-14592	ending	_
99-21	14593-14597	1000	_
99-22	14598-14600	ms	_
99-23	14601-14605	post	_
99-24	14606-14614	stimulus	_
99-25	14614-14615	.	_

#Text=After pre-processing, bands of 0.1 Hz-30 Hz were separated into 6 equal 5-Hz intervals, and different combinations of these intervals (all subsets of the full band including the full band itself), in addition to the classical Alpha/Beta/Theta/Delta/Gamma bands, were tested.
100-1	14616-14621	After	_
100-2	14622-14636	pre-processing	_
100-3	14636-14637	,	_
100-4	14638-14643	bands	_
100-5	14644-14646	of	_
100-6	14647-14650	0.1	_
100-7	14651-14653	Hz	_
100-8	14653-14654	-	_
100-9	14654-14656	30	_
100-10	14657-14659	Hz	_
100-11	14660-14664	were	_
100-12	14665-14674	separated	_
100-13	14675-14679	into	_
100-14	14680-14681	6	_
100-15	14682-14687	equal	_
100-16	14688-14689	5	_
100-17	14689-14690	-	_
100-18	14690-14692	Hz	_
100-19	14693-14702	intervals	_
100-20	14702-14703	,	_
100-21	14704-14707	and	_
100-22	14708-14717	different	_
100-23	14718-14730	combinations	_
100-24	14731-14733	of	_
100-25	14734-14739	these	_
100-26	14740-14749	intervals	_
100-27	14750-14751	(	_
100-28	14751-14754	all	_
100-29	14755-14762	subsets	_
100-30	14763-14765	of	_
100-31	14766-14769	the	_
100-32	14770-14774	full	_
100-33	14775-14779	band	_
100-34	14780-14789	including	_
100-35	14790-14793	the	_
100-36	14794-14798	full	_
100-37	14799-14803	band	_
100-38	14804-14810	itself	_
100-39	14810-14811	)	_
100-40	14811-14812	,	_
100-41	14813-14815	in	_
100-42	14816-14824	addition	_
100-43	14825-14827	to	_
100-44	14828-14831	the	_
100-45	14832-14841	classical	_
100-46	14842-14847	Alpha	_
100-47	14847-14848	/	_
100-48	14848-14852	Beta	_
100-49	14852-14853	/	_
100-50	14853-14858	Theta	_
100-51	14858-14859	/	_
100-52	14859-14864	Delta	_
100-53	14864-14865	/	_
100-54	14865-14870	Gamma	_
100-55	14871-14876	bands	_
100-56	14876-14877	,	_
100-57	14878-14882	were	_
100-58	14883-14889	tested	_
100-59	14889-14890	.	_

#Text=The responses to 5 to 15 stimuli from the beginning of each recording were analyzed, as described previously ; the number of responses analyzed was constant per iteration.
101-1	14891-14894	The	_
101-2	14895-14904	responses	_
101-3	14905-14907	to	_
101-4	14908-14909	5	_
101-5	14910-14912	to	_
101-6	14913-14915	15	_
101-7	14916-14923	stimuli	_
101-8	14924-14928	from	_
101-9	14929-14932	the	_
101-10	14933-14942	beginning	_
101-11	14943-14945	of	_
101-12	14946-14950	each	_
101-13	14951-14960	recording	_
101-14	14961-14965	were	_
101-15	14966-14974	analyzed	_
101-16	14974-14975	,	_
101-17	14976-14978	as	_
101-18	14979-14988	described	_
101-19	14989-14999	previously	_
101-20	15000-15001	;	_
101-21	15002-15005	the	_
101-22	15006-15012	number	_
101-23	15013-15015	of	_
101-24	15016-15025	responses	_
101-25	15026-15034	analyzed	_
101-26	15035-15038	was	_
101-27	15039-15047	constant	_
101-28	15048-15051	per	_
101-29	15052-15061	iteration	_
101-30	15061-15062	.	_

#Text=The full data set included 50 subjects: 25 were healthy, with no history of psychiatric illness or problematic behavior, and 25 had been diagnosed with schizophrenia, hospitalized and treated with appropriate medication.
102-1	15063-15066	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-2	15067-15071	full	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-3	15072-15076	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-4	15077-15080	set	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-5	15081-15089	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-6	15090-15092	50	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-7	15093-15101	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-8	15101-15102	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-9	15103-15105	25	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-10	15106-15110	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-11	15111-15118	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-12	15118-15119	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-13	15120-15124	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-14	15125-15127	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-15	15128-15135	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-16	15136-15138	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-17	15139-15150	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-18	15151-15158	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-19	15159-15161	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-20	15162-15173	problematic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-21	15174-15182	behavior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-22	15182-15183	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-23	15184-15187	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-24	15188-15190	25	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-25	15191-15194	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-26	15195-15199	been	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-27	15200-15209	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-28	15210-15214	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-29	15215-15228	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]
102-30	15228-15229	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-31	15230-15242	hospitalized	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-32	15243-15246	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-33	15247-15254	treated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-34	15255-15259	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-35	15260-15271	appropriate	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-36	15272-15282	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
102-37	15282-15283	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]

#Text=Signed, informed consent was obtained from all subjects.
103-1	15284-15290	Signed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-2	15290-15291	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-3	15292-15300	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-4	15301-15308	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-5	15309-15312	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-6	15313-15321	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-7	15322-15326	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-8	15327-15330	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-9	15331-15339	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
103-10	15339-15340	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]

#Text=All participants had full capacity to consent, following a clinical evaluation of a psychiatrist.
104-1	15341-15344	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-2	15345-15357	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-3	15358-15361	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-4	15362-15366	full	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-5	15367-15375	capacity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-6	15376-15378	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-7	15379-15386	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-8	15386-15387	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-9	15388-15397	following	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-10	15398-15399	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-11	15400-15408	clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-12	15409-15419	evaluation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-13	15420-15422	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-14	15423-15424	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-15	15425-15437	psychiatrist	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
104-16	15437-15438	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]

#Text=The local ethics committees of A Curuna University and Shaar Menashe Hospital approved the study.
105-1	15439-15442	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-2	15443-15448	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-3	15449-15455	ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-4	15456-15466	committees	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-5	15467-15469	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-6	15470-15471	A	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-7	15472-15478	Curuna	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-8	15479-15489	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-9	15490-15493	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-10	15494-15499	Shaar	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-11	15500-15507	Menashe	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-12	15508-15516	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-13	15517-15525	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-14	15526-15529	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-15	15530-15535	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]
105-16	15535-15536	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]

#Text=Patients were diagnosed with schizophrenia according to the Structured Clinical Interview for DMS-IV-Tr, and the severity of their symptoms was rated using the Positive (SAPS) and Negative (SANS) Syndrome Scale .
106-1	15537-15545	Patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-2	15546-15550	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-3	15551-15560	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-4	15561-15565	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-5	15566-15579	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]
106-6	15580-15589	according	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-7	15590-15592	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-8	15593-15596	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-9	15597-15607	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[6]
106-10	15608-15616	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[6]
106-11	15617-15626	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[6]
106-12	15627-15630	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[6]
106-13	15631-15640	DMS-IV-Tr	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[6]
106-14	15640-15641	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-15	15642-15645	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-16	15646-15649	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-17	15650-15658	severity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-18	15659-15661	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-19	15662-15667	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-20	15668-15676	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-21	15677-15680	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-22	15681-15686	rated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-23	15687-15692	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-24	15693-15696	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-25	15697-15705	Positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[7]
106-26	15706-15707	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[7]
106-27	15707-15711	SAPS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[7]
106-28	15711-15712	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[7]
106-29	15713-15716	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
106-30	15717-15725	Negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[8]
106-31	15726-15727	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[8]
106-32	15727-15731	SANS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[8]
106-33	15731-15732	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[8]
106-34	15733-15741	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[8]
106-35	15742-15747	Scale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[8]
106-36	15748-15749	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]

#Text=We note that during the recording phase, schizophrenia patients were receiving their regular medications.
#Text=3 Results
#Text=3.1 General overview
#Text=Our results are presented in four sections: (I) Significant connectivity maps with significant ability to discriminate between healthy subjects and schizophrenia patients.
107-1	15750-15752	We	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-2	15753-15757	note	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-3	15758-15762	that	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-4	15763-15769	during	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-5	15770-15773	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-6	15774-15783	recording	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-7	15784-15789	phase	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-8	15789-15790	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-9	15791-15804	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]
107-10	15805-15813	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-11	15814-15818	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-12	15819-15828	receiving	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-13	15829-15834	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-14	15835-15842	regular	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-15	15843-15854	medications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
107-16	15854-15855	.	_
107-17	15856-15857	3	_
107-18	15858-15865	Results	_
107-19	15866-15869	3.1	_
107-20	15870-15877	General	_
107-21	15878-15886	overview	_
107-22	15887-15890	Our	_
107-23	15891-15898	results	_
107-24	15899-15902	are	_
107-25	15903-15912	presented	_
107-26	15913-15915	in	_
107-27	15916-15920	four	_
107-28	15921-15929	sections	_
107-29	15929-15930	:	_
107-30	15931-15932	(	_
107-31	15932-15933	I	_
107-32	15933-15934	)	_
107-33	15935-15946	Significant	_
107-34	15947-15959	connectivity	_
107-35	15960-15964	maps	_
107-36	15965-15969	with	_
107-37	15970-15981	significant	_
107-38	15982-15989	ability	_
107-39	15990-15992	to	_
107-40	15993-16005	discriminate	_
107-41	16006-16013	between	_
107-42	16014-16021	healthy	_
107-43	16022-16030	subjects	_
107-44	16031-16034	and	_
107-45	16035-16048	schizophrenia	_
107-46	16049-16057	patients	_
107-47	16057-16058	.	_

#Text=(II) Time windows that exhibit strong differences in connectivity features yet a high correlation in brain activity.
108-1	16059-16060	(	_
108-2	16060-16062	II	_
108-3	16062-16063	)	_
108-4	16064-16068	Time	_
108-5	16069-16076	windows	_
108-6	16077-16081	that	_
108-7	16082-16089	exhibit	_
108-8	16090-16096	strong	_
108-9	16097-16108	differences	_
108-10	16109-16111	in	_
108-11	16112-16124	connectivity	_
108-12	16125-16133	features	_
108-13	16134-16137	yet	_
108-14	16138-16139	a	_
108-15	16140-16144	high	_
108-16	16145-16156	correlation	_
108-17	16157-16159	in	_
108-18	16160-16165	brain	_
108-19	16166-16174	activity	_
108-20	16174-16175	.	_

#Text=(III) Fisher-based analysis to obtain connectivity maps calculated using the most significant connections.
109-1	16176-16177	(	_
109-2	16177-16180	III	_
109-3	16180-16181	)	_
109-4	16182-16194	Fisher-based	_
109-5	16195-16203	analysis	_
109-6	16204-16206	to	_
109-7	16207-16213	obtain	_
109-8	16214-16226	connectivity	_
109-9	16227-16231	maps	_
109-10	16232-16242	calculated	_
109-11	16243-16248	using	_
109-12	16249-16252	the	_
109-13	16253-16257	most	_
109-14	16258-16269	significant	_
109-15	16270-16281	connections	_
109-16	16281-16282	.	_

#Text=(IV) The accuracy of the discrimination methodology based on the prediction of schizophrenia.
#Text=3.2 Connectivity maps
#Text=The connectivity maps that were based on posterior electrodes showed large differences between healthy subjects and schizophrenia patients.
110-1	16283-16284	(	_
110-2	16284-16286	IV	_
110-3	16286-16287	)	_
110-4	16288-16291	The	_
110-5	16292-16300	accuracy	_
110-6	16301-16303	of	_
110-7	16304-16307	the	_
110-8	16308-16322	discrimination	_
110-9	16323-16334	methodology	_
110-10	16335-16340	based	_
110-11	16341-16343	on	_
110-12	16344-16347	the	_
110-13	16348-16358	prediction	_
110-14	16359-16361	of	_
110-15	16362-16375	schizophrenia	_
110-16	16375-16376	.	_
110-17	16377-16380	3.2	_
110-18	16381-16393	Connectivity	_
110-19	16394-16398	maps	_
110-20	16399-16402	The	_
110-21	16403-16415	connectivity	_
110-22	16416-16420	maps	_
110-23	16421-16425	that	_
110-24	16426-16430	were	_
110-25	16431-16436	based	_
110-26	16437-16439	on	_
110-27	16440-16449	posterior	_
110-28	16450-16460	electrodes	_
110-29	16461-16467	showed	_
110-30	16468-16473	large	_
110-31	16474-16485	differences	_
110-32	16486-16493	between	_
110-33	16494-16501	healthy	_
110-34	16502-16510	subjects	_
110-35	16511-16514	and	_
110-36	16515-16528	schizophrenia	_
110-37	16529-16537	patients	_
110-38	16537-16538	.	_

#Text=The below figures demonstrate that from different posterior locations.
111-1	16539-16542	The	_
111-2	16543-16548	below	_
111-3	16549-16556	figures	_
111-4	16557-16568	demonstrate	_
111-5	16569-16573	that	_
111-6	16574-16578	from	_
111-7	16579-16588	different	_
111-8	16589-16598	posterior	_
111-9	16599-16608	locations	_
111-10	16608-16609	.	_

#Text=Fig 3, below, depicts connectivity maps for healthy individuals and schizophrenia patients, with respect to reference electrode O2.
112-1	16610-16613	Fig	_
112-2	16614-16615	3	_
112-3	16615-16616	,	_
112-4	16617-16622	below	_
112-5	16622-16623	,	_
112-6	16624-16631	depicts	_
112-7	16632-16644	connectivity	_
112-8	16645-16649	maps	_
112-9	16650-16653	for	_
112-10	16654-16661	healthy	_
112-11	16662-16673	individuals	_
112-12	16674-16677	and	_
112-13	16678-16691	schizophrenia	_
112-14	16692-16700	patients	_
112-15	16700-16701	,	_
112-16	16702-16706	with	_
112-17	16707-16714	respect	_
112-18	16715-16717	to	_
112-19	16718-16727	reference	_
112-20	16728-16737	electrode	_
112-21	16738-16740	O2	_
112-22	16740-16741	.	_

#Text=The average score for electrode F2 among healthy subjects was 0.784 compared with 0.531 among schizophrenia patients.
113-1	16742-16745	The	_
113-2	16746-16753	average	_
113-3	16754-16759	score	_
113-4	16760-16763	for	_
113-5	16764-16773	electrode	_
113-6	16774-16776	F2	_
113-7	16777-16782	among	_
113-8	16783-16790	healthy	_
113-9	16791-16799	subjects	_
113-10	16800-16803	was	_
113-11	16804-16809	0.784	_
113-12	16810-16818	compared	_
113-13	16819-16823	with	_
113-14	16824-16829	0.531	_
113-15	16830-16835	among	_
113-16	16836-16849	schizophrenia	_
113-17	16850-16858	patients	_
113-18	16858-16859	.	_

#Text=The average score gap between Cz and FCz was 0.122 among healthy subjects and 0.186 among schizophrenia patients.
114-1	16860-16863	The	_
114-2	16864-16871	average	_
114-3	16872-16877	score	_
114-4	16878-16881	gap	_
114-5	16882-16889	between	_
114-6	16890-16892	Cz	_
114-7	16893-16896	and	_
114-8	16897-16900	FCz	_
114-9	16901-16904	was	_
114-10	16905-16910	0.122	_
114-11	16911-16916	among	_
114-12	16917-16924	healthy	_
114-13	16925-16933	subjects	_
114-14	16934-16937	and	_
114-15	16938-16943	0.186	_
114-16	16944-16949	among	_
114-17	16950-16963	schizophrenia	_
114-18	16964-16972	patients	_
114-19	16972-16973	.	_

#Text=(A): Connectivity map for healthy subjects, with respect to reference electrode O2 located on the posterior area of the scalp.
115-1	16974-16975	(	_
115-2	16975-16976	A	_
115-3	16976-16977	)	_
115-4	16977-16978	:	_
115-5	16979-16991	Connectivity	_
115-6	16992-16995	map	_
115-7	16996-16999	for	_
115-8	17000-17007	healthy	_
115-9	17008-17016	subjects	_
115-10	17016-17017	,	_
115-11	17018-17022	with	_
115-12	17023-17030	respect	_
115-13	17031-17033	to	_
115-14	17034-17043	reference	_
115-15	17044-17053	electrode	_
115-16	17054-17056	O2	_
115-17	17057-17064	located	_
115-18	17065-17067	on	_
115-19	17068-17071	the	_
115-20	17072-17081	posterior	_
115-21	17082-17086	area	_
115-22	17087-17089	of	_
115-23	17090-17093	the	_
115-24	17094-17099	scalp	_
115-25	17099-17100	.	_

#Text=(B): Connectivity map of schizophrenia patients with respect to the same base electrode, O2.
116-1	17101-17102	(	_
116-2	17102-17103	B	_
116-3	17103-17104	)	_
116-4	17104-17105	:	_
116-5	17106-17118	Connectivity	_
116-6	17119-17122	map	_
116-7	17123-17125	of	_
116-8	17126-17139	schizophrenia	_
116-9	17140-17148	patients	_
116-10	17149-17153	with	_
116-11	17154-17161	respect	_
116-12	17162-17164	to	_
116-13	17165-17168	the	_
116-14	17169-17173	same	_
116-15	17174-17178	base	_
116-16	17179-17188	electrode	_
116-17	17188-17189	,	_
116-18	17190-17192	O2	_
116-19	17192-17193	.	_

#Text=(C): Fisher score for the difference in each electrode’s connectivity with respect to reference electrode O2 between healthy subjects and schizophrenia patients.
117-1	17194-17195	(	_
117-2	17195-17196	C	_
117-3	17196-17197	)	_
117-4	17197-17198	:	_
117-5	17199-17205	Fisher	_
117-6	17206-17211	score	_
117-7	17212-17215	for	_
117-8	17216-17219	the	_
117-9	17220-17230	difference	_
117-10	17231-17233	in	_
117-11	17234-17238	each	_
117-12	17239-17248	electrode	_
117-13	17248-17249	’	_
117-14	17249-17250	s	_
117-15	17251-17263	connectivity	_
117-16	17264-17268	with	_
117-17	17269-17276	respect	_
117-18	17277-17279	to	_
117-19	17280-17289	reference	_
117-20	17290-17299	electrode	_
117-21	17300-17302	O2	_
117-22	17303-17310	between	_
117-23	17311-17318	healthy	_
117-24	17319-17327	subjects	_
117-25	17328-17331	and	_
117-26	17332-17345	schizophrenia	_
117-27	17346-17354	patients	_
117-28	17354-17355	.	_

#Text=The location from which significant gaps in the flow of information between healthy subjects and schizophrenia patients originate (with respect to the specific reference electrode) can be determined.
118-1	17356-17359	The	_
118-2	17360-17368	location	_
118-3	17369-17373	from	_
118-4	17374-17379	which	_
118-5	17380-17391	significant	_
118-6	17392-17396	gaps	_
118-7	17397-17399	in	_
118-8	17400-17403	the	_
118-9	17404-17408	flow	_
118-10	17409-17411	of	_
118-11	17412-17423	information	_
118-12	17424-17431	between	_
118-13	17432-17439	healthy	_
118-14	17440-17448	subjects	_
118-15	17449-17452	and	_
118-16	17453-17466	schizophrenia	_
118-17	17467-17475	patients	_
118-18	17476-17485	originate	_
118-19	17486-17487	(	_
118-20	17487-17491	with	_
118-21	17492-17499	respect	_
118-22	17500-17502	to	_
118-23	17503-17506	the	_
118-24	17507-17515	specific	_
118-25	17516-17525	reference	_
118-26	17526-17535	electrode	_
118-27	17535-17536	)	_
118-28	17537-17540	can	_
118-29	17541-17543	be	_
118-30	17544-17554	determined	_
118-31	17554-17555	.	_

#Text=Fig 4, below, shows connectivity maps of healthy and schizophrenia patients, with source electrode P7.
119-1	17556-17559	Fig	_
119-2	17560-17561	4	_
119-3	17561-17562	,	_
119-4	17563-17568	below	_
119-5	17568-17569	,	_
119-6	17570-17575	shows	_
119-7	17576-17588	connectivity	_
119-8	17589-17593	maps	_
119-9	17594-17596	of	_
119-10	17597-17604	healthy	_
119-11	17605-17608	and	_
119-12	17609-17622	schizophrenia	_
119-13	17623-17631	patients	_
119-14	17631-17632	,	_
119-15	17633-17637	with	_
119-16	17638-17644	source	_
119-17	17645-17654	electrode	_
119-18	17655-17657	P7	_
119-19	17657-17658	.	_

#Text=The average score for electrode F2 among healthy subjects was 0.797 compared with 0.596 among schizophrenia patients.
120-1	17659-17662	The	_
120-2	17663-17670	average	_
120-3	17671-17676	score	_
120-4	17677-17680	for	_
120-5	17681-17690	electrode	_
120-6	17691-17693	F2	_
120-7	17694-17699	among	_
120-8	17700-17707	healthy	_
120-9	17708-17716	subjects	_
120-10	17717-17720	was	_
120-11	17721-17726	0.797	_
120-12	17727-17735	compared	_
120-13	17736-17740	with	_
120-14	17741-17746	0.596	_
120-15	17747-17752	among	_
120-16	17753-17766	schizophrenia	_
120-17	17767-17775	patients	_
120-18	17775-17776	.	_

#Text=The average score gap between Cz and FCz was 0.083 among healthy subjects and 0.139 among schizophrenia patients.
121-1	17777-17780	The	_
121-2	17781-17788	average	_
121-3	17789-17794	score	_
121-4	17795-17798	gap	_
121-5	17799-17806	between	_
121-6	17807-17809	Cz	_
121-7	17810-17813	and	_
121-8	17814-17817	FCz	_
121-9	17818-17821	was	_
121-10	17822-17827	0.083	_
121-11	17828-17833	among	_
121-12	17834-17841	healthy	_
121-13	17842-17850	subjects	_
121-14	17851-17854	and	_
121-15	17855-17860	0.139	_
121-16	17861-17866	among	_
121-17	17867-17880	schizophrenia	_
121-18	17881-17889	patients	_
121-19	17889-17890	.	_

#Text=(A): Connectivity map for healthy subjects with respect to reference electrode P7, located in the posterior area of the scalp.
122-1	17891-17892	(	_
122-2	17892-17893	A	_
122-3	17893-17894	)	_
122-4	17894-17895	:	_
122-5	17896-17908	Connectivity	_
122-6	17909-17912	map	_
122-7	17913-17916	for	_
122-8	17917-17924	healthy	_
122-9	17925-17933	subjects	_
122-10	17934-17938	with	_
122-11	17939-17946	respect	_
122-12	17947-17949	to	_
122-13	17950-17959	reference	_
122-14	17960-17969	electrode	_
122-15	17970-17972	P7	_
122-16	17972-17973	,	_
122-17	17974-17981	located	_
122-18	17982-17984	in	_
122-19	17985-17988	the	_
122-20	17989-17998	posterior	_
122-21	17999-18003	area	_
122-22	18004-18006	of	_
122-23	18007-18010	the	_
122-24	18011-18016	scalp	_
122-25	18016-18017	.	_

#Text=(B): Connectivity map for schizophrenia patients with respect to the same base electrode, P7.
123-1	18018-18019	(	_
123-2	18019-18020	B	_
123-3	18020-18021	)	_
123-4	18021-18022	:	_
123-5	18023-18035	Connectivity	_
123-6	18036-18039	map	_
123-7	18040-18043	for	_
123-8	18044-18057	schizophrenia	_
123-9	18058-18066	patients	_
123-10	18067-18071	with	_
123-11	18072-18079	respect	_
123-12	18080-18082	to	_
123-13	18083-18086	the	_
123-14	18087-18091	same	_
123-15	18092-18096	base	_
123-16	18097-18106	electrode	_
123-17	18106-18107	,	_
123-18	18108-18110	P7	_
123-19	18110-18111	.	_

#Text=(C): Fisher score for the difference in each electrode’s connectivity with respect to reference electrode, P7, between healthy subjects and schizophrenia patients.
124-1	18112-18113	(	_
124-2	18113-18114	C	_
124-3	18114-18115	)	_
124-4	18115-18116	:	_
124-5	18117-18123	Fisher	_
124-6	18124-18129	score	_
124-7	18130-18133	for	_
124-8	18134-18137	the	_
124-9	18138-18148	difference	_
124-10	18149-18151	in	_
124-11	18152-18156	each	_
124-12	18157-18166	electrode	_
124-13	18166-18167	’	_
124-14	18167-18168	s	_
124-15	18169-18181	connectivity	_
124-16	18182-18186	with	_
124-17	18187-18194	respect	_
124-18	18195-18197	to	_
124-19	18198-18207	reference	_
124-20	18208-18217	electrode	_
124-21	18217-18218	,	_
124-22	18219-18221	P7	_
124-23	18221-18222	,	_
124-24	18223-18230	between	_
124-25	18231-18238	healthy	_
124-26	18239-18247	subjects	_
124-27	18248-18251	and	_
124-28	18252-18265	schizophrenia	_
124-29	18266-18274	patients	_
124-30	18274-18275	.	_

#Text=The location from which significant gaps in the flow of information between healthy subjects and schizophrenia patients (with respect to the specific reference electrode) can be determined.
125-1	18276-18279	The	_
125-2	18280-18288	location	_
125-3	18289-18293	from	_
125-4	18294-18299	which	_
125-5	18300-18311	significant	_
125-6	18312-18316	gaps	_
125-7	18317-18319	in	_
125-8	18320-18323	the	_
125-9	18324-18328	flow	_
125-10	18329-18331	of	_
125-11	18332-18343	information	_
125-12	18344-18351	between	_
125-13	18352-18359	healthy	_
125-14	18360-18368	subjects	_
125-15	18369-18372	and	_
125-16	18373-18386	schizophrenia	_
125-17	18387-18395	patients	_
125-18	18396-18397	(	_
125-19	18397-18401	with	_
125-20	18402-18409	respect	_
125-21	18410-18412	to	_
125-22	18413-18416	the	_
125-23	18417-18425	specific	_
125-24	18426-18435	reference	_
125-25	18436-18445	electrode	_
125-26	18445-18446	)	_
125-27	18447-18450	can	_
125-28	18451-18453	be	_
125-29	18454-18464	determined	_
125-30	18464-18465	.	_

#Text=Fig 5, below, shows connectivity maps for healthy and schizophrenia patients with source electrode P8.
126-1	18466-18469	Fig	_
126-2	18470-18471	5	_
126-3	18471-18472	,	_
126-4	18473-18478	below	_
126-5	18478-18479	,	_
126-6	18480-18485	shows	_
126-7	18486-18498	connectivity	_
126-8	18499-18503	maps	_
126-9	18504-18507	for	_
126-10	18508-18515	healthy	_
126-11	18516-18519	and	_
126-12	18520-18533	schizophrenia	_
126-13	18534-18542	patients	_
126-14	18543-18547	with	_
126-15	18548-18554	source	_
126-16	18555-18564	electrode	_
126-17	18565-18567	P8	_
126-18	18567-18568	.	_

#Text=The average score for electrode F2 among healthy subjects was 0.76 compared with 0.642 among schizophrenia patients.
127-1	18569-18572	The	_
127-2	18573-18580	average	_
127-3	18581-18586	score	_
127-4	18587-18590	for	_
127-5	18591-18600	electrode	_
127-6	18601-18603	F2	_
127-7	18604-18609	among	_
127-8	18610-18617	healthy	_
127-9	18618-18626	subjects	_
127-10	18627-18630	was	_
127-11	18631-18635	0.76	_
127-12	18636-18644	compared	_
127-13	18645-18649	with	_
127-14	18650-18655	0.642	_
127-15	18656-18661	among	_
127-16	18662-18675	schizophrenia	_
127-17	18676-18684	patients	_
127-18	18684-18685	.	_

#Text=The average score gap between Cz and FCz was 0.097 among healthy subjects and 0.14 among schizophrenia patients.
128-1	18686-18689	The	_
128-2	18690-18697	average	_
128-3	18698-18703	score	_
128-4	18704-18707	gap	_
128-5	18708-18715	between	_
128-6	18716-18718	Cz	_
128-7	18719-18722	and	_
128-8	18723-18726	FCz	_
128-9	18727-18730	was	_
128-10	18731-18736	0.097	_
128-11	18737-18742	among	_
128-12	18743-18750	healthy	_
128-13	18751-18759	subjects	_
128-14	18760-18763	and	_
128-15	18764-18768	0.14	_
128-16	18769-18774	among	_
128-17	18775-18788	schizophrenia	_
128-18	18789-18797	patients	_
128-19	18797-18798	.	_

#Text=(A): Connectivity map for healthy subjects with respect to reference electrode P8 located on the posterior area of the scalp.
129-1	18799-18800	(	_
129-2	18800-18801	A	_
129-3	18801-18802	)	_
129-4	18802-18803	:	_
129-5	18804-18816	Connectivity	_
129-6	18817-18820	map	_
129-7	18821-18824	for	_
129-8	18825-18832	healthy	_
129-9	18833-18841	subjects	_
129-10	18842-18846	with	_
129-11	18847-18854	respect	_
129-12	18855-18857	to	_
129-13	18858-18867	reference	_
129-14	18868-18877	electrode	_
129-15	18878-18880	P8	_
129-16	18881-18888	located	_
129-17	18889-18891	on	_
129-18	18892-18895	the	_
129-19	18896-18905	posterior	_
129-20	18906-18910	area	_
129-21	18911-18913	of	_
129-22	18914-18917	the	_
129-23	18918-18923	scalp	_
129-24	18923-18924	.	_

#Text=(B): Connectivity map for schizophrenia patients with respect to the same base electrode, P8.
130-1	18925-18926	(	_
130-2	18926-18927	B	_
130-3	18927-18928	)	_
130-4	18928-18929	:	_
130-5	18930-18942	Connectivity	_
130-6	18943-18946	map	_
130-7	18947-18950	for	_
130-8	18951-18964	schizophrenia	_
130-9	18965-18973	patients	_
130-10	18974-18978	with	_
130-11	18979-18986	respect	_
130-12	18987-18989	to	_
130-13	18990-18993	the	_
130-14	18994-18998	same	_
130-15	18999-19003	base	_
130-16	19004-19013	electrode	_
130-17	19013-19014	,	_
130-18	19015-19017	P8	_
130-19	19017-19018	.	_

#Text=(C): Fisher scores for the difference in each electrode’s connectivity with respect to the reference electrode, P8, between healthy subjects and schizophrenia patients.
131-1	19019-19020	(	_
131-2	19020-19021	C	_
131-3	19021-19022	)	_
131-4	19022-19023	:	_
131-5	19024-19030	Fisher	_
131-6	19031-19037	scores	_
131-7	19038-19041	for	_
131-8	19042-19045	the	_
131-9	19046-19056	difference	_
131-10	19057-19059	in	_
131-11	19060-19064	each	_
131-12	19065-19074	electrode	_
131-13	19074-19075	’	_
131-14	19075-19076	s	_
131-15	19077-19089	connectivity	_
131-16	19090-19094	with	_
131-17	19095-19102	respect	_
131-18	19103-19105	to	_
131-19	19106-19109	the	_
131-20	19110-19119	reference	_
131-21	19120-19129	electrode	_
131-22	19129-19130	,	_
131-23	19131-19133	P8	_
131-24	19133-19134	,	_
131-25	19135-19142	between	_
131-26	19143-19150	healthy	_
131-27	19151-19159	subjects	_
131-28	19160-19163	and	_
131-29	19164-19177	schizophrenia	_
131-30	19178-19186	patients	_
131-31	19186-19187	.	_

#Text=The location from which significant gaps in the flow of information between healthy individuals and schizophrenia patients (with respect to the specific reference electrode) can be determined.
#Text=3.3 Time windows exhibit strong differences in connectivity yet a high correlation in brain activity
#Text=Considering P9 as the source electrode and using a Euclidian distance function to find the closest activity states between patients and healthy individuals, a time window of 10 ms was found 420 ms after the appearance of the stimulus.
132-1	19188-19191	The	_
132-2	19192-19200	location	_
132-3	19201-19205	from	_
132-4	19206-19211	which	_
132-5	19212-19223	significant	_
132-6	19224-19228	gaps	_
132-7	19229-19231	in	_
132-8	19232-19235	the	_
132-9	19236-19240	flow	_
132-10	19241-19243	of	_
132-11	19244-19255	information	_
132-12	19256-19263	between	_
132-13	19264-19271	healthy	_
132-14	19272-19283	individuals	_
132-15	19284-19287	and	_
132-16	19288-19301	schizophrenia	_
132-17	19302-19310	patients	_
132-18	19311-19312	(	_
132-19	19312-19316	with	_
132-20	19317-19324	respect	_
132-21	19325-19327	to	_
132-22	19328-19331	the	_
132-23	19332-19340	specific	_
132-24	19341-19350	reference	_
132-25	19351-19360	electrode	_
132-26	19360-19361	)	_
132-27	19362-19365	can	_
132-28	19366-19368	be	_
132-29	19369-19379	determined	_
132-30	19379-19380	.	_
132-31	19381-19384	3.3	_
132-32	19385-19389	Time	_
132-33	19390-19397	windows	_
132-34	19398-19405	exhibit	_
132-35	19406-19412	strong	_
132-36	19413-19424	differences	_
132-37	19425-19427	in	_
132-38	19428-19440	connectivity	_
132-39	19441-19444	yet	_
132-40	19445-19446	a	_
132-41	19447-19451	high	_
132-42	19452-19463	correlation	_
132-43	19464-19466	in	_
132-44	19467-19472	brain	_
132-45	19473-19481	activity	_
132-46	19482-19493	Considering	_
132-47	19494-19496	P9	_
132-48	19497-19499	as	_
132-49	19500-19503	the	_
132-50	19504-19510	source	_
132-51	19511-19520	electrode	_
132-52	19521-19524	and	_
132-53	19525-19530	using	_
132-54	19531-19532	a	_
132-55	19533-19542	Euclidian	_
132-56	19543-19551	distance	_
132-57	19552-19560	function	_
132-58	19561-19563	to	_
132-59	19564-19568	find	_
132-60	19569-19572	the	_
132-61	19573-19580	closest	_
132-62	19581-19589	activity	_
132-63	19590-19596	states	_
132-64	19597-19604	between	_
132-65	19605-19613	patients	_
132-66	19614-19617	and	_
132-67	19618-19625	healthy	_
132-68	19626-19637	individuals	_
132-69	19637-19638	,	_
132-70	19639-19640	a	_
132-71	19641-19645	time	_
132-72	19646-19652	window	_
132-73	19653-19655	of	_
132-74	19656-19658	10	_
132-75	19659-19661	ms	_
132-76	19662-19665	was	_
132-77	19666-19671	found	_
132-78	19672-19675	420	_
132-79	19676-19678	ms	_
132-80	19679-19684	after	_
132-81	19685-19688	the	_
132-82	19689-19699	appearance	_
132-83	19700-19702	of	_
132-84	19703-19706	the	_
132-85	19707-19715	stimulus	_
132-86	19715-19716	.	_

#Text=Fig 6 below shows similar brain activity (in the top sub-plots) and relatively different connectivity distances (in the bottom sub-plots).
133-1	19717-19720	Fig	_
133-2	19721-19722	6	_
133-3	19723-19728	below	_
133-4	19729-19734	shows	_
133-5	19735-19742	similar	_
133-6	19743-19748	brain	_
133-7	19749-19757	activity	_
133-8	19758-19759	(	_
133-9	19759-19761	in	_
133-10	19762-19765	the	_
133-11	19766-19769	top	_
133-12	19770-19779	sub-plots	_
133-13	19779-19780	)	_
133-14	19781-19784	and	_
133-15	19785-19795	relatively	_
133-16	19796-19805	different	_
133-17	19806-19818	connectivity	_
133-18	19819-19828	distances	_
133-19	19829-19830	(	_
133-20	19830-19832	in	_
133-21	19833-19836	the	_
133-22	19837-19843	bottom	_
133-23	19844-19853	sub-plots	_
133-24	19853-19854	)	_
133-25	19854-19855	.	_

#Text=A (Top left): The brain activity of healthy subjects 420 ms after the presentation of a stimulus.
134-1	19856-19857	A	_
134-2	19858-19859	(	_
134-3	19859-19862	Top	_
134-4	19863-19867	left	_
134-5	19867-19868	)	_
134-6	19868-19869	:	_
134-7	19870-19873	The	_
134-8	19874-19879	brain	_
134-9	19880-19888	activity	_
134-10	19889-19891	of	_
134-11	19892-19899	healthy	_
134-12	19900-19908	subjects	_
134-13	19909-19912	420	_
134-14	19913-19915	ms	_
134-15	19916-19921	after	_
134-16	19922-19925	the	_
134-17	19926-19938	presentation	_
134-18	19939-19941	of	_
134-19	19942-19943	a	_
134-20	19944-19952	stimulus	_
134-21	19952-19953	.	_

#Text=Fig 6B (Top right): The brain activity of schizophrenia patients 420 ms after the presentation of a stimulus.
135-1	19954-19957	Fig	_
135-2	19958-19960	6B	_
135-3	19961-19962	(	_
135-4	19962-19965	Top	_
135-5	19966-19971	right	_
135-6	19971-19972	)	_
135-7	19972-19973	:	_
135-8	19974-19977	The	_
135-9	19978-19983	brain	_
135-10	19984-19992	activity	_
135-11	19993-19995	of	_
135-12	19996-20009	schizophrenia	_
135-13	20010-20018	patients	_
135-14	20019-20022	420	_
135-15	20023-20025	ms	_
135-16	20026-20031	after	_
135-17	20032-20035	the	_
135-18	20036-20048	presentation	_
135-19	20049-20051	of	_
135-20	20052-20053	a	_
135-21	20054-20062	stimulus	_
135-22	20062-20063	.	_

#Text=Fig 6C (Bottom left): The connectivity features obtained 420 ms after the presentation of a stimulus for healthy subjects.
136-1	20064-20067	Fig	_
136-2	20068-20070	6C	_
136-3	20071-20072	(	_
136-4	20072-20078	Bottom	_
136-5	20079-20083	left	_
136-6	20083-20084	)	_
136-7	20084-20085	:	_
136-8	20086-20089	The	_
136-9	20090-20102	connectivity	_
136-10	20103-20111	features	_
136-11	20112-20120	obtained	_
136-12	20121-20124	420	_
136-13	20125-20127	ms	_
136-14	20128-20133	after	_
136-15	20134-20137	the	_
136-16	20138-20150	presentation	_
136-17	20151-20153	of	_
136-18	20154-20155	a	_
136-19	20156-20164	stimulus	_
136-20	20165-20168	for	_
136-21	20169-20176	healthy	_
136-22	20177-20185	subjects	_
136-23	20185-20186	.	_

#Text=Fig 6D (Bottom right): The connectivity features obtained 420 ms after the presentation of a stimulus for schizophrenia patients.
137-1	20187-20190	Fig	_
137-2	20191-20193	6D	_
137-3	20194-20195	(	_
137-4	20195-20201	Bottom	_
137-5	20202-20207	right	_
137-6	20207-20208	)	_
137-7	20208-20209	:	_
137-8	20210-20213	The	_
137-9	20214-20226	connectivity	_
137-10	20227-20235	features	_
137-11	20236-20244	obtained	_
137-12	20245-20248	420	_
137-13	20249-20251	ms	_
137-14	20252-20257	after	_
137-15	20258-20261	the	_
137-16	20262-20274	presentation	_
137-17	20275-20277	of	_
137-18	20278-20279	a	_
137-19	20280-20288	stimulus	_
137-20	20289-20292	for	_
137-21	20293-20306	schizophrenia	_
137-22	20307-20315	patients	_
137-23	20315-20316	.	_

#Text=Strong connectivity can be observed within the healthy subjects, and weak connectivity can be observed within the schizophrenia patients, even though the general brain activity level is similar in both populations.
138-1	20317-20323	Strong	_
138-2	20324-20336	connectivity	_
138-3	20337-20340	can	_
138-4	20341-20343	be	_
138-5	20344-20352	observed	_
138-6	20353-20359	within	_
138-7	20360-20363	the	_
138-8	20364-20371	healthy	_
138-9	20372-20380	subjects	_
138-10	20380-20381	,	_
138-11	20382-20385	and	_
138-12	20386-20390	weak	_
138-13	20391-20403	connectivity	_
138-14	20404-20407	can	_
138-15	20408-20410	be	_
138-16	20411-20419	observed	_
138-17	20420-20426	within	_
138-18	20427-20430	the	_
138-19	20431-20444	schizophrenia	_
138-20	20445-20453	patients	_
138-21	20453-20454	,	_
138-22	20455-20459	even	_
138-23	20460-20466	though	_
138-24	20467-20470	the	_
138-25	20471-20478	general	_
138-26	20479-20484	brain	_
138-27	20485-20493	activity	_
138-28	20494-20499	level	_
138-29	20500-20502	is	_
138-30	20503-20510	similar	_
138-31	20511-20513	in	_
138-32	20514-20518	both	_
138-33	20519-20530	populations	_
138-34	20530-20531	.	_

#Text=Considering the average of all base electrodes from the posterior section of the scalp, the average time at which brain activity was most similar was at 404 ms post stimulus.
139-1	20532-20543	Considering	_
139-2	20544-20547	the	_
139-3	20548-20555	average	_
139-4	20556-20558	of	_
139-5	20559-20562	all	_
139-6	20563-20567	base	_
139-7	20568-20578	electrodes	_
139-8	20579-20583	from	_
139-9	20584-20587	the	_
139-10	20588-20597	posterior	_
139-11	20598-20605	section	_
139-12	20606-20608	of	_
139-13	20609-20612	the	_
139-14	20613-20618	scalp	_
139-15	20618-20619	,	_
139-16	20620-20623	the	_
139-17	20624-20631	average	_
139-18	20632-20636	time	_
139-19	20637-20639	at	_
139-20	20640-20645	which	_
139-21	20646-20651	brain	_
139-22	20652-20660	activity	_
139-23	20661-20664	was	_
139-24	20665-20669	most	_
139-25	20670-20677	similar	_
139-26	20678-20681	was	_
139-27	20682-20684	at	_
139-28	20685-20688	404	_
139-29	20689-20691	ms	_
139-30	20692-20696	post	_
139-31	20697-20705	stimulus	_
139-32	20705-20706	.	_

#Text=Among selected features by the methodology, the frequency 25 Hz - 30Hz was found most common (41%).
140-1	20707-20712	Among	_
140-2	20713-20721	selected	_
140-3	20722-20730	features	_
140-4	20731-20733	by	_
140-5	20734-20737	the	_
140-6	20738-20749	methodology	_
140-7	20749-20750	,	_
140-8	20751-20754	the	_
140-9	20755-20764	frequency	_
140-10	20765-20767	25	_
140-11	20768-20770	Hz	_
140-12	20771-20772	-	_
140-13	20773-20777	30Hz	_
140-14	20778-20781	was	_
140-15	20782-20787	found	_
140-16	20788-20792	most	_
140-17	20793-20799	common	_
140-18	20800-20801	(	_
140-19	20801-20804	41%	_
140-20	20804-20805	)	_
140-21	20805-20806	.	_

#Text=Such activity in low-gamma band indicates neural oscillation is similar given substantial time interval from the stimulus.
#Text=3.4 Fisher-based analysis to identify the most significant connectivity maps
#Text=Considering Fisher score averages for connections based on posterior base electrodes, Fig 7, below, shows a map of connections with a Fisher score higher than a threshold of 0.6.
141-1	20807-20811	Such	_
141-2	20812-20820	activity	_
141-3	20821-20823	in	_
141-4	20824-20833	low-gamma	_
141-5	20834-20838	band	_
141-6	20839-20848	indicates	_
141-7	20849-20855	neural	_
141-8	20856-20867	oscillation	_
141-9	20868-20870	is	_
141-10	20871-20878	similar	_
141-11	20879-20884	given	_
141-12	20885-20896	substantial	_
141-13	20897-20901	time	_
141-14	20902-20910	interval	_
141-15	20911-20915	from	_
141-16	20916-20919	the	_
141-17	20920-20928	stimulus	_
141-18	20928-20929	.	_
141-19	20930-20933	3.4	_
141-20	20934-20946	Fisher-based	_
141-21	20947-20955	analysis	_
141-22	20956-20958	to	_
141-23	20959-20967	identify	_
141-24	20968-20971	the	_
141-25	20972-20976	most	_
141-26	20977-20988	significant	_
141-27	20989-21001	connectivity	_
141-28	21002-21006	maps	_
141-29	21007-21018	Considering	_
141-30	21019-21025	Fisher	_
141-31	21026-21031	score	_
141-32	21032-21040	averages	_
141-33	21041-21044	for	_
141-34	21045-21056	connections	_
141-35	21057-21062	based	_
141-36	21063-21065	on	_
141-37	21066-21075	posterior	_
141-38	21076-21080	base	_
141-39	21081-21091	electrodes	_
141-40	21091-21092	,	_
141-41	21093-21096	Fig	_
141-42	21097-21098	7	_
141-43	21098-21099	,	_
141-44	21100-21105	below	_
141-45	21105-21106	,	_
141-46	21107-21112	shows	_
141-47	21113-21114	a	_
141-48	21115-21118	map	_
141-49	21119-21121	of	_
141-50	21122-21133	connections	_
141-51	21134-21138	with	_
141-52	21139-21140	a	_
141-53	21141-21147	Fisher	_
141-54	21148-21153	score	_
141-55	21154-21160	higher	_
141-56	21161-21165	than	_
141-57	21166-21167	a	_
141-58	21168-21177	threshold	_
141-59	21178-21180	of	_
141-60	21181-21184	0.6	_
141-61	21184-21185	.	_

#Text=Connectivity maps showing electrode connectivity from posterior sources to frontal destinations with Fisher scores of at least >0.6, zoomed in to the relevant interval.
142-1	21186-21198	Connectivity	_
142-2	21199-21203	maps	_
142-3	21204-21211	showing	_
142-4	21212-21221	electrode	_
142-5	21222-21234	connectivity	_
142-6	21235-21239	from	_
142-7	21240-21249	posterior	_
142-8	21250-21257	sources	_
142-9	21258-21260	to	_
142-10	21261-21268	frontal	_
142-11	21269-21281	destinations	_
142-12	21282-21286	with	_
142-13	21287-21293	Fisher	_
142-14	21294-21300	scores	_
142-15	21301-21303	of	_
142-16	21304-21306	at	_
142-17	21307-21312	least	_
142-18	21313-21314	>	_
142-19	21314-21317	0.6	_
142-20	21317-21318	,	_
142-21	21319-21325	zoomed	_
142-22	21326-21328	in	_
142-23	21329-21331	to	_
142-24	21332-21335	the	_
142-25	21336-21344	relevant	_
142-26	21345-21353	interval	_
142-27	21353-21354	.	_

#Text=After averaging the top 5 connection scores for each electrode, the following Fisher score connectivity map is obtained, as shown in Fig 8 below.
143-1	21355-21360	After	_
143-2	21361-21370	averaging	_
143-3	21371-21374	the	_
143-4	21375-21378	top	_
143-5	21379-21380	5	_
143-6	21381-21391	connection	_
143-7	21392-21398	scores	_
143-8	21399-21402	for	_
143-9	21403-21407	each	_
143-10	21408-21417	electrode	_
143-11	21417-21418	,	_
143-12	21419-21422	the	_
143-13	21423-21432	following	_
143-14	21433-21439	Fisher	_
143-15	21440-21445	score	_
143-16	21446-21458	connectivity	_
143-17	21459-21462	map	_
143-18	21463-21465	is	_
143-19	21466-21474	obtained	_
143-20	21474-21475	,	_
143-21	21476-21478	as	_
143-22	21479-21484	shown	_
143-23	21485-21487	in	_
143-24	21488-21491	Fig	_
143-25	21492-21493	8	_
143-26	21494-21499	below	_
143-27	21499-21500	.	_

#Text=The Fisher score for each electrode based on the average score of the top five maximal connections in which it is involved.
144-1	21501-21504	The	_
144-2	21505-21511	Fisher	_
144-3	21512-21517	score	_
144-4	21518-21521	for	_
144-5	21522-21526	each	_
144-6	21527-21536	electrode	_
144-7	21537-21542	based	_
144-8	21543-21545	on	_
144-9	21546-21549	the	_
144-10	21550-21557	average	_
144-11	21558-21563	score	_
144-12	21564-21566	of	_
144-13	21567-21570	the	_
144-14	21571-21574	top	_
144-15	21575-21579	five	_
144-16	21580-21587	maximal	_
144-17	21588-21599	connections	_
144-18	21600-21602	in	_
144-19	21603-21608	which	_
144-20	21609-21611	it	_
144-21	21612-21614	is	_
144-22	21615-21623	involved	_
144-23	21623-21624	.	_

#Text=There is a significant fall in the aggregated Fisher score in the prefrontal area from 0.4 to 2.
#Text=3.5 Accuracy of the prediction-based discrimination methodology
#Text=The accuracy of the connectivity maps in identifying schizophrenia was compared with that of several state-of-the-art methodologies for identifying this disorder.
145-1	21625-21630	There	_
145-2	21631-21633	is	_
145-3	21634-21635	a	_
145-4	21636-21647	significant	_
145-5	21648-21652	fall	_
145-6	21653-21655	in	_
145-7	21656-21659	the	_
145-8	21660-21670	aggregated	_
145-9	21671-21677	Fisher	_
145-10	21678-21683	score	_
145-11	21684-21686	in	_
145-12	21687-21690	the	_
145-13	21691-21701	prefrontal	_
145-14	21702-21706	area	_
145-15	21707-21711	from	_
145-16	21712-21715	0.4	_
145-17	21716-21718	to	_
145-18	21719-21720	2	_
145-19	21720-21721	.	_
145-20	21722-21725	3.5	_
145-21	21726-21734	Accuracy	_
145-22	21735-21737	of	_
145-23	21738-21741	the	_
145-24	21742-21758	prediction-based	_
145-25	21759-21773	discrimination	_
145-26	21774-21785	methodology	_
145-27	21786-21789	The	_
145-28	21790-21798	accuracy	_
145-29	21799-21801	of	_
145-30	21802-21805	the	_
145-31	21806-21818	connectivity	_
145-32	21819-21823	maps	_
145-33	21824-21826	in	_
145-34	21827-21838	identifying	_
145-35	21839-21852	schizophrenia	_
145-36	21853-21856	was	_
145-37	21857-21865	compared	_
145-38	21866-21870	with	_
145-39	21871-21875	that	_
145-40	21876-21878	of	_
145-41	21879-21886	several	_
145-42	21887-21903	state-of-the-art	_
145-43	21904-21917	methodologies	_
145-44	21918-21921	for	_
145-45	21922-21933	identifying	_
145-46	21934-21938	this	_
145-47	21939-21947	disorder	_
145-48	21947-21948	.	_

#Text=All methodologies were applied to the described dataset.
146-1	21949-21952	All	_
146-2	21953-21966	methodologies	_
146-3	21967-21971	were	_
146-4	21972-21979	applied	_
146-5	21980-21982	to	_
146-6	21983-21986	the	_
146-7	21987-21996	described	_
146-8	21997-22004	dataset	_
146-9	22004-22005	.	_

#Text=The output of each methodology per tested data was binary and total correct calls as percentage were used as measurement for accuracy.
147-1	22006-22009	The	_
147-2	22010-22016	output	_
147-3	22017-22019	of	_
147-4	22020-22024	each	_
147-5	22025-22036	methodology	_
147-6	22037-22040	per	_
147-7	22041-22047	tested	_
147-8	22048-22052	data	_
147-9	22053-22056	was	_
147-10	22057-22063	binary	_
147-11	22064-22067	and	_
147-12	22068-22073	total	_
147-13	22074-22081	correct	_
147-14	22082-22087	calls	_
147-15	22088-22090	as	_
147-16	22091-22101	percentage	_
147-17	22102-22106	were	_
147-18	22107-22111	used	_
147-19	22112-22114	as	_
147-20	22115-22126	measurement	_
147-21	22127-22130	for	_
147-22	22131-22139	accuracy	_
147-23	22139-22140	.	_

#Text=The methods compared included the following:
#Text=TFFO: time and frequency optimization-based methodology for distinguishing between healthy individuals and schizophrenia patients based on input from several electrodes .
148-1	22141-22144	The	_
148-2	22145-22152	methods	_
148-3	22153-22161	compared	_
148-4	22162-22170	included	_
148-5	22171-22174	the	_
148-6	22175-22184	following	_
148-7	22184-22185	:	_
148-8	22186-22190	TFFO	_
148-9	22190-22191	:	_
148-10	22192-22196	time	_
148-11	22197-22200	and	_
148-12	22201-22210	frequency	_
148-13	22211-22229	optimization-based	_
148-14	22230-22241	methodology	_
148-15	22242-22245	for	_
148-16	22246-22260	distinguishing	_
148-17	22261-22268	between	_
148-18	22269-22276	healthy	_
148-19	22277-22288	individuals	_
148-20	22289-22292	and	_
148-21	22293-22306	schizophrenia	_
148-22	22307-22315	patients	_
148-23	22316-22321	based	_
148-24	22322-22324	on	_
148-25	22325-22330	input	_
148-26	22331-22335	from	_
148-27	22336-22343	several	_
148-28	22344-22354	electrodes	_
148-29	22355-22356	.	_

#Text=P-300 derived features, as analyzed by “RT ANOVA”: a reaction times-based approach for discriminating between healthy individuals and patients diagnosed with schizophrenia .
149-1	22357-22358	P	_
149-2	22358-22359	-	_
149-3	22359-22362	300	_
149-4	22363-22370	derived	_
149-5	22371-22379	features	_
149-6	22379-22380	,	_
149-7	22381-22383	as	_
149-8	22384-22392	analyzed	_
149-9	22393-22395	by	_
149-10	22396-22397	“	_
149-11	22397-22399	RT	_
149-12	22400-22405	ANOVA	_
149-13	22405-22406	”	_
149-14	22406-22407	:	_
149-15	22408-22409	a	_
149-16	22410-22418	reaction	_
149-17	22419-22430	times-based	_
149-18	22431-22439	approach	_
149-19	22440-22443	for	_
149-20	22444-22458	discriminating	_
149-21	22459-22466	between	_
149-22	22467-22474	healthy	_
149-23	22475-22486	individuals	_
149-24	22487-22490	and	_
149-25	22491-22499	patients	_
149-26	22500-22509	diagnosed	_
149-27	22510-22514	with	_
149-28	22515-22528	schizophrenia	_
149-29	22529-22530	.	_

#Text=Latency-based methodologies: a basic comparison with subject latency analysis was performed by: (a) calculating for each stimulus its distance to peak energy amplitude and clustering using K-means (“PE-Latency”) , (b) repeating the post feature extraction methodology but replacing the time-frequency features with the distribution of the energy peak located in the P300 area (“P300-RF-Latency”) .
150-1	22531-22544	Latency-based	_
150-2	22545-22558	methodologies	_
150-3	22558-22559	:	_
150-4	22560-22561	a	_
150-5	22562-22567	basic	_
150-6	22568-22578	comparison	_
150-7	22579-22583	with	_
150-8	22584-22591	subject	_
150-9	22592-22599	latency	_
150-10	22600-22608	analysis	_
150-11	22609-22612	was	_
150-12	22613-22622	performed	_
150-13	22623-22625	by	_
150-14	22625-22626	:	_
150-15	22627-22628	(	_
150-16	22628-22629	a	_
150-17	22629-22630	)	_
150-18	22631-22642	calculating	_
150-19	22643-22646	for	_
150-20	22647-22651	each	_
150-21	22652-22660	stimulus	_
150-22	22661-22664	its	_
150-23	22665-22673	distance	_
150-24	22674-22676	to	_
150-25	22677-22681	peak	_
150-26	22682-22688	energy	_
150-27	22689-22698	amplitude	_
150-28	22699-22702	and	_
150-29	22703-22713	clustering	_
150-30	22714-22719	using	_
150-31	22720-22727	K-means	_
150-32	22728-22729	(	_
150-33	22729-22730	“	_
150-34	22730-22740	PE-Latency	_
150-35	22740-22741	”	_
150-36	22741-22742	)	_
150-37	22743-22744	,	_
150-38	22745-22746	(	_
150-39	22746-22747	b	_
150-40	22747-22748	)	_
150-41	22749-22758	repeating	_
150-42	22759-22762	the	_
150-43	22763-22767	post	_
150-44	22768-22775	feature	_
150-45	22776-22786	extraction	_
150-46	22787-22798	methodology	_
150-47	22799-22802	but	_
150-48	22803-22812	replacing	_
150-49	22813-22816	the	_
150-50	22817-22831	time-frequency	_
150-51	22832-22840	features	_
150-52	22841-22845	with	_
150-53	22846-22849	the	_
150-54	22850-22862	distribution	_
150-55	22863-22865	of	_
150-56	22866-22869	the	_
150-57	22870-22876	energy	_
150-58	22877-22881	peak	_
150-59	22882-22889	located	_
150-60	22890-22892	in	_
150-61	22893-22896	the	_
150-62	22897-22901	P300	_
150-63	22902-22906	area	_
150-64	22907-22908	(	_
150-65	22908-22909	“	_
150-66	22909-22913	P300	_
150-67	22913-22914	-	_
150-68	22914-22924	RF-Latency	_
150-69	22924-22925	”	_
150-70	22925-22926	)	_
150-71	22927-22928	.	_

#Text=“Direct connectivity only” approach: using the “Connectivity Maps” methodology without relative features (or using only CM_VAL-based features, as presented in section 2), simulating an approach to evaluating the connectivity between two nodes with data only from the pair itself.
151-1	22929-22930	“	_
151-2	22930-22936	Direct	_
151-3	22937-22949	connectivity	_
151-4	22950-22954	only	_
151-5	22954-22955	”	_
151-6	22956-22964	approach	_
151-7	22964-22965	:	_
151-8	22966-22971	using	_
151-9	22972-22975	the	_
151-10	22976-22977	“	_
151-11	22977-22989	Connectivity	_
151-12	22990-22994	Maps	_
151-13	22994-22995	”	_
151-14	22996-23007	methodology	_
151-15	23008-23015	without	_
151-16	23016-23024	relative	_
151-17	23025-23033	features	_
151-18	23034-23035	(	_
151-19	23035-23037	or	_
151-20	23038-23043	using	_
151-21	23044-23048	only	_
151-22	23049-23061	CM_VAL-based	_
151-23	23062-23070	features	_
151-24	23070-23071	,	_
151-25	23072-23074	as	_
151-26	23075-23084	presented	_
151-27	23085-23087	in	_
151-28	23088-23095	section	_
151-29	23096-23097	2	_
151-30	23097-23098	)	_
151-31	23098-23099	,	_
151-32	23100-23110	simulating	_
151-33	23111-23113	an	_
151-34	23114-23122	approach	_
151-35	23123-23125	to	_
151-36	23126-23136	evaluating	_
151-37	23137-23140	the	_
151-38	23141-23153	connectivity	_
151-39	23154-23161	between	_
151-40	23162-23165	two	_
151-41	23166-23171	nodes	_
151-42	23172-23176	with	_
151-43	23177-23181	data	_
151-44	23182-23186	only	_
151-45	23187-23191	from	_
151-46	23192-23195	the	_
151-47	23196-23200	pair	_
151-48	23201-23207	itself	_
151-49	23207-23208	.	_

#Text=Such an approach was used in a recently published patent .
152-1	23209-23213	Such	_
152-2	23214-23216	an	_
152-3	23217-23225	approach	_
152-4	23226-23229	was	_
152-5	23230-23234	used	_
152-6	23235-23237	in	_
152-7	23238-23239	a	_
152-8	23240-23248	recently	_
152-9	23249-23258	published	_
152-10	23259-23265	patent	_
152-11	23266-23267	.	_

#Text=The strongest 5 connectivity maps were chosen according to maximum Fisher scores, as shown above in Fig 6).
153-1	23268-23271	The	_
153-2	23272-23281	strongest	_
153-3	23282-23283	5	_
153-4	23284-23296	connectivity	_
153-5	23297-23301	maps	_
153-6	23302-23306	were	_
153-7	23307-23313	chosen	_
153-8	23314-23323	according	_
153-9	23324-23326	to	_
153-10	23327-23334	maximum	_
153-11	23335-23341	Fisher	_
153-12	23342-23348	scores	_
153-13	23348-23349	,	_
153-14	23350-23352	as	_
153-15	23353-23358	shown	_
153-16	23359-23364	above	_
153-17	23365-23367	in	_
153-18	23368-23371	Fig	_
153-19	23372-23373	6	_
153-20	23373-23374	)	_
153-21	23374-23375	.	_

#Text=The connectivity maps’ features were stable and consistent during the cross validation phase.
154-1	23376-23379	The	_
154-2	23380-23392	connectivity	_
154-3	23393-23397	maps	_
154-4	23397-23398	’	_
154-5	23399-23407	features	_
154-6	23408-23412	were	_
154-7	23413-23419	stable	_
154-8	23420-23423	and	_
154-9	23424-23434	consistent	_
154-10	23435-23441	during	_
154-11	23442-23445	the	_
154-12	23446-23451	cross	_
154-13	23452-23462	validation	_
154-14	23463-23468	phase	_
154-15	23468-23469	.	_

#Text=Maximal separation was achieved using 11 stimuli from the beginning of each recording.
155-1	23470-23477	Maximal	_
155-2	23478-23488	separation	_
155-3	23489-23492	was	_
155-4	23493-23501	achieved	_
155-5	23502-23507	using	_
155-6	23508-23510	11	_
155-7	23511-23518	stimuli	_
155-8	23519-23523	from	_
155-9	23524-23527	the	_
155-10	23528-23537	beginning	_
155-11	23538-23540	of	_
155-12	23541-23545	each	_
155-13	23546-23555	recording	_
155-14	23555-23556	.	_

#Text=The inclusion of all bands (use of a full set of bands) and use of the interval between 200 ms and 450 ms after the appearance of the stimulus helped to achieve the best result.
156-1	23557-23560	The	_
156-2	23561-23570	inclusion	_
156-3	23571-23573	of	_
156-4	23574-23577	all	_
156-5	23578-23583	bands	_
156-6	23584-23585	(	_
156-7	23585-23588	use	_
156-8	23589-23591	of	_
156-9	23592-23593	a	_
156-10	23594-23598	full	_
156-11	23599-23602	set	_
156-12	23603-23605	of	_
156-13	23606-23611	bands	_
156-14	23611-23612	)	_
156-15	23613-23616	and	_
156-16	23617-23620	use	_
156-17	23621-23623	of	_
156-18	23624-23627	the	_
156-19	23628-23636	interval	_
156-20	23637-23644	between	_
156-21	23645-23648	200	_
156-22	23649-23651	ms	_
156-23	23652-23655	and	_
156-24	23656-23659	450	_
156-25	23660-23662	ms	_
156-26	23663-23668	after	_
156-27	23669-23672	the	_
156-28	23673-23683	appearance	_
156-29	23684-23686	of	_
156-30	23687-23690	the	_
156-31	23691-23699	stimulus	_
156-32	23700-23706	helped	_
156-33	23707-23709	to	_
156-34	23710-23717	achieve	_
156-35	23718-23721	the	_
156-36	23722-23726	best	_
156-37	23727-23733	result	_
156-38	23733-23734	.	_

#Text=Using only 5 maximum-variance connections (involving a total of 5 electrodes) resulted in correct discrimination 92.1% of the time; this accuracy was very similar to that observed when using all connections (93.8%).
157-1	23735-23740	Using	_
157-2	23741-23745	only	_
157-3	23746-23747	5	_
157-4	23748-23764	maximum-variance	_
157-5	23765-23776	connections	_
157-6	23777-23778	(	_
157-7	23778-23787	involving	_
157-8	23788-23789	a	_
157-9	23790-23795	total	_
157-10	23796-23798	of	_
157-11	23799-23800	5	_
157-12	23801-23811	electrodes	_
157-13	23811-23812	)	_
157-14	23813-23821	resulted	_
157-15	23822-23824	in	_
157-16	23825-23832	correct	_
157-17	23833-23847	discrimination	_
157-18	23848-23853	92.1%	_
157-19	23854-23856	of	_
157-20	23857-23860	the	_
157-21	23861-23865	time	_
157-22	23865-23866	;	_
157-23	23867-23871	this	_
157-24	23872-23880	accuracy	_
157-25	23881-23884	was	_
157-26	23885-23889	very	_
157-27	23890-23897	similar	_
157-28	23898-23900	to	_
157-29	23901-23905	that	_
157-30	23906-23914	observed	_
157-31	23915-23919	when	_
157-32	23920-23925	using	_
157-33	23926-23929	all	_
157-34	23930-23941	connections	_
157-35	23942-23943	(	_
157-36	23943-23948	93.8%	_
157-37	23948-23949	)	_
157-38	23949-23950	.	_

#Text=In both cases, no false-positive cases with a strong statistical separation were observed (P = 0.0045).
158-1	23951-23953	In	_
158-2	23954-23958	both	_
158-3	23959-23964	cases	_
158-4	23964-23965	,	_
158-5	23966-23968	no	_
158-6	23969-23983	false-positive	_
158-7	23984-23989	cases	_
158-8	23990-23994	with	_
158-9	23995-23996	a	_
158-10	23997-24003	strong	_
158-11	24004-24015	statistical	_
158-12	24016-24026	separation	_
158-13	24027-24031	were	_
158-14	24032-24040	observed	_
158-15	24041-24042	(	_
158-16	24042-24043	P	_
158-17	24044-24045	=	_
158-18	24046-24052	0.0045	_
158-19	24052-24053	)	_
158-20	24053-24054	.	_

#Text=No predictive classification results using this set of parameters contained false positives (classifying healthy subjects as schizophrenia patients).
#Text=4.
159-1	24055-24057	No	_
159-2	24058-24068	predictive	_
159-3	24069-24083	classification	_
159-4	24084-24091	results	_
159-5	24092-24097	using	_
159-6	24098-24102	this	_
159-7	24103-24106	set	_
159-8	24107-24109	of	_
159-9	24110-24120	parameters	_
159-10	24121-24130	contained	_
159-11	24131-24136	false	_
159-12	24137-24146	positives	_
159-13	24147-24148	(	_
159-14	24148-24159	classifying	_
159-15	24160-24167	healthy	_
159-16	24168-24176	subjects	_
159-17	24177-24179	as	_
159-18	24180-24193	schizophrenia	_
159-19	24194-24202	patients	_
159-20	24202-24203	)	_
159-21	24203-24204	.	_
159-22	24205-24206	4	_
159-23	24206-24207	.	_

#Text=Discussion
#Text=We have presented a novel method for quantifying the connectivity between brain regions as measured by the correlation of activity among electrodes.
160-1	24208-24218	Discussion	_
160-2	24219-24221	We	_
160-3	24222-24226	have	_
160-4	24227-24236	presented	_
160-5	24237-24238	a	_
160-6	24239-24244	novel	_
160-7	24245-24251	method	_
160-8	24252-24255	for	_
160-9	24256-24267	quantifying	_
160-10	24268-24271	the	_
160-11	24272-24284	connectivity	_
160-12	24285-24292	between	_
160-13	24293-24298	brain	_
160-14	24299-24306	regions	_
160-15	24307-24309	as	_
160-16	24310-24318	measured	_
160-17	24319-24321	by	_
160-18	24322-24325	the	_
160-19	24326-24337	correlation	_
160-20	24338-24340	of	_
160-21	24341-24349	activity	_
160-22	24350-24355	among	_
160-23	24356-24366	electrodes	_
160-24	24366-24367	.	_

#Text=The novelty of this method is primarily due to two features of the method: i) a holistic view of the connectivity at every electrode is created, and this view is easily interpretable and summarizes the connectivity features, ii) a novel method is used to identify the initiating (reference) electrodes from which the connectivity map is most indicative of the difference between two pathologies.
161-1	24368-24371	The	_
161-2	24372-24379	novelty	_
161-3	24380-24382	of	_
161-4	24383-24387	this	_
161-5	24388-24394	method	_
161-6	24395-24397	is	_
161-7	24398-24407	primarily	_
161-8	24408-24411	due	_
161-9	24412-24414	to	_
161-10	24415-24418	two	_
161-11	24419-24427	features	_
161-12	24428-24430	of	_
161-13	24431-24434	the	_
161-14	24435-24441	method	_
161-15	24441-24442	:	_
161-16	24443-24444	i	_
161-17	24444-24445	)	_
161-18	24446-24447	a	_
161-19	24448-24456	holistic	_
161-20	24457-24461	view	_
161-21	24462-24464	of	_
161-22	24465-24468	the	_
161-23	24469-24481	connectivity	_
161-24	24482-24484	at	_
161-25	24485-24490	every	_
161-26	24491-24500	electrode	_
161-27	24501-24503	is	_
161-28	24504-24511	created	_
161-29	24511-24512	,	_
161-30	24513-24516	and	_
161-31	24517-24521	this	_
161-32	24522-24526	view	_
161-33	24527-24529	is	_
161-34	24530-24536	easily	_
161-35	24537-24550	interpretable	_
161-36	24551-24554	and	_
161-37	24555-24565	summarizes	_
161-38	24566-24569	the	_
161-39	24570-24582	connectivity	_
161-40	24583-24591	features	_
161-41	24591-24592	,	_
161-42	24593-24595	ii	_
161-43	24595-24596	)	_
161-44	24597-24598	a	_
161-45	24599-24604	novel	_
161-46	24605-24611	method	_
161-47	24612-24614	is	_
161-48	24615-24619	used	_
161-49	24620-24622	to	_
161-50	24623-24631	identify	_
161-51	24632-24635	the	_
161-52	24636-24646	initiating	_
161-53	24647-24648	(	_
161-54	24648-24657	reference	_
161-55	24657-24658	)	_
161-56	24659-24669	electrodes	_
161-57	24670-24674	from	_
161-58	24675-24680	which	_
161-59	24681-24684	the	_
161-60	24685-24697	connectivity	_
161-61	24698-24701	map	_
161-62	24702-24704	is	_
161-63	24705-24709	most	_
161-64	24710-24720	indicative	_
161-65	24721-24723	of	_
161-66	24724-24727	the	_
161-67	24728-24738	difference	_
161-68	24739-24746	between	_
161-69	24747-24750	two	_
161-70	24751-24762	pathologies	_
161-71	24762-24763	.	_

#Text=This method can be used to diagnose or monitor a pathology.
162-1	24764-24768	This	_
162-2	24769-24775	method	_
162-3	24776-24779	can	_
162-4	24780-24782	be	_
162-5	24783-24787	used	_
162-6	24788-24790	to	_
162-7	24791-24799	diagnose	_
162-8	24800-24802	or	_
162-9	24803-24810	monitor	_
162-10	24811-24812	a	_
162-11	24813-24822	pathology	_
162-12	24822-24823	.	_

#Text=An analysis of the results obtained using the schizophrenia data suggests the following conclusions:
#Text=I.
163-1	24824-24826	An	_
163-2	24827-24835	analysis	_
163-3	24836-24838	of	_
163-4	24839-24842	the	_
163-5	24843-24850	results	_
163-6	24851-24859	obtained	_
163-7	24860-24865	using	_
163-8	24866-24869	the	_
163-9	24870-24883	schizophrenia	_
163-10	24884-24888	data	_
163-11	24889-24897	suggests	_
163-12	24898-24901	the	_
163-13	24902-24911	following	_
163-14	24912-24923	conclusions	_
163-15	24923-24924	:	_
163-16	24925-24926	I	_
163-17	24926-24927	.	_

#Text=Connectivity maps with a strong ability to discriminate between healthy subjects and schizophrenia patients
#Text=The results presented in section 3.2 show a repeating pattern of substantial differences at prefrontal electrodes when the base electrodes are at the posterior part of the brain.
164-1	24928-24940	Connectivity	_
164-2	24941-24945	maps	_
164-3	24946-24950	with	_
164-4	24951-24952	a	_
164-5	24953-24959	strong	_
164-6	24960-24967	ability	_
164-7	24968-24970	to	_
164-8	24971-24983	discriminate	_
164-9	24984-24991	between	_
164-10	24992-24999	healthy	_
164-11	25000-25008	subjects	_
164-12	25009-25012	and	_
164-13	25013-25026	schizophrenia	_
164-14	25027-25035	patients	_
164-15	25036-25039	The	_
164-16	25040-25047	results	_
164-17	25048-25057	presented	_
164-18	25058-25060	in	_
164-19	25061-25068	section	_
164-20	25069-25072	3.2	_
164-21	25073-25077	show	_
164-22	25078-25079	a	_
164-23	25080-25089	repeating	_
164-24	25090-25097	pattern	_
164-25	25098-25100	of	_
164-26	25101-25112	substantial	_
164-27	25113-25124	differences	_
164-28	25125-25127	at	_
164-29	25128-25138	prefrontal	_
164-30	25139-25149	electrodes	_
164-31	25150-25154	when	_
164-32	25155-25158	the	_
164-33	25159-25163	base	_
164-34	25164-25174	electrodes	_
164-35	25175-25178	are	_
164-36	25179-25181	at	_
164-37	25182-25185	the	_
164-38	25186-25195	posterior	_
164-39	25196-25200	part	_
164-40	25201-25203	of	_
164-41	25204-25207	the	_
164-42	25208-25213	brain	_
164-43	25213-25214	.	_

#Text=Figs 3–5 demonstrate clearly how the degradation of connectivity strength is being accelerated within the patients.
165-1	25215-25219	Figs	_
165-2	25220-25221	3	_
165-3	25221-25222	–	_
165-4	25222-25223	5	_
165-5	25224-25235	demonstrate	_
165-6	25236-25243	clearly	_
165-7	25244-25247	how	_
165-8	25248-25251	the	_
165-9	25252-25263	degradation	_
165-10	25264-25266	of	_
165-11	25267-25279	connectivity	_
165-12	25280-25288	strength	_
165-13	25289-25291	is	_
165-14	25292-25297	being	_
165-15	25298-25309	accelerated	_
165-16	25310-25316	within	_
165-17	25317-25320	the	_
165-18	25321-25329	patients	_
165-19	25329-25330	.	_

#Text=Target electrode F2 brings an absolute score difference that ranges from 18.74% to 34.5% depending on the posterior reference electrode chosen.
166-1	25331-25337	Target	_
166-2	25338-25347	electrode	_
166-3	25348-25350	F2	_
166-4	25351-25357	brings	_
166-5	25358-25360	an	_
166-6	25361-25369	absolute	_
166-7	25370-25375	score	_
166-8	25376-25386	difference	_
166-9	25387-25391	that	_
166-10	25392-25398	ranges	_
166-11	25399-25403	from	_
166-12	25404-25410	18.74%	_
166-13	25411-25413	to	_
166-14	25414-25419	34.5%	_
166-15	25420-25429	depending	_
166-16	25430-25432	on	_
166-17	25433-25436	the	_
166-18	25437-25446	posterior	_
166-19	25447-25456	reference	_
166-20	25457-25466	electrode	_
166-21	25467-25473	chosen	_
166-22	25473-25474	.	_

#Text=Links in the prefrontal area also show significant differences in connectivity scores based on the selection of the posterior base electrodes.
167-1	25475-25480	Links	_
167-2	25481-25483	in	_
167-3	25484-25487	the	_
167-4	25488-25498	prefrontal	_
167-5	25499-25503	area	_
167-6	25504-25508	also	_
167-7	25509-25513	show	_
167-8	25514-25525	significant	_
167-9	25526-25537	differences	_
167-10	25538-25540	in	_
167-11	25541-25553	connectivity	_
167-12	25554-25560	scores	_
167-13	25561-25566	based	_
167-14	25567-25569	on	_
167-15	25570-25573	the	_
167-16	25574-25583	selection	_
167-17	25584-25586	of	_
167-18	25587-25590	the	_
167-19	25591-25600	posterior	_
167-20	25601-25605	base	_
167-21	25606-25616	electrodes	_
167-22	25616-25617	.	_

#Text=Specifically, the link Cz-FCz degradation gap between healthy subjects and schizophrenia patients ranges from 35.8% to 67.5%, with maximum results obtained with P7 as the base electrode.
168-1	25618-25630	Specifically	_
168-2	25630-25631	,	_
168-3	25632-25635	the	_
168-4	25636-25640	link	_
168-5	25641-25647	Cz-FCz	_
168-6	25648-25659	degradation	_
168-7	25660-25663	gap	_
168-8	25664-25671	between	_
168-9	25672-25679	healthy	_
168-10	25680-25688	subjects	_
168-11	25689-25692	and	_
168-12	25693-25706	schizophrenia	_
168-13	25707-25715	patients	_
168-14	25716-25722	ranges	_
168-15	25723-25727	from	_
168-16	25728-25733	35.8%	_
168-17	25734-25736	to	_
168-18	25737-25742	67.5%	_
168-19	25742-25743	,	_
168-20	25744-25748	with	_
168-21	25749-25756	maximum	_
168-22	25757-25764	results	_
168-23	25765-25773	obtained	_
168-24	25774-25778	with	_
168-25	25779-25781	P7	_
168-26	25782-25784	as	_
168-27	25785-25788	the	_
168-28	25789-25793	base	_
168-29	25794-25803	electrode	_
168-30	25803-25804	.	_

#Text=These results indicate that information relay changes in an abnormal manner primarily in the prefrontal area.
169-1	25805-25810	These	_
169-2	25811-25818	results	_
169-3	25819-25827	indicate	_
169-4	25828-25832	that	_
169-5	25833-25844	information	_
169-6	25845-25850	relay	_
169-7	25851-25858	changes	_
169-8	25859-25861	in	_
169-9	25862-25864	an	_
169-10	25865-25873	abnormal	_
169-11	25874-25880	manner	_
169-12	25881-25890	primarily	_
169-13	25891-25893	in	_
169-14	25894-25897	the	_
169-15	25898-25908	prefrontal	_
169-16	25909-25913	area	_
169-17	25913-25914	.	_

#Text=These results correlate with past connectivity analyses conducted using fMRI .
170-1	25915-25920	These	_
170-2	25921-25928	results	_
170-3	25929-25938	correlate	_
170-4	25939-25943	with	_
170-5	25944-25948	past	_
170-6	25949-25961	connectivity	_
170-7	25962-25970	analyses	_
170-8	25971-25980	conducted	_
170-9	25981-25986	using	_
170-10	25987-25991	fMRI	_
170-11	25992-25993	.	_

#Text=A high difference in the score of target electrode F2 has been found in previous work using the TFFO method ; in that study, F2 was found to be able to discriminate between healthy subjects and schizophrenia patients better than any other single electrode.
171-1	25994-25995	A	_
171-2	25996-26000	high	_
171-3	26001-26011	difference	_
171-4	26012-26014	in	_
171-5	26015-26018	the	_
171-6	26019-26024	score	_
171-7	26025-26027	of	_
171-8	26028-26034	target	_
171-9	26035-26044	electrode	_
171-10	26045-26047	F2	_
171-11	26048-26051	has	_
171-12	26052-26056	been	_
171-13	26057-26062	found	_
171-14	26063-26065	in	_
171-15	26066-26074	previous	_
171-16	26075-26079	work	_
171-17	26080-26085	using	_
171-18	26086-26089	the	_
171-19	26090-26094	TFFO	_
171-20	26095-26101	method	_
171-21	26102-26103	;	_
171-22	26104-26106	in	_
171-23	26107-26111	that	_
171-24	26112-26117	study	_
171-25	26117-26118	,	_
171-26	26119-26121	F2	_
171-27	26122-26125	was	_
171-28	26126-26131	found	_
171-29	26132-26134	to	_
171-30	26135-26137	be	_
171-31	26138-26142	able	_
171-32	26143-26145	to	_
171-33	26146-26158	discriminate	_
171-34	26159-26166	between	_
171-35	26167-26174	healthy	_
171-36	26175-26183	subjects	_
171-37	26184-26187	and	_
171-38	26188-26201	schizophrenia	_
171-39	26202-26210	patients	_
171-40	26211-26217	better	_
171-41	26218-26222	than	_
171-42	26223-26226	any	_
171-43	26227-26232	other	_
171-44	26233-26239	single	_
171-45	26240-26249	electrode	_
171-46	26249-26250	.	_

#Text=Frontal electrodes have previously been shown to be significant in recent research that addressed schizophrenia , together with other illnesses with psychiatric components, such as Parkinson’s disease .
172-1	26251-26258	Frontal	_
172-2	26259-26269	electrodes	_
172-3	26270-26274	have	_
172-4	26275-26285	previously	_
172-5	26286-26290	been	_
172-6	26291-26296	shown	_
172-7	26297-26299	to	_
172-8	26300-26302	be	_
172-9	26303-26314	significant	_
172-10	26315-26317	in	_
172-11	26318-26324	recent	_
172-12	26325-26333	research	_
172-13	26334-26338	that	_
172-14	26339-26348	addressed	_
172-15	26349-26362	schizophrenia	_
172-16	26363-26364	,	_
172-17	26365-26373	together	_
172-18	26374-26378	with	_
172-19	26379-26384	other	_
172-20	26385-26394	illnesses	_
172-21	26395-26399	with	_
172-22	26400-26411	psychiatric	_
172-23	26412-26422	components	_
172-24	26422-26423	,	_
172-25	26424-26428	such	_
172-26	26429-26431	as	_
172-27	26432-26441	Parkinson	_
172-28	26441-26442	’	_
172-29	26442-26443	s	_
172-30	26444-26451	disease	_
172-31	26452-26453	.	_

#Text=The results in both scenarios—using all the Connectivity Maps and using those from picked 5 electrodes—featured no cases of false-positives.
173-1	26454-26457	The	_
173-2	26458-26465	results	_
173-3	26466-26468	in	_
173-4	26469-26473	both	_
173-5	26474-26489	scenarios—using	_
173-6	26490-26493	all	_
173-7	26494-26497	the	_
173-8	26498-26510	Connectivity	_
173-9	26511-26515	Maps	_
173-10	26516-26519	and	_
173-11	26520-26525	using	_
173-12	26526-26531	those	_
173-13	26532-26536	from	_
173-14	26537-26543	picked	_
173-15	26544-26545	5	_
173-16	26546-26565	electrodes—featured	_
173-17	26566-26568	no	_
173-18	26569-26574	cases	_
173-19	26575-26577	of	_
173-20	26578-26593	false-positives	_
173-21	26593-26594	.	_

#Text=This is an indication that the Connectivity Maps’ features are powerful for discriminating between the healthy subjects and the Schizophrenia patients with less disease severity, that were the main source of false-positives in previous work .
174-1	26595-26599	This	_
174-2	26600-26602	is	_
174-3	26603-26605	an	_
174-4	26606-26616	indication	_
174-5	26617-26621	that	_
174-6	26622-26625	the	_
174-7	26626-26638	Connectivity	_
174-8	26639-26643	Maps	_
174-9	26643-26644	’	_
174-10	26645-26653	features	_
174-11	26654-26657	are	_
174-12	26658-26666	powerful	_
174-13	26667-26670	for	_
174-14	26671-26685	discriminating	_
174-15	26686-26693	between	_
174-16	26694-26697	the	_
174-17	26698-26705	healthy	_
174-18	26706-26714	subjects	_
174-19	26715-26718	and	_
174-20	26719-26722	the	_
174-21	26723-26736	Schizophrenia	_
174-22	26737-26745	patients	_
174-23	26746-26750	with	_
174-24	26751-26755	less	_
174-25	26756-26763	disease	_
174-26	26764-26772	severity	_
174-27	26772-26773	,	_
174-28	26774-26778	that	_
174-29	26779-26783	were	_
174-30	26784-26787	the	_
174-31	26788-26792	main	_
174-32	26793-26799	source	_
174-33	26800-26802	of	_
174-34	26803-26818	false-positives	_
174-35	26819-26821	in	_
174-36	26822-26830	previous	_
174-37	26831-26835	work	_
174-38	26836-26837	.	_

#Text=It shall be also noted that while “Leave One Out” is a standard cross-validation technique, it is known to be relatively optimistic  and more likely statistically to converge with lower false positives, especially when analyzing relatively small data sets.
175-1	26838-26840	It	_
175-2	26841-26846	shall	_
175-3	26847-26849	be	_
175-4	26850-26854	also	_
175-5	26855-26860	noted	_
175-6	26861-26865	that	_
175-7	26866-26871	while	_
175-8	26872-26873	“	_
175-9	26873-26878	Leave	_
175-10	26879-26882	One	_
175-11	26883-26886	Out	_
175-12	26886-26887	”	_
175-13	26888-26890	is	_
175-14	26891-26892	a	_
175-15	26893-26901	standard	_
175-16	26902-26918	cross-validation	_
175-17	26919-26928	technique	_
175-18	26928-26929	,	_
175-19	26930-26932	it	_
175-20	26933-26935	is	_
175-21	26936-26941	known	_
175-22	26942-26944	to	_
175-23	26945-26947	be	_
175-24	26948-26958	relatively	_
175-25	26959-26969	optimistic	_
175-26	26971-26974	and	_
175-27	26975-26979	more	_
175-28	26980-26986	likely	_
175-29	26987-27000	statistically	_
175-30	27001-27003	to	_
175-31	27004-27012	converge	_
175-32	27013-27017	with	_
175-33	27018-27023	lower	_
175-34	27024-27029	false	_
175-35	27030-27039	positives	_
175-36	27039-27040	,	_
175-37	27041-27051	especially	_
175-38	27052-27056	when	_
175-39	27057-27066	analyzing	_
175-40	27067-27077	relatively	_
175-41	27078-27083	small	_
175-42	27084-27088	data	_
175-43	27089-27093	sets	_
175-44	27093-27094	.	_

#Text=II.
176-1	27095-27097	II	_
176-2	27097-27098	.	_

#Text=Time windows in which a substantial difference in connectivity is observed yet in which brain activity is highly correlated
#Text=As presented in section 3.3, connectivity features were not necessarily correlated with brain activity.
177-1	27099-27103	Time	_
177-2	27104-27111	windows	_
177-3	27112-27114	in	_
177-4	27115-27120	which	_
177-5	27121-27122	a	_
177-6	27123-27134	substantial	_
177-7	27135-27145	difference	_
177-8	27146-27148	in	_
177-9	27149-27161	connectivity	_
177-10	27162-27164	is	_
177-11	27165-27173	observed	_
177-12	27174-27177	yet	_
177-13	27178-27180	in	_
177-14	27181-27186	which	_
177-15	27187-27192	brain	_
177-16	27193-27201	activity	_
177-17	27202-27204	is	_
177-18	27205-27211	highly	_
177-19	27212-27222	correlated	_
177-20	27223-27225	As	_
177-21	27226-27235	presented	_
177-22	27236-27238	in	_
177-23	27239-27246	section	_
177-24	27247-27250	3.3	_
177-25	27250-27251	,	_
177-26	27252-27264	connectivity	_
177-27	27265-27273	features	_
177-28	27274-27278	were	_
177-29	27279-27282	not	_
177-30	27283-27294	necessarily	_
177-31	27295-27305	correlated	_
177-32	27306-27310	with	_
177-33	27311-27316	brain	_
177-34	27317-27325	activity	_
177-35	27325-27326	.	_

#Text=Between 400 and 425 ms post stimulus, when brain activity was most similar between healthy individuals and schizophrenia patients, connectivity features differed significantly.
178-1	27327-27334	Between	_
178-2	27335-27338	400	_
178-3	27339-27342	and	_
178-4	27343-27346	425	_
178-5	27347-27349	ms	_
178-6	27350-27354	post	_
178-7	27355-27363	stimulus	_
178-8	27363-27364	,	_
178-9	27365-27369	when	_
178-10	27370-27375	brain	_
178-11	27376-27384	activity	_
178-12	27385-27388	was	_
178-13	27389-27393	most	_
178-14	27394-27401	similar	_
178-15	27402-27409	between	_
178-16	27410-27417	healthy	_
178-17	27418-27429	individuals	_
178-18	27430-27433	and	_
178-19	27434-27447	schizophrenia	_
178-20	27448-27456	patients	_
178-21	27456-27457	,	_
178-22	27458-27470	connectivity	_
178-23	27471-27479	features	_
178-24	27480-27488	differed	_
178-25	27489-27502	significantly	_
178-26	27502-27503	.	_

#Text=Maximal classification accuracy was obtained in the time window of 200 ms-450 ms, suggesting that the P300 area is most able to discriminate between patients and health individuals, as was suggested previously .
179-1	27504-27511	Maximal	_
179-2	27512-27526	classification	_
179-3	27527-27535	accuracy	_
179-4	27536-27539	was	_
179-5	27540-27548	obtained	_
179-6	27549-27551	in	_
179-7	27552-27555	the	_
179-8	27556-27560	time	_
179-9	27561-27567	window	_
179-10	27568-27570	of	_
179-11	27571-27574	200	_
179-12	27575-27577	ms	_
179-13	27577-27578	-	_
179-14	27578-27581	450	_
179-15	27582-27584	ms	_
179-16	27584-27585	,	_
179-17	27586-27596	suggesting	_
179-18	27597-27601	that	_
179-19	27602-27605	the	_
179-20	27606-27610	P300	_
179-21	27611-27615	area	_
179-22	27616-27618	is	_
179-23	27619-27623	most	_
179-24	27624-27628	able	_
179-25	27629-27631	to	_
179-26	27632-27644	discriminate	_
179-27	27645-27652	between	_
179-28	27653-27661	patients	_
179-29	27662-27665	and	_
179-30	27666-27672	health	_
179-31	27673-27684	individuals	_
179-32	27684-27685	,	_
179-33	27686-27688	as	_
179-34	27689-27692	was	_
179-35	27693-27702	suggested	_
179-36	27703-27713	previously	_
179-37	27714-27715	.	_

#Text=There is also a ‘latency recovery’ effect, in which schizophrenia patients’ response times to a stimulus improved during the recording when the stimulus was followed by a visual analysis task.
180-1	27716-27721	There	_
180-2	27722-27724	is	_
180-3	27725-27729	also	_
180-4	27730-27731	a	_
180-5	27732-27733	‘	_
180-6	27733-27740	latency	_
180-7	27741-27749	recovery	_
180-8	27749-27750	’	_
180-9	27751-27757	effect	_
180-10	27757-27758	,	_
180-11	27759-27761	in	_
180-12	27762-27767	which	_
180-13	27768-27781	schizophrenia	_
180-14	27782-27790	patients	_
180-15	27790-27791	’	_
180-16	27792-27800	response	_
180-17	27801-27806	times	_
180-18	27807-27809	to	_
180-19	27810-27811	a	_
180-20	27812-27820	stimulus	_
180-21	27821-27829	improved	_
180-22	27830-27836	during	_
180-23	27837-27840	the	_
180-24	27841-27850	recording	_
180-25	27851-27855	when	_
180-26	27856-27859	the	_
180-27	27860-27868	stimulus	_
180-28	27869-27872	was	_
180-29	27873-27881	followed	_
180-30	27882-27884	by	_
180-31	27885-27886	a	_
180-32	27887-27893	visual	_
180-33	27894-27902	analysis	_
180-34	27903-27907	task	_
180-35	27907-27908	.	_

#Text=Such an effect is evident in a number of psychiatric illnesses .
181-1	27909-27913	Such	_
181-2	27914-27916	an	_
181-3	27917-27923	effect	_
181-4	27924-27926	is	_
181-5	27927-27934	evident	_
181-6	27935-27937	in	_
181-7	27938-27939	a	_
181-8	27940-27946	number	_
181-9	27947-27949	of	_
181-10	27950-27961	psychiatric	_
181-11	27962-27971	illnesses	_
181-12	27972-27973	.	_

#Text=Our connectivity maps features demonstrated strong connectivity in both the posterior and the prefrontal/frontal areas within healthy subjects, while strong connectivity was only observed in the posterior area within the patients with schizophrenia.
182-1	27974-27977	Our	_
182-2	27978-27990	connectivity	_
182-3	27991-27995	maps	_
182-4	27996-28004	features	_
182-5	28005-28017	demonstrated	_
182-6	28018-28024	strong	_
182-7	28025-28037	connectivity	_
182-8	28038-28040	in	_
182-9	28041-28045	both	_
182-10	28046-28049	the	_
182-11	28050-28059	posterior	_
182-12	28060-28063	and	_
182-13	28064-28067	the	_
182-14	28068-28078	prefrontal	_
182-15	28078-28079	/	_
182-16	28079-28086	frontal	_
182-17	28087-28092	areas	_
182-18	28093-28099	within	_
182-19	28100-28107	healthy	_
182-20	28108-28116	subjects	_
182-21	28116-28117	,	_
182-22	28118-28123	while	_
182-23	28124-28130	strong	_
182-24	28131-28143	connectivity	_
182-25	28144-28147	was	_
182-26	28148-28152	only	_
182-27	28153-28161	observed	_
182-28	28162-28164	in	_
182-29	28165-28168	the	_
182-30	28169-28178	posterior	_
182-31	28179-28183	area	_
182-32	28184-28190	within	_
182-33	28191-28194	the	_
182-34	28195-28203	patients	_
182-35	28204-28208	with	_
182-36	28209-28222	schizophrenia	_
182-37	28222-28223	.	_

#Text=As this observation is consistent with previous findings of posterior-frontal differences , it provides clear evidence of the independence of the features obtained in relation to more common brain activity measurements used as input for feature classification.
183-1	28224-28226	As	_
183-2	28227-28231	this	_
183-3	28232-28243	observation	_
183-4	28244-28246	is	_
183-5	28247-28257	consistent	_
183-6	28258-28262	with	_
183-7	28263-28271	previous	_
183-8	28272-28280	findings	_
183-9	28281-28283	of	_
183-10	28284-28301	posterior-frontal	_
183-11	28302-28313	differences	_
183-12	28314-28315	,	_
183-13	28316-28318	it	_
183-14	28319-28327	provides	_
183-15	28328-28333	clear	_
183-16	28334-28342	evidence	_
183-17	28343-28345	of	_
183-18	28346-28349	the	_
183-19	28350-28362	independence	_
183-20	28363-28365	of	_
183-21	28366-28369	the	_
183-22	28370-28378	features	_
183-23	28379-28387	obtained	_
183-24	28388-28390	in	_
183-25	28391-28399	relation	_
183-26	28400-28402	to	_
183-27	28403-28407	more	_
183-28	28408-28414	common	_
183-29	28415-28420	brain	_
183-30	28421-28429	activity	_
183-31	28430-28442	measurements	_
183-32	28443-28447	used	_
183-33	28448-28450	as	_
183-34	28451-28456	input	_
183-35	28457-28460	for	_
183-36	28461-28468	feature	_
183-37	28469-28483	classification	_
183-38	28483-28484	.	_

#Text=Methodology results demonstrated significantly superior results to the standard latency-based methodologies .
184-1	28485-28496	Methodology	_
184-2	28497-28504	results	_
184-3	28505-28517	demonstrated	_
184-4	28518-28531	significantly	_
184-5	28532-28540	superior	_
184-6	28541-28548	results	_
184-7	28549-28551	to	_
184-8	28552-28555	the	_
184-9	28556-28564	standard	_
184-10	28565-28578	latency-based	_
184-11	28579-28592	methodologies	_
184-12	28593-28594	.	_

#Text=III.
185-1	28595-28598	III	_
185-2	28598-28599	.	_

#Text=Fisher-based analysis to obtain connectivity maps using the most significant connections
#Text=In the results in section 3.4, one can see that the most significant results in the aggregated Fisher score matrix (as presented in Fig 8) involve the posterior electrodes and the frontal electrodes.
186-1	28600-28612	Fisher-based	_
186-2	28613-28621	analysis	_
186-3	28622-28624	to	_
186-4	28625-28631	obtain	_
186-5	28632-28644	connectivity	_
186-6	28645-28649	maps	_
186-7	28650-28655	using	_
186-8	28656-28659	the	_
186-9	28660-28664	most	_
186-10	28665-28676	significant	_
186-11	28677-28688	connections	_
186-12	28689-28691	In	_
186-13	28692-28695	the	_
186-14	28696-28703	results	_
186-15	28704-28706	in	_
186-16	28707-28714	section	_
186-17	28715-28718	3.4	_
186-18	28718-28719	,	_
186-19	28720-28723	one	_
186-20	28724-28727	can	_
186-21	28728-28731	see	_
186-22	28732-28736	that	_
186-23	28737-28740	the	_
186-24	28741-28745	most	_
186-25	28746-28757	significant	_
186-26	28758-28765	results	_
186-27	28766-28768	in	_
186-28	28769-28772	the	_
186-29	28773-28783	aggregated	_
186-30	28784-28790	Fisher	_
186-31	28791-28796	score	_
186-32	28797-28803	matrix	_
186-33	28804-28805	(	_
186-34	28805-28807	as	_
186-35	28808-28817	presented	_
186-36	28818-28820	in	_
186-37	28821-28824	Fig	_
186-38	28825-28826	8	_
186-39	28826-28827	)	_
186-40	28828-28835	involve	_
186-41	28836-28839	the	_
186-42	28840-28849	posterior	_
186-43	28850-28860	electrodes	_
186-44	28861-28864	and	_
186-45	28865-28868	the	_
186-46	28869-28876	frontal	_
186-47	28877-28887	electrodes	_
186-48	28887-28888	.	_

#Text=Delving into the data more deeply (such as in the zoomed area shown in Fig 7) reveals that the most significant connections are long-distance ones (connections between posterior electrodes and frontal electrodes, instead of close connections).
187-1	28889-28896	Delving	_
187-2	28897-28901	into	_
187-3	28902-28905	the	_
187-4	28906-28910	data	_
187-5	28911-28915	more	_
187-6	28916-28922	deeply	_
187-7	28923-28924	(	_
187-8	28924-28928	such	_
187-9	28929-28931	as	_
187-10	28932-28934	in	_
187-11	28935-28938	the	_
187-12	28939-28945	zoomed	_
187-13	28946-28950	area	_
187-14	28951-28956	shown	_
187-15	28957-28959	in	_
187-16	28960-28963	Fig	_
187-17	28964-28965	7	_
187-18	28965-28966	)	_
187-19	28967-28974	reveals	_
187-20	28975-28979	that	_
187-21	28980-28983	the	_
187-22	28984-28988	most	_
187-23	28989-29000	significant	_
187-24	29001-29012	connections	_
187-25	29013-29016	are	_
187-26	29017-29030	long-distance	_
187-27	29031-29035	ones	_
187-28	29036-29037	(	_
187-29	29037-29048	connections	_
187-30	29049-29056	between	_
187-31	29057-29066	posterior	_
187-32	29067-29077	electrodes	_
187-33	29078-29081	and	_
187-34	29082-29089	frontal	_
187-35	29090-29100	electrodes	_
187-36	29100-29101	,	_
187-37	29102-29109	instead	_
187-38	29110-29112	of	_
187-39	29113-29118	close	_
187-40	29119-29130	connections	_
187-41	29130-29131	)	_
187-42	29131-29132	.	_

#Text=Fig 8 also reveals that the smallest number of electrodes with such significant connections can be observed in the central/central parietal area, between Cz and CPz, for example.
188-1	29133-29136	Fig	_
188-2	29137-29138	8	_
188-3	29139-29143	also	_
188-4	29144-29151	reveals	_
188-5	29152-29156	that	_
188-6	29157-29160	the	_
188-7	29161-29169	smallest	_
188-8	29170-29176	number	_
188-9	29177-29179	of	_
188-10	29180-29190	electrodes	_
188-11	29191-29195	with	_
188-12	29196-29200	such	_
188-13	29201-29212	significant	_
188-14	29213-29224	connections	_
188-15	29225-29228	can	_
188-16	29229-29231	be	_
188-17	29232-29240	observed	_
188-18	29241-29243	in	_
188-19	29244-29247	the	_
188-20	29248-29255	central	_
188-21	29255-29256	/	_
188-22	29256-29263	central	_
188-23	29264-29272	parietal	_
188-24	29273-29277	area	_
188-25	29277-29278	,	_
188-26	29279-29286	between	_
188-27	29287-29289	Cz	_
188-28	29290-29293	and	_
188-29	29294-29297	CPz	_
188-30	29297-29298	,	_
188-31	29299-29302	for	_
188-32	29303-29310	example	_
188-33	29310-29311	.	_

#Text=There are two implications to these findings.
189-1	29312-29317	There	_
189-2	29318-29321	are	_
189-3	29322-29325	two	_
189-4	29326-29338	implications	_
189-5	29339-29341	to	_
189-6	29342-29347	these	_
189-7	29348-29356	findings	_
189-8	29356-29357	.	_

#Text=First, they support the claim that measuring the connectivity strength between the most posterior electrode and the frontal electrode is a strong tool for classifying and predicting schizophrenia.
190-1	29358-29363	First	_
190-2	29363-29364	,	_
190-3	29365-29369	they	_
190-4	29370-29377	support	_
190-5	29378-29381	the	_
190-6	29382-29387	claim	_
190-7	29388-29392	that	_
190-8	29393-29402	measuring	_
190-9	29403-29406	the	_
190-10	29407-29419	connectivity	_
190-11	29420-29428	strength	_
190-12	29429-29436	between	_
190-13	29437-29440	the	_
190-14	29441-29445	most	_
190-15	29446-29455	posterior	_
190-16	29456-29465	electrode	_
190-17	29466-29469	and	_
190-18	29470-29473	the	_
190-19	29474-29481	frontal	_
190-20	29482-29491	electrode	_
190-21	29492-29494	is	_
190-22	29495-29496	a	_
190-23	29497-29503	strong	_
190-24	29504-29508	tool	_
190-25	29509-29512	for	_
190-26	29513-29524	classifying	_
190-27	29525-29528	and	_
190-28	29529-29539	predicting	_
190-29	29540-29553	schizophrenia	_
190-30	29553-29554	.	_

#Text=Secondly, these findings help us to understand that although the maximal differences are observed for the longest distances, the bigger picture is that an examination of degrading connectivity features in schizophrenia patients shows us that changes in the flow of information occur in their most significant form in prefrontal areas.
191-1	29555-29563	Secondly	_
191-2	29563-29564	,	_
191-3	29565-29570	these	_
191-4	29571-29579	findings	_
191-5	29580-29584	help	_
191-6	29585-29587	us	_
191-7	29588-29590	to	_
191-8	29591-29601	understand	_
191-9	29602-29606	that	_
191-10	29607-29615	although	_
191-11	29616-29619	the	_
191-12	29620-29627	maximal	_
191-13	29628-29639	differences	_
191-14	29640-29643	are	_
191-15	29644-29652	observed	_
191-16	29653-29656	for	_
191-17	29657-29660	the	_
191-18	29661-29668	longest	_
191-19	29669-29678	distances	_
191-20	29678-29679	,	_
191-21	29680-29683	the	_
191-22	29684-29690	bigger	_
191-23	29691-29698	picture	_
191-24	29699-29701	is	_
191-25	29702-29706	that	_
191-26	29707-29709	an	_
191-27	29710-29721	examination	_
191-28	29722-29724	of	_
191-29	29725-29734	degrading	_
191-30	29735-29747	connectivity	_
191-31	29748-29756	features	_
191-32	29757-29759	in	_
191-33	29760-29773	schizophrenia	_
191-34	29774-29782	patients	_
191-35	29783-29788	shows	_
191-36	29789-29791	us	_
191-37	29792-29796	that	_
191-38	29797-29804	changes	_
191-39	29805-29807	in	_
191-40	29808-29811	the	_
191-41	29812-29816	flow	_
191-42	29817-29819	of	_
191-43	29820-29831	information	_
191-44	29832-29837	occur	_
191-45	29838-29840	in	_
191-46	29841-29846	their	_
191-47	29847-29851	most	_
191-48	29852-29863	significant	_
191-49	29864-29868	form	_
191-50	29869-29871	in	_
191-51	29872-29882	prefrontal	_
191-52	29883-29888	areas	_
191-53	29888-29889	.	_

#Text=IV.
192-1	29890-29892	IV	_
192-2	29892-29893	.	_

#Text=The accuracy of the discrimination methodology based on its ability to predict schizophrenia
#Text=As observed in the results presented in Table 1, it is evident that connectivity maps were able to discriminate between healthy subjects and schizophrenia patients.
193-1	29894-29897	The	_
193-2	29898-29906	accuracy	_
193-3	29907-29909	of	_
193-4	29910-29913	the	_
193-5	29914-29928	discrimination	_
193-6	29929-29940	methodology	_
193-7	29941-29946	based	_
193-8	29947-29949	on	_
193-9	29950-29953	its	_
193-10	29954-29961	ability	_
193-11	29962-29964	to	_
193-12	29965-29972	predict	_
193-13	29973-29986	schizophrenia	_
193-14	29987-29989	As	_
193-15	29990-29998	observed	_
193-16	29999-30001	in	_
193-17	30002-30005	the	_
193-18	30006-30013	results	_
193-19	30014-30023	presented	_
193-20	30024-30026	in	_
193-21	30027-30032	Table	_
193-22	30033-30034	1	_
193-23	30034-30035	,	_
193-24	30036-30038	it	_
193-25	30039-30041	is	_
193-26	30042-30049	evident	_
193-27	30050-30054	that	_
193-28	30055-30067	connectivity	_
193-29	30068-30072	maps	_
193-30	30073-30077	were	_
193-31	30078-30082	able	_
193-32	30083-30085	to	_
193-33	30086-30098	discriminate	_
193-34	30099-30106	between	_
193-35	30107-30114	healthy	_
193-36	30115-30123	subjects	_
193-37	30124-30127	and	_
193-38	30128-30141	schizophrenia	_
193-39	30142-30150	patients	_
193-40	30150-30151	.	_

#Text=As the data used for this analysis was acquired from each subject in only the first minute of testing (the optimal number of repetitions from the beginning of the recording was in the range of 8–12, depending on the set of electrodes used), these results can be considered to be firm.
194-1	30152-30154	As	_
194-2	30155-30158	the	_
194-3	30159-30163	data	_
194-4	30164-30168	used	_
194-5	30169-30172	for	_
194-6	30173-30177	this	_
194-7	30178-30186	analysis	_
194-8	30187-30190	was	_
194-9	30191-30199	acquired	_
194-10	30200-30204	from	_
194-11	30205-30209	each	_
194-12	30210-30217	subject	_
194-13	30218-30220	in	_
194-14	30221-30225	only	_
194-15	30226-30229	the	_
194-16	30230-30235	first	_
194-17	30236-30242	minute	_
194-18	30243-30245	of	_
194-19	30246-30253	testing	_
194-20	30254-30255	(	_
194-21	30255-30258	the	_
194-22	30259-30266	optimal	_
194-23	30267-30273	number	_
194-24	30274-30276	of	_
194-25	30277-30288	repetitions	_
194-26	30289-30293	from	_
194-27	30294-30297	the	_
194-28	30298-30307	beginning	_
194-29	30308-30310	of	_
194-30	30311-30314	the	_
194-31	30315-30324	recording	_
194-32	30325-30328	was	_
194-33	30329-30331	in	_
194-34	30332-30335	the	_
194-35	30336-30341	range	_
194-36	30342-30344	of	_
194-37	30345-30346	8	_
194-38	30346-30347	–	_
194-39	30347-30349	12	_
194-40	30349-30350	,	_
194-41	30351-30360	depending	_
194-42	30361-30363	on	_
194-43	30364-30367	the	_
194-44	30368-30371	set	_
194-45	30372-30374	of	_
194-46	30375-30385	electrodes	_
194-47	30386-30390	used	_
194-48	30390-30391	)	_
194-49	30391-30392	,	_
194-50	30393-30398	these	_
194-51	30399-30406	results	_
194-52	30407-30410	can	_
194-53	30411-30413	be	_
194-54	30414-30424	considered	_
194-55	30425-30427	to	_
194-56	30428-30430	be	_
194-57	30431-30435	firm	_
194-58	30435-30436	.	_

#Text=The best analysis configuration used all bands of frequencies (up to 30Hz as filtered in the preprocessing phase); using all frequency bands produced better results than using only a subset of the frequencies.
195-1	30437-30440	The	_
195-2	30441-30445	best	_
195-3	30446-30454	analysis	_
195-4	30455-30468	configuration	_
195-5	30469-30473	used	_
195-6	30474-30477	all	_
195-7	30478-30483	bands	_
195-8	30484-30486	of	_
195-9	30487-30498	frequencies	_
195-10	30499-30500	(	_
195-11	30500-30502	up	_
195-12	30503-30505	to	_
195-13	30506-30510	30Hz	_
195-14	30511-30513	as	_
195-15	30514-30522	filtered	_
195-16	30523-30525	in	_
195-17	30526-30529	the	_
195-18	30530-30543	preprocessing	_
195-19	30544-30549	phase	_
195-20	30549-30550	)	_
195-21	30550-30551	;	_
195-22	30552-30557	using	_
195-23	30558-30561	all	_
195-24	30562-30571	frequency	_
195-25	30572-30577	bands	_
195-26	30578-30586	produced	_
195-27	30587-30593	better	_
195-28	30594-30601	results	_
195-29	30602-30606	than	_
195-30	30607-30612	using	_
195-31	30613-30617	only	_
195-32	30618-30619	a	_
195-33	30620-30626	subset	_
195-34	30627-30629	of	_
195-35	30630-30633	the	_
195-36	30634-30645	frequencies	_
195-37	30645-30646	.	_

#Text=Discrimination accuracy for each tested methodology.
196-1	30647-30661	Discrimination	_
196-2	30662-30670	accuracy	_
196-3	30671-30674	for	_
196-4	30675-30679	each	_
196-5	30680-30686	tested	_
196-6	30687-30698	methodology	_
196-7	30698-30699	.	_

#Text=Methodology\tDiscrimination Accuracy\tSpecificity Rate\tSensitivity Rate\tSignificance P-Value\t \tConnectivity Maps (All Maps)\t93.8%±4%\t100%\t87.6%±5.1%\t0.0041\t \tConnectivity Maps (Best 5)\t92.4%±3.8%\t100%\t84.8%±4.7%\t0.005\t \tTFFO \t88.7%±4%\t100%\t77.4%±5%\t0.0078\t \tConnectivity Maps—Direct Connectivity Only \t88.7%±5.5%\t96.5%±2.5%\t81%±5.8%\t0.0089\t \tP300-Derived Features–Reaction Time \t73.9%±4.3%\t87.3%±3.1%\t60.6%±4.6%\t0.043\t \tP300-RF-Latency \t68.1%±4.8%\t82%±3.9%\t54.2%±6.9%\t0.0919\t \tPE-Latency \t64.5%±5.5%\t74.2%±4.2%\t54.8%±6.4%\t0.1746\t \t
#Text=These results are clearly powerful in comparison with standard ANOVA methodologies  and latency-based feature analyses .
197-1	30700-30711	Methodology	_
197-2	30712-30726	Discrimination	_
197-3	30727-30735	Accuracy	_
197-4	30736-30747	Specificity	_
197-5	30748-30752	Rate	_
197-6	30753-30764	Sensitivity	_
197-7	30765-30769	Rate	_
197-8	30770-30782	Significance	_
197-9	30783-30790	P-Value	_
197-10	30793-30805	Connectivity	_
197-11	30806-30810	Maps	_
197-12	30811-30812	(	_
197-13	30812-30815	All	_
197-14	30816-30820	Maps	_
197-15	30820-30821	)	_
197-16	30822-30827	93.8%	_
197-17	30827-30828	±	_
197-18	30828-30830	4%	_
197-19	30831-30835	100%	_
197-20	30836-30841	87.6%	_
197-21	30841-30842	±	_
197-22	30842-30846	5.1%	_
197-23	30847-30853	0.0041	_
197-24	30856-30868	Connectivity	_
197-25	30869-30873	Maps	_
197-26	30874-30875	(	_
197-27	30875-30879	Best	_
197-28	30880-30881	5	_
197-29	30881-30882	)	_
197-30	30883-30888	92.4%	_
197-31	30888-30889	±	_
197-32	30889-30893	3.8%	_
197-33	30894-30898	100%	_
197-34	30899-30904	84.8%	_
197-35	30904-30905	±	_
197-36	30905-30909	4.7%	_
197-37	30910-30915	0.005	_
197-38	30918-30922	TFFO	_
197-39	30924-30929	88.7%	_
197-40	30929-30930	±	_
197-41	30930-30932	4%	_
197-42	30933-30937	100%	_
197-43	30938-30943	77.4%	_
197-44	30943-30944	±	_
197-45	30944-30946	5%	_
197-46	30947-30953	0.0078	_
197-47	30956-30968	Connectivity	_
197-48	30969-30980	Maps—Direct	_
197-49	30981-30993	Connectivity	_
197-50	30994-30998	Only	_
197-51	31000-31005	88.7%	_
197-52	31005-31006	±	_
197-53	31006-31010	5.5%	_
197-54	31011-31016	96.5%	_
197-55	31016-31017	±	_
197-56	31017-31021	2.5%	_
197-57	31022-31025	81%	_
197-58	31025-31026	±	_
197-59	31026-31030	5.8%	_
197-60	31031-31037	0.0089	_
197-61	31040-31044	P300	_
197-62	31044-31045	-	_
197-63	31045-31052	Derived	_
197-64	31053-31070	Features–Reaction	_
197-65	31071-31075	Time	_
197-66	31077-31082	73.9%	_
197-67	31082-31083	±	_
197-68	31083-31087	4.3%	_
197-69	31088-31093	87.3%	_
197-70	31093-31094	±	_
197-71	31094-31098	3.1%	_
197-72	31099-31104	60.6%	_
197-73	31104-31105	±	_
197-74	31105-31109	4.6%	_
197-75	31110-31115	0.043	_
197-76	31118-31122	P300	_
197-77	31122-31123	-	_
197-78	31123-31133	RF-Latency	_
197-79	31135-31140	68.1%	_
197-80	31140-31141	±	_
197-81	31141-31145	4.8%	_
197-82	31146-31149	82%	_
197-83	31149-31150	±	_
197-84	31150-31154	3.9%	_
197-85	31155-31160	54.2%	_
197-86	31160-31161	±	_
197-87	31161-31165	6.9%	_
197-88	31166-31172	0.0919	_
197-89	31175-31185	PE-Latency	_
197-90	31187-31192	64.5%	_
197-91	31192-31193	±	_
197-92	31193-31197	5.5%	_
197-93	31198-31203	74.2%	_
197-94	31203-31204	±	_
197-95	31204-31208	4.2%	_
197-96	31209-31214	54.8%	_
197-97	31214-31215	±	_
197-98	31215-31219	6.4%	_
197-99	31220-31226	0.1746	_
197-100	31230-31235	These	_
197-101	31236-31243	results	_
197-102	31244-31247	are	_
197-103	31248-31255	clearly	_
197-104	31256-31264	powerful	_
197-105	31265-31267	in	_
197-106	31268-31278	comparison	_
197-107	31279-31283	with	_
197-108	31284-31292	standard	_
197-109	31293-31298	ANOVA	_
197-110	31299-31312	methodologies	_
197-111	31314-31317	and	_
197-112	31318-31331	latency-based	_
197-113	31332-31339	feature	_
197-114	31340-31348	analyses	_
197-115	31349-31350	.	_

#Text=There is also a significant improvement compared to optimization-based methodologies with a strong machine-learning focus .
198-1	31351-31356	There	_
198-2	31357-31359	is	_
198-3	31360-31364	also	_
198-4	31365-31366	a	_
198-5	31367-31378	significant	_
198-6	31379-31390	improvement	_
198-7	31391-31399	compared	_
198-8	31400-31402	to	_
198-9	31403-31421	optimization-based	_
198-10	31422-31435	methodologies	_
198-11	31436-31440	with	_
198-12	31441-31442	a	_
198-13	31443-31449	strong	_
198-14	31450-31466	machine-learning	_
198-15	31467-31472	focus	_
198-16	31473-31474	.	_

#Text=Results of section 3.5 regarding the use of 5 electrodes to obtain classification accuracy just shy to the one achieved when using all the data, reaffirm results of past research  of ability to achieve strong discrimination using a small subset of the original input electrodes.
199-1	31475-31482	Results	_
199-2	31483-31485	of	_
199-3	31486-31493	section	_
199-4	31494-31497	3.5	_
199-5	31498-31507	regarding	_
199-6	31508-31511	the	_
199-7	31512-31515	use	_
199-8	31516-31518	of	_
199-9	31519-31520	5	_
199-10	31521-31531	electrodes	_
199-11	31532-31534	to	_
199-12	31535-31541	obtain	_
199-13	31542-31556	classification	_
199-14	31557-31565	accuracy	_
199-15	31566-31570	just	_
199-16	31571-31574	shy	_
199-17	31575-31577	to	_
199-18	31578-31581	the	_
199-19	31582-31585	one	_
199-20	31586-31594	achieved	_
199-21	31595-31599	when	_
199-22	31600-31605	using	_
199-23	31606-31609	all	_
199-24	31610-31613	the	_
199-25	31614-31618	data	_
199-26	31618-31619	,	_
199-27	31620-31628	reaffirm	_
199-28	31629-31636	results	_
199-29	31637-31639	of	_
199-30	31640-31644	past	_
199-31	31645-31653	research	_
199-32	31655-31657	of	_
199-33	31658-31665	ability	_
199-34	31666-31668	to	_
199-35	31669-31676	achieve	_
199-36	31677-31683	strong	_
199-37	31684-31698	discrimination	_
199-38	31699-31704	using	_
199-39	31705-31706	a	_
199-40	31707-31712	small	_
199-41	31713-31719	subset	_
199-42	31720-31722	of	_
199-43	31723-31726	the	_
199-44	31727-31735	original	_
199-45	31736-31741	input	_
199-46	31742-31752	electrodes	_
199-47	31752-31753	.	_

#Text=Using direct connectivity only and achieving significantly less accurate classification results in comparison with the full list of features clearly indicates the orthogonal added value of the three-electrode approach, in which the connectivity between a pair of electrodes is measured with respect to a third electrode rather using input from that pair alone.
200-1	31754-31759	Using	_
200-2	31760-31766	direct	_
200-3	31767-31779	connectivity	_
200-4	31780-31784	only	_
200-5	31785-31788	and	_
200-6	31789-31798	achieving	_
200-7	31799-31812	significantly	_
200-8	31813-31817	less	_
200-9	31818-31826	accurate	_
200-10	31827-31841	classification	_
200-11	31842-31849	results	_
200-12	31850-31852	in	_
200-13	31853-31863	comparison	_
200-14	31864-31868	with	_
200-15	31869-31872	the	_
200-16	31873-31877	full	_
200-17	31878-31882	list	_
200-18	31883-31885	of	_
200-19	31886-31894	features	_
200-20	31895-31902	clearly	_
200-21	31903-31912	indicates	_
200-22	31913-31916	the	_
200-23	31917-31927	orthogonal	_
200-24	31928-31933	added	_
200-25	31934-31939	value	_
200-26	31940-31942	of	_
200-27	31943-31946	the	_
200-28	31947-31962	three-electrode	_
200-29	31963-31971	approach	_
200-30	31971-31972	,	_
200-31	31973-31975	in	_
200-32	31976-31981	which	_
200-33	31982-31985	the	_
200-34	31986-31998	connectivity	_
200-35	31999-32006	between	_
200-36	32007-32008	a	_
200-37	32009-32013	pair	_
200-38	32014-32016	of	_
200-39	32017-32027	electrodes	_
200-40	32028-32030	is	_
200-41	32031-32039	measured	_
200-42	32040-32044	with	_
200-43	32045-32052	respect	_
200-44	32053-32055	to	_
200-45	32056-32057	a	_
200-46	32058-32063	third	_
200-47	32064-32073	electrode	_
200-48	32074-32080	rather	_
200-49	32081-32086	using	_
200-50	32087-32092	input	_
200-51	32093-32097	from	_
200-52	32098-32102	that	_
200-53	32103-32107	pair	_
200-54	32108-32113	alone	_
200-55	32113-32114	.	_

#Text=Approaches considering only direct connectivity and related differences have been described previously.
201-1	32115-32125	Approaches	_
201-2	32126-32137	considering	_
201-3	32138-32142	only	_
201-4	32143-32149	direct	_
201-5	32150-32162	connectivity	_
201-6	32163-32166	and	_
201-7	32167-32174	related	_
201-8	32175-32186	differences	_
201-9	32187-32191	have	_
201-10	32192-32196	been	_
201-11	32197-32206	described	_
201-12	32207-32217	previously	_
201-13	32217-32218	.	_

#Text=Results also indicate that robust discrimination can be achieved with an analysis of about a minute of playing a certain game with a strategically placed set of only 4–6 electrodes.
202-1	32220-32227	Results	_
202-2	32228-32232	also	_
202-3	32233-32241	indicate	_
202-4	32242-32246	that	_
202-5	32247-32253	robust	_
202-6	32254-32268	discrimination	_
202-7	32269-32272	can	_
202-8	32273-32275	be	_
202-9	32276-32284	achieved	_
202-10	32285-32289	with	_
202-11	32290-32292	an	_
202-12	32293-32301	analysis	_
202-13	32302-32304	of	_
202-14	32305-32310	about	_
202-15	32311-32312	a	_
202-16	32313-32319	minute	_
202-17	32320-32322	of	_
202-18	32323-32330	playing	_
202-19	32331-32332	a	_
202-20	32333-32340	certain	_
202-21	32341-32345	game	_
202-22	32346-32350	with	_
202-23	32351-32352	a	_
202-24	32353-32366	strategically	_
202-25	32367-32373	placed	_
202-26	32374-32377	set	_
202-27	32378-32380	of	_
202-28	32381-32385	only	_
202-29	32386-32387	4	_
202-30	32387-32388	–	_
202-31	32388-32389	6	_
202-32	32390-32400	electrodes	_
202-33	32400-32401	.	_

#Text=The relatively short time needed to acquire data for this analysis can be an enabling feature as patients with psychiatric disorders have difficulty completing tasks as recording sessions get longer.
#Text=5 Conclusion and further work
#Text=We have presented a novel tool for the analysis of connectivity termed ‘Connectivity Maps’.
203-1	32402-32405	The	_
203-2	32406-32416	relatively	_
203-3	32417-32422	short	_
203-4	32423-32427	time	_
203-5	32428-32434	needed	_
203-6	32435-32437	to	_
203-7	32438-32445	acquire	_
203-8	32446-32450	data	_
203-9	32451-32454	for	_
203-10	32455-32459	this	_
203-11	32460-32468	analysis	_
203-12	32469-32472	can	_
203-13	32473-32475	be	_
203-14	32476-32478	an	_
203-15	32479-32487	enabling	_
203-16	32488-32495	feature	_
203-17	32496-32498	as	_
203-18	32499-32507	patients	_
203-19	32508-32512	with	_
203-20	32513-32524	psychiatric	_
203-21	32525-32534	disorders	_
203-22	32535-32539	have	_
203-23	32540-32550	difficulty	_
203-24	32551-32561	completing	_
203-25	32562-32567	tasks	_
203-26	32568-32570	as	_
203-27	32571-32580	recording	_
203-28	32581-32589	sessions	_
203-29	32590-32593	get	_
203-30	32594-32600	longer	_
203-31	32600-32601	.	_
203-32	32602-32603	5	_
203-33	32604-32614	Conclusion	_
203-34	32615-32618	and	_
203-35	32619-32626	further	_
203-36	32627-32631	work	_
203-37	32632-32634	We	_
203-38	32635-32639	have	_
203-39	32640-32649	presented	_
203-40	32650-32651	a	_
203-41	32652-32657	novel	_
203-42	32658-32662	tool	_
203-43	32663-32666	for	_
203-44	32667-32670	the	_
203-45	32671-32679	analysis	_
203-46	32680-32682	of	_
203-47	32683-32695	connectivity	_
203-48	32696-32702	termed	_
203-49	32703-32704	‘	_
203-50	32704-32716	Connectivity	_
203-51	32717-32721	Maps	_
203-52	32721-32722	’	_
203-53	32722-32723	.	_

#Text=We have demonstrated that features identified using these maps, which were acquired using only a small number of strategically-placed electrodes and a relatively short length of recording time, can predict and classify schizophrenia using EEG data with high accuracy.
204-1	32724-32726	We	_
204-2	32727-32731	have	_
204-3	32732-32744	demonstrated	_
204-4	32745-32749	that	_
204-5	32750-32758	features	_
204-6	32759-32769	identified	_
204-7	32770-32775	using	_
204-8	32776-32781	these	_
204-9	32782-32786	maps	_
204-10	32786-32787	,	_
204-11	32788-32793	which	_
204-12	32794-32798	were	_
204-13	32799-32807	acquired	_
204-14	32808-32813	using	_
204-15	32814-32818	only	_
204-16	32819-32820	a	_
204-17	32821-32826	small	_
204-18	32827-32833	number	_
204-19	32834-32836	of	_
204-20	32837-32857	strategically-placed	_
204-21	32858-32868	electrodes	_
204-22	32869-32872	and	_
204-23	32873-32874	a	_
204-24	32875-32885	relatively	_
204-25	32886-32891	short	_
204-26	32892-32898	length	_
204-27	32899-32901	of	_
204-28	32902-32911	recording	_
204-29	32912-32916	time	_
204-30	32916-32917	,	_
204-31	32918-32921	can	_
204-32	32922-32929	predict	_
204-33	32930-32933	and	_
204-34	32934-32942	classify	_
204-35	32943-32956	schizophrenia	_
204-36	32957-32962	using	_
204-37	32963-32966	EEG	_
204-38	32967-32971	data	_
204-39	32972-32976	with	_
204-40	32977-32981	high	_
204-41	32982-32990	accuracy	_
204-42	32990-32991	.	_

#Text=We are aware that the results we have presented may merely be distinguishing between subjects who are taking anti-schizophrenia medications and those who are not.
205-1	32992-32994	We	_
205-2	32995-32998	are	_
205-3	32999-33004	aware	_
205-4	33005-33009	that	_
205-5	33010-33013	the	_
205-6	33014-33021	results	_
205-7	33022-33024	we	_
205-8	33025-33029	have	_
205-9	33030-33039	presented	_
205-10	33040-33043	may	_
205-11	33044-33050	merely	_
205-12	33051-33053	be	_
205-13	33054-33068	distinguishing	_
205-14	33069-33076	between	_
205-15	33077-33085	subjects	_
205-16	33086-33089	who	_
205-17	33090-33093	are	_
205-18	33094-33100	taking	_
205-19	33101-33119	anti-schizophrenia	_
205-20	33120-33131	medications	_
205-21	33132-33135	and	_
205-22	33136-33141	those	_
205-23	33142-33145	who	_
205-24	33146-33149	are	_
205-25	33150-33153	not	_
205-26	33153-33154	.	_

#Text=Further studies should determine whether our findings are more correlated with the schizophrenia condition or schizophrenia medications.
206-1	33155-33162	Further	_
206-2	33163-33170	studies	_
206-3	33171-33177	should	_
206-4	33178-33187	determine	_
206-5	33188-33195	whether	_
206-6	33196-33199	our	_
206-7	33200-33208	findings	_
206-8	33209-33212	are	_
206-9	33213-33217	more	_
206-10	33218-33228	correlated	_
206-11	33229-33233	with	_
206-12	33234-33237	the	_
206-13	33238-33251	schizophrenia	_
206-14	33252-33261	condition	_
206-15	33262-33264	or	_
206-16	33265-33278	schizophrenia	_
206-17	33279-33290	medications	_
206-18	33290-33291	.	_

#Text=The described method is relatively efficient as the total number of created maps is n3.
207-1	33292-33295	The	_
207-2	33296-33305	described	_
207-3	33306-33312	method	_
207-4	33313-33315	is	_
207-5	33316-33326	relatively	_
207-6	33327-33336	efficient	_
207-7	33337-33339	as	_
207-8	33340-33343	the	_
207-9	33344-33349	total	_
207-10	33350-33356	number	_
207-11	33357-33359	of	_
207-12	33360-33367	created	_
207-13	33368-33372	maps	_
207-14	33373-33375	is	_
207-15	33376-33378	n3	_
207-16	33378-33379	.	_

#Text=In case number of nodes is high, further efficiency can be gained by adding a distance function D between nodes and limiting features computed only to nodes that meet a distance threshold from the relevant reference node.
208-1	33380-33382	In	_
208-2	33383-33387	case	_
208-3	33388-33394	number	_
208-4	33395-33397	of	_
208-5	33398-33403	nodes	_
208-6	33404-33406	is	_
208-7	33407-33411	high	_
208-8	33411-33412	,	_
208-9	33413-33420	further	_
208-10	33421-33431	efficiency	_
208-11	33432-33435	can	_
208-12	33436-33438	be	_
208-13	33439-33445	gained	_
208-14	33446-33448	by	_
208-15	33449-33455	adding	_
208-16	33456-33457	a	_
208-17	33458-33466	distance	_
208-18	33467-33475	function	_
208-19	33476-33477	D	_
208-20	33478-33485	between	_
208-21	33486-33491	nodes	_
208-22	33492-33495	and	_
208-23	33496-33504	limiting	_
208-24	33505-33513	features	_
208-25	33514-33522	computed	_
208-26	33523-33527	only	_
208-27	33528-33530	to	_
208-28	33531-33536	nodes	_
208-29	33537-33541	that	_
208-30	33542-33546	meet	_
208-31	33547-33548	a	_
208-32	33549-33557	distance	_
208-33	33558-33567	threshold	_
208-34	33568-33572	from	_
208-35	33573-33576	the	_
208-36	33577-33585	relevant	_
208-37	33586-33595	reference	_
208-38	33596-33600	node	_
208-39	33600-33601	.	_

#Text=Such modification can dramatically reduce the size of the connectivity maps.
209-1	33602-33606	Such	_
209-2	33607-33619	modification	_
209-3	33620-33623	can	_
209-4	33624-33636	dramatically	_
209-5	33637-33643	reduce	_
209-6	33644-33647	the	_
209-7	33648-33652	size	_
209-8	33653-33655	of	_
209-9	33656-33659	the	_
209-10	33660-33672	connectivity	_
209-11	33673-33677	maps	_
209-12	33677-33678	.	_

#Text=The method we describe here is very suitable for describing changes in connectivity between groups of subjects.
210-1	33679-33682	The	_
210-2	33683-33689	method	_
210-3	33690-33692	we	_
210-4	33693-33701	describe	_
210-5	33702-33706	here	_
210-6	33707-33709	is	_
210-7	33710-33714	very	_
210-8	33715-33723	suitable	_
210-9	33724-33727	for	_
210-10	33728-33738	describing	_
210-11	33739-33746	changes	_
210-12	33747-33749	in	_
210-13	33750-33762	connectivity	_
210-14	33763-33770	between	_
210-15	33771-33777	groups	_
210-16	33778-33780	of	_
210-17	33781-33789	subjects	_
210-18	33789-33790	.	_

#Text=Unlike other connectivity methods, this method also suggests the physical location (or the electrode closest to it) at which observed changes in connectivity are best exemplified.
211-1	33791-33797	Unlike	_
211-2	33798-33803	other	_
211-3	33804-33816	connectivity	_
211-4	33817-33824	methods	_
211-5	33824-33825	,	_
211-6	33826-33830	this	_
211-7	33831-33837	method	_
211-8	33838-33842	also	_
211-9	33843-33851	suggests	_
211-10	33852-33855	the	_
211-11	33856-33864	physical	_
211-12	33865-33873	location	_
211-13	33874-33875	(	_
211-14	33875-33877	or	_
211-15	33878-33881	the	_
211-16	33882-33891	electrode	_
211-17	33892-33899	closest	_
211-18	33900-33902	to	_
211-19	33903-33905	it	_
211-20	33905-33906	)	_
211-21	33907-33909	at	_
211-22	33910-33915	which	_
211-23	33916-33924	observed	_
211-24	33925-33932	changes	_
211-25	33933-33935	in	_
211-26	33936-33948	connectivity	_
211-27	33949-33952	are	_
211-28	33953-33957	best	_
211-29	33958-33969	exemplified	_
211-30	33969-33970	.	_

#Text=Because results using this method can be easily interpreted, they can aid research into the origin of schizophrenia and serve as a good diagnostic tool.
212-1	33971-33978	Because	_
212-2	33979-33986	results	_
212-3	33987-33992	using	_
212-4	33993-33997	this	_
212-5	33998-34004	method	_
212-6	34005-34008	can	_
212-7	34009-34011	be	_
212-8	34012-34018	easily	_
212-9	34019-34030	interpreted	_
212-10	34030-34031	,	_
212-11	34032-34036	they	_
212-12	34037-34040	can	_
212-13	34041-34044	aid	_
212-14	34045-34053	research	_
212-15	34054-34058	into	_
212-16	34059-34062	the	_
212-17	34063-34069	origin	_
212-18	34070-34072	of	_
212-19	34073-34086	schizophrenia	_
212-20	34087-34090	and	_
212-21	34091-34096	serve	_
212-22	34097-34099	as	_
212-23	34100-34101	a	_
212-24	34102-34106	good	_
212-25	34107-34117	diagnostic	_
212-26	34118-34122	tool	_
212-27	34122-34123	.	_

#Text=This method can also be used to provide neurofeedback.
213-1	34124-34128	This	_
213-2	34129-34135	method	_
213-3	34136-34139	can	_
213-4	34140-34144	also	_
213-5	34145-34147	be	_
213-6	34148-34152	used	_
213-7	34153-34155	to	_
213-8	34156-34163	provide	_
213-9	34164-34177	neurofeedback	_
213-10	34177-34178	.	_

#Text=Portable, fast and inexpensive EEG, together with such effective analysis tools, can therefore result in new diagnostic and treatment alternatives, especially for mobile health, which is used to verify the effectiveness of medication, allowing real-time treatment decision-making via medicine pumps, among other possibilities.
214-1	34179-34187	Portable	_
214-2	34187-34188	,	_
214-3	34189-34193	fast	_
214-4	34194-34197	and	_
214-5	34198-34209	inexpensive	_
214-6	34210-34213	EEG	_
214-7	34213-34214	,	_
214-8	34215-34223	together	_
214-9	34224-34228	with	_
214-10	34229-34233	such	_
214-11	34234-34243	effective	_
214-12	34244-34252	analysis	_
214-13	34253-34258	tools	_
214-14	34258-34259	,	_
214-15	34260-34263	can	_
214-16	34264-34273	therefore	_
214-17	34274-34280	result	_
214-18	34281-34283	in	_
214-19	34284-34287	new	_
214-20	34288-34298	diagnostic	_
214-21	34299-34302	and	_
214-22	34303-34312	treatment	_
214-23	34313-34325	alternatives	_
214-24	34325-34326	,	_
214-25	34327-34337	especially	_
214-26	34338-34341	for	_
214-27	34342-34348	mobile	_
214-28	34349-34355	health	_
214-29	34355-34356	,	_
214-30	34357-34362	which	_
214-31	34363-34365	is	_
214-32	34366-34370	used	_
214-33	34371-34373	to	_
214-34	34374-34380	verify	_
214-35	34381-34384	the	_
214-36	34385-34398	effectiveness	_
214-37	34399-34401	of	_
214-38	34402-34412	medication	_
214-39	34412-34413	,	_
214-40	34414-34422	allowing	_
214-41	34423-34432	real-time	_
214-42	34433-34442	treatment	_
214-43	34443-34458	decision-making	_
214-44	34459-34462	via	_
214-45	34463-34471	medicine	_
214-46	34472-34477	pumps	_
214-47	34477-34478	,	_
214-48	34479-34484	among	_
214-49	34485-34490	other	_
214-50	34491-34504	possibilities	_
214-51	34504-34505	.	_

#Text=All of these benefits can be applicable to other pathological conditions, as well, including disorders affecting emotions and attention, as the Connectivity Maps method is very general.
215-1	34506-34509	All	_
215-2	34510-34512	of	_
215-3	34513-34518	these	_
215-4	34519-34527	benefits	_
215-5	34528-34531	can	_
215-6	34532-34534	be	_
215-7	34535-34545	applicable	_
215-8	34546-34548	to	_
215-9	34549-34554	other	_
215-10	34555-34567	pathological	_
215-11	34568-34578	conditions	_
215-12	34578-34579	,	_
215-13	34580-34582	as	_
215-14	34583-34587	well	_
215-15	34587-34588	,	_
215-16	34589-34598	including	_
215-17	34599-34608	disorders	_
215-18	34609-34618	affecting	_
215-19	34619-34627	emotions	_
215-20	34628-34631	and	_
215-21	34632-34641	attention	_
215-22	34641-34642	,	_
215-23	34643-34645	as	_
215-24	34646-34649	the	_
215-25	34650-34662	Connectivity	_
215-26	34663-34667	Maps	_
215-27	34668-34674	method	_
215-28	34675-34677	is	_
215-29	34678-34682	very	_
215-30	34683-34690	general	_
215-31	34690-34691	.	_

#Text=Embedded machine learning mechanisms can help devices to assist or even replace traditional medical and diagnostic procedures in the future, as accuracy and the methods for analyzing the severity of psychiatric disorders may be improved to the point where their credibility surpasses that of existing approaches.
216-1	34692-34700	Embedded	_
216-2	34701-34708	machine	_
216-3	34709-34717	learning	_
216-4	34718-34728	mechanisms	_
216-5	34729-34732	can	_
216-6	34733-34737	help	_
216-7	34738-34745	devices	_
216-8	34746-34748	to	_
216-9	34749-34755	assist	_
216-10	34756-34758	or	_
216-11	34759-34763	even	_
216-12	34764-34771	replace	_
216-13	34772-34783	traditional	_
216-14	34784-34791	medical	_
216-15	34792-34795	and	_
216-16	34796-34806	diagnostic	_
216-17	34807-34817	procedures	_
216-18	34818-34820	in	_
216-19	34821-34824	the	_
216-20	34825-34831	future	_
216-21	34831-34832	,	_
216-22	34833-34835	as	_
216-23	34836-34844	accuracy	_
216-24	34845-34848	and	_
216-25	34849-34852	the	_
216-26	34853-34860	methods	_
216-27	34861-34864	for	_
216-28	34865-34874	analyzing	_
216-29	34875-34878	the	_
216-30	34879-34887	severity	_
216-31	34888-34890	of	_
216-32	34891-34902	psychiatric	_
216-33	34903-34912	disorders	_
216-34	34913-34916	may	_
216-35	34917-34919	be	_
216-36	34920-34928	improved	_
216-37	34929-34931	to	_
216-38	34932-34935	the	_
216-39	34936-34941	point	_
216-40	34942-34947	where	_
216-41	34948-34953	their	_
216-42	34954-34965	credibility	_
216-43	34966-34975	surpasses	_
216-44	34976-34980	that	_
216-45	34981-34983	of	_
216-46	34984-34992	existing	_
216-47	34993-35003	approaches	_
216-48	35003-35004	.	_

#Text=It may be possible to use this method for brain-computer interface applications as well.
217-1	35005-35007	It	_
217-2	35008-35011	may	_
217-3	35012-35014	be	_
217-4	35015-35023	possible	_
217-5	35024-35026	to	_
217-6	35027-35030	use	_
217-7	35031-35035	this	_
217-8	35036-35042	method	_
217-9	35043-35046	for	_
217-10	35047-35061	brain-computer	_
217-11	35062-35071	interface	_
217-12	35072-35084	applications	_
217-13	35085-35087	as	_
217-14	35088-35092	well	_
217-15	35092-35093	.	_

#Text=References
#Text=“Estimation of the Cortical Functional Connectivity with the Multimodal Integration of High-Resolution EEG and fMRI data by Directed Transfer Function”
#Text=“Improved Localization of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach”
#Text=“Brain Activation and Hypothalamic Functional Connectivity during Human non-rapid Eye Movement Sleep: An EEG/fMRI Study”
#Text=“Emotion Recognition From EEG Using Higher Order Crossings”
#Text=“EEG-based Emotion Recognition—The Influence of Visual and Auditory Stimuli”
#Text=“Machine Learning Framework for Inferring Cognitive State from Magnetoencephalographic (MEG) Signals”
#Text=“Inferring Functional Brain States using Temporal Evolution of Regularized Classifiers”
#Text=“Comparing SVM and Convolutional Networks for Epileptic Seizure Prediction from Intracarnial EEG”
#Text=“Forecasting Generalized Epileptic Seizures from the EEG Signal by Wavelet Analysis and Dynamic Unsupervised Fuzzy Clustering“
#Text=“Resting State Cortical Connectivity reflected in EEG Coherence in individuals and Autism”
#Text=“Comparison of Different Cortical Connectivity Estimators for High-Resolution EEG Recordings”
#Text=“A review of classification algorithms for EEG-based brain-computer interfaces”
#Text="Functional Connectivity and Working Memory in Schizophrenia: An EEG Study”
#Text=“Decreased functional connectivity of EEG theta-frequency activity in first-episode, neuroleptic-naïve patients with schizophrenia: preliminary results”
#Text=“Schizophrenia Detection and Classification by Advanced Analysis of EEG Recordings Using a Single Electrode Approach”
#Text=“Inference of Brain Mental States from Spatio-Temporal Analysis of EEG Single Trials”
#Text=“fMRI Connectivity Analysis of Acupuncture Effects on an Amygdata-associated Brain Network"
#Text=“Discriminative Analysis of Resting-State Functional Connectivity Patterns of Schizophrenia Using Low Dimensional Embedding of fMRI”
#Text=“Potential Risk for Healthy Siblings to Develop Schizophrenia: Evidence from Pattern Classification with Whole-Brain Connectivity”
#Text=”Heritability of Small-World Networks in the Brain: A Graph Theoretical Analysis of Resting-State EEG Functional Connectivity”
#Text=Patent EP2526500A2, “Method and System for Weighted Analysis of Neurophysiological Data”
#Text=Elminda LTD-Israel, “Brain Network Activation (BNA)–Brain Network Mapping Technology–Test Retest Reliability”
#Text=“Differentiating Between Psychogenic Nonepileptic Seizures and Epilepsy Based on Common Spatial Pattern of Weighted EEG Resting Networks”
#Text=“Neural correlates of local contextual processing deficits in schizophrenic patients”
#Text=Y.
218-1	35094-35104	References	_
218-2	35105-35106	“	_
218-3	35106-35116	Estimation	_
218-4	35117-35119	of	_
218-5	35120-35123	the	_
218-6	35124-35132	Cortical	_
218-7	35133-35143	Functional	_
218-8	35144-35156	Connectivity	_
218-9	35157-35161	with	_
218-10	35162-35165	the	_
218-11	35166-35176	Multimodal	_
218-12	35177-35188	Integration	_
218-13	35189-35191	of	_
218-14	35192-35207	High-Resolution	_
218-15	35208-35211	EEG	_
218-16	35212-35215	and	_
218-17	35216-35220	fMRI	_
218-18	35221-35225	data	_
218-19	35226-35228	by	_
218-20	35229-35237	Directed	_
218-21	35238-35246	Transfer	_
218-22	35247-35255	Function	_
218-23	35255-35256	”	_
218-24	35257-35258	“	_
218-25	35258-35266	Improved	_
218-26	35267-35279	Localization	_
218-27	35280-35282	of	_
218-28	35283-35291	Cortical	_
218-29	35292-35300	Activity	_
218-30	35301-35303	by	_
218-31	35304-35313	Combining	_
218-32	35314-35317	EEG	_
218-33	35318-35321	and	_
218-34	35322-35325	MEG	_
218-35	35326-35330	with	_
218-36	35331-35334	MRI	_
218-37	35335-35343	Cortical	_
218-38	35344-35351	Surface	_
218-39	35352-35366	Reconstruction	_
218-40	35366-35367	:	_
218-41	35368-35369	A	_
218-42	35370-35376	Linear	_
218-43	35377-35385	Approach	_
218-44	35385-35386	”	_
218-45	35387-35388	“	_
218-46	35388-35393	Brain	_
218-47	35394-35404	Activation	_
218-48	35405-35408	and	_
218-49	35409-35421	Hypothalamic	_
218-50	35422-35432	Functional	_
218-51	35433-35445	Connectivity	_
218-52	35446-35452	during	_
218-53	35453-35458	Human	_
218-54	35459-35468	non-rapid	_
218-55	35469-35472	Eye	_
218-56	35473-35481	Movement	_
218-57	35482-35487	Sleep	_
218-58	35487-35488	:	_
218-59	35489-35491	An	_
218-60	35492-35495	EEG	_
218-61	35495-35496	/	_
218-62	35496-35500	fMRI	_
218-63	35501-35506	Study	_
218-64	35506-35507	”	_
218-65	35508-35509	“	_
218-66	35509-35516	Emotion	_
218-67	35517-35528	Recognition	_
218-68	35529-35533	From	_
218-69	35534-35537	EEG	_
218-70	35538-35543	Using	_
218-71	35544-35550	Higher	_
218-72	35551-35556	Order	_
218-73	35557-35566	Crossings	_
218-74	35566-35567	”	_
218-75	35568-35569	“	_
218-76	35569-35578	EEG-based	_
218-77	35579-35586	Emotion	_
218-78	35587-35602	Recognition—The	_
218-79	35603-35612	Influence	_
218-80	35613-35615	of	_
218-81	35616-35622	Visual	_
218-82	35623-35626	and	_
218-83	35627-35635	Auditory	_
218-84	35636-35643	Stimuli	_
218-85	35643-35644	”	_
218-86	35645-35646	“	_
218-87	35646-35653	Machine	_
218-88	35654-35662	Learning	_
218-89	35663-35672	Framework	_
218-90	35673-35676	for	_
218-91	35677-35686	Inferring	_
218-92	35687-35696	Cognitive	_
218-93	35697-35702	State	_
218-94	35703-35707	from	_
218-95	35708-35731	Magnetoencephalographic	_
218-96	35732-35733	(	_
218-97	35733-35736	MEG	_
218-98	35736-35737	)	_
218-99	35738-35745	Signals	_
218-100	35745-35746	”	_
218-101	35747-35748	“	_
218-102	35748-35757	Inferring	_
218-103	35758-35768	Functional	_
218-104	35769-35774	Brain	_
218-105	35775-35781	States	_
218-106	35782-35787	using	_
218-107	35788-35796	Temporal	_
218-108	35797-35806	Evolution	_
218-109	35807-35809	of	_
218-110	35810-35821	Regularized	_
218-111	35822-35833	Classifiers	_
218-112	35833-35834	”	_
218-113	35835-35836	“	_
218-114	35836-35845	Comparing	_
218-115	35846-35849	SVM	_
218-116	35850-35853	and	_
218-117	35854-35867	Convolutional	_
218-118	35868-35876	Networks	_
218-119	35877-35880	for	_
218-120	35881-35890	Epileptic	_
218-121	35891-35898	Seizure	_
218-122	35899-35909	Prediction	_
218-123	35910-35914	from	_
218-124	35915-35927	Intracarnial	_
218-125	35928-35931	EEG	_
218-126	35931-35932	”	_
218-127	35933-35934	“	_
218-128	35934-35945	Forecasting	_
218-129	35946-35957	Generalized	_
218-130	35958-35967	Epileptic	_
218-131	35968-35976	Seizures	_
218-132	35977-35981	from	_
218-133	35982-35985	the	_
218-134	35986-35989	EEG	_
218-135	35990-35996	Signal	_
218-136	35997-35999	by	_
218-137	36000-36007	Wavelet	_
218-138	36008-36016	Analysis	_
218-139	36017-36020	and	_
218-140	36021-36028	Dynamic	_
218-141	36029-36041	Unsupervised	_
218-142	36042-36047	Fuzzy	_
218-143	36048-36058	Clustering	_
218-144	36058-36059	“	_
218-145	36060-36061	“	_
218-146	36061-36068	Resting	_
218-147	36069-36074	State	_
218-148	36075-36083	Cortical	_
218-149	36084-36096	Connectivity	_
218-150	36097-36106	reflected	_
218-151	36107-36109	in	_
218-152	36110-36113	EEG	_
218-153	36114-36123	Coherence	_
218-154	36124-36126	in	_
218-155	36127-36138	individuals	_
218-156	36139-36142	and	_
218-157	36143-36149	Autism	_
218-158	36149-36150	”	_
218-159	36151-36152	“	_
218-160	36152-36162	Comparison	_
218-161	36163-36165	of	_
218-162	36166-36175	Different	_
218-163	36176-36184	Cortical	_
218-164	36185-36197	Connectivity	_
218-165	36198-36208	Estimators	_
218-166	36209-36212	for	_
218-167	36213-36228	High-Resolution	_
218-168	36229-36232	EEG	_
218-169	36233-36243	Recordings	_
218-170	36243-36244	”	_
218-171	36245-36246	“	_
218-172	36246-36247	A	_
218-173	36248-36254	review	_
218-174	36255-36257	of	_
218-175	36258-36272	classification	_
218-176	36273-36283	algorithms	_
218-177	36284-36287	for	_
218-178	36288-36297	EEG-based	_
218-179	36298-36312	brain-computer	_
218-180	36313-36323	interfaces	_
218-181	36323-36324	”	_
218-182	36325-36326	"	_
218-183	36326-36336	Functional	_
218-184	36337-36349	Connectivity	_
218-185	36350-36353	and	_
218-186	36354-36361	Working	_
218-187	36362-36368	Memory	_
218-188	36369-36371	in	_
218-189	36372-36385	Schizophrenia	_
218-190	36385-36386	:	_
218-191	36387-36389	An	_
218-192	36390-36393	EEG	_
218-193	36394-36399	Study	_
218-194	36399-36400	”	_
218-195	36401-36402	“	_
218-196	36402-36411	Decreased	_
218-197	36412-36422	functional	_
218-198	36423-36435	connectivity	_
218-199	36436-36438	of	_
218-200	36439-36442	EEG	_
218-201	36443-36458	theta-frequency	_
218-202	36459-36467	activity	_
218-203	36468-36470	in	_
218-204	36471-36484	first-episode	_
218-205	36484-36485	,	_
218-206	36486-36503	neuroleptic-naïve	_
218-207	36504-36512	patients	_
218-208	36513-36517	with	_
218-209	36518-36531	schizophrenia	_
218-210	36531-36532	:	_
218-211	36533-36544	preliminary	_
218-212	36545-36552	results	_
218-213	36552-36553	”	_
218-214	36554-36555	“	_
218-215	36555-36568	Schizophrenia	_
218-216	36569-36578	Detection	_
218-217	36579-36582	and	_
218-218	36583-36597	Classification	_
218-219	36598-36600	by	_
218-220	36601-36609	Advanced	_
218-221	36610-36618	Analysis	_
218-222	36619-36621	of	_
218-223	36622-36625	EEG	_
218-224	36626-36636	Recordings	_
218-225	36637-36642	Using	_
218-226	36643-36644	a	_
218-227	36645-36651	Single	_
218-228	36652-36661	Electrode	_
218-229	36662-36670	Approach	_
218-230	36670-36671	”	_
218-231	36672-36673	“	_
218-232	36673-36682	Inference	_
218-233	36683-36685	of	_
218-234	36686-36691	Brain	_
218-235	36692-36698	Mental	_
218-236	36699-36705	States	_
218-237	36706-36710	from	_
218-238	36711-36726	Spatio-Temporal	_
218-239	36727-36735	Analysis	_
218-240	36736-36738	of	_
218-241	36739-36742	EEG	_
218-242	36743-36749	Single	_
218-243	36750-36756	Trials	_
218-244	36756-36757	”	_
218-245	36758-36759	“	_
218-246	36759-36763	fMRI	_
218-247	36764-36776	Connectivity	_
218-248	36777-36785	Analysis	_
218-249	36786-36788	of	_
218-250	36789-36800	Acupuncture	_
218-251	36801-36808	Effects	_
218-252	36809-36811	on	_
218-253	36812-36814	an	_
218-254	36815-36834	Amygdata-associated	_
218-255	36835-36840	Brain	_
218-256	36841-36848	Network	_
218-257	36848-36849	"	_
218-258	36850-36851	“	_
218-259	36851-36865	Discriminative	_
218-260	36866-36874	Analysis	_
218-261	36875-36877	of	_
218-262	36878-36891	Resting-State	_
218-263	36892-36902	Functional	_
218-264	36903-36915	Connectivity	_
218-265	36916-36924	Patterns	_
218-266	36925-36927	of	_
218-267	36928-36941	Schizophrenia	_
218-268	36942-36947	Using	_
218-269	36948-36951	Low	_
218-270	36952-36963	Dimensional	_
218-271	36964-36973	Embedding	_
218-272	36974-36976	of	_
218-273	36977-36981	fMRI	_
218-274	36981-36982	”	_
218-275	36983-36984	“	_
218-276	36984-36993	Potential	_
218-277	36994-36998	Risk	_
218-278	36999-37002	for	_
218-279	37003-37010	Healthy	_
218-280	37011-37019	Siblings	_
218-281	37020-37022	to	_
218-282	37023-37030	Develop	_
218-283	37031-37044	Schizophrenia	_
218-284	37044-37045	:	_
218-285	37046-37054	Evidence	_
218-286	37055-37059	from	_
218-287	37060-37067	Pattern	_
218-288	37068-37082	Classification	_
218-289	37083-37087	with	_
218-290	37088-37099	Whole-Brain	_
218-291	37100-37112	Connectivity	_
218-292	37112-37113	”	_
218-293	37114-37115	”	_
218-294	37115-37127	Heritability	_
218-295	37128-37130	of	_
218-296	37131-37142	Small-World	_
218-297	37143-37151	Networks	_
218-298	37152-37154	in	_
218-299	37155-37158	the	_
218-300	37159-37164	Brain	_
218-301	37164-37165	:	_
218-302	37166-37167	A	_
218-303	37168-37173	Graph	_
218-304	37174-37185	Theoretical	_
218-305	37186-37194	Analysis	_
218-306	37195-37197	of	_
218-307	37198-37211	Resting-State	_
218-308	37212-37215	EEG	_
218-309	37216-37226	Functional	_
218-310	37227-37239	Connectivity	_
218-311	37239-37240	”	_
218-312	37241-37247	Patent	_
218-313	37248-37259	EP2526500A2	_
218-314	37259-37260	,	_
218-315	37261-37262	“	_
218-316	37262-37268	Method	_
218-317	37269-37272	and	_
218-318	37273-37279	System	_
218-319	37280-37283	for	_
218-320	37284-37292	Weighted	_
218-321	37293-37301	Analysis	_
218-322	37302-37304	of	_
218-323	37305-37323	Neurophysiological	_
218-324	37324-37328	Data	_
218-325	37328-37329	”	_
218-326	37330-37337	Elminda	_
218-327	37338-37348	LTD-Israel	_
218-328	37348-37349	,	_
218-329	37350-37351	“	_
218-330	37351-37356	Brain	_
218-331	37357-37364	Network	_
218-332	37365-37375	Activation	_
218-333	37376-37377	(	_
218-334	37377-37380	BNA	_
218-335	37380-37381	)	_
218-336	37381-37382	–	_
218-337	37382-37387	Brain	_
218-338	37388-37395	Network	_
218-339	37396-37403	Mapping	_
218-340	37404-37419	Technology–Test	_
218-341	37420-37426	Retest	_
218-342	37427-37438	Reliability	_
218-343	37438-37439	”	_
218-344	37440-37441	“	_
218-345	37441-37456	Differentiating	_
218-346	37457-37464	Between	_
218-347	37465-37476	Psychogenic	_
218-348	37477-37489	Nonepileptic	_
218-349	37490-37498	Seizures	_
218-350	37499-37502	and	_
218-351	37503-37511	Epilepsy	_
218-352	37512-37517	Based	_
218-353	37518-37520	on	_
218-354	37521-37527	Common	_
218-355	37528-37535	Spatial	_
218-356	37536-37543	Pattern	_
218-357	37544-37546	of	_
218-358	37547-37555	Weighted	_
218-359	37556-37559	EEG	_
218-360	37560-37567	Resting	_
218-361	37568-37576	Networks	_
218-362	37576-37577	”	_
218-363	37578-37579	“	_
218-364	37579-37585	Neural	_
218-365	37586-37596	correlates	_
218-366	37597-37599	of	_
218-367	37600-37605	local	_
218-368	37606-37616	contextual	_
218-369	37617-37627	processing	_
218-370	37628-37636	deficits	_
218-371	37637-37639	in	_
218-372	37640-37653	schizophrenic	_
218-373	37654-37662	patients	_
218-374	37662-37663	”	_
218-375	37664-37665	Y	_
218-376	37665-37666	.	_

#Text=Han, L.
219-1	37667-37670	Han	_
219-2	37670-37671	,	_
219-3	37672-37673	L	_
219-4	37673-37674	.	_

#Text=Yu, “A Variance Reduction Framework for Stable Feature Selection”, 2010 International Conference on Data Mining, 2010
#Text=“A Variance Minimization Criterion to Feature Selection Using Laplacian Regularization”
#Text=“Approximate Statistical Tests for Comparing Supervised Classification Learning Algorithms”
#Text=“Clustring Validity Assessment Using Multi Representatives”
#Text="Automatic Removal of the Eye Blink Artifact from EEG using an ICA-based Template Matching Approach,"
#Text=“Negative and positive Schizophrenia: Definition and validation.
220-1	37675-37677	Yu	_
220-2	37677-37678	,	_
220-3	37679-37680	“	_
220-4	37680-37681	A	_
220-5	37682-37690	Variance	_
220-6	37691-37700	Reduction	_
220-7	37701-37710	Framework	_
220-8	37711-37714	for	_
220-9	37715-37721	Stable	_
220-10	37722-37729	Feature	_
220-11	37730-37739	Selection	_
220-12	37739-37740	”	_
220-13	37740-37741	,	_
220-14	37742-37746	2010	_
220-15	37747-37760	International	_
220-16	37761-37771	Conference	_
220-17	37772-37774	on	_
220-18	37775-37779	Data	_
220-19	37780-37786	Mining	_
220-20	37786-37787	,	_
220-21	37788-37792	2010	_
220-22	37793-37794	“	_
220-23	37794-37795	A	_
220-24	37796-37804	Variance	_
220-25	37805-37817	Minimization	_
220-26	37818-37827	Criterion	_
220-27	37828-37830	to	_
220-28	37831-37838	Feature	_
220-29	37839-37848	Selection	_
220-30	37849-37854	Using	_
220-31	37855-37864	Laplacian	_
220-32	37865-37879	Regularization	_
220-33	37879-37880	”	_
220-34	37881-37882	“	_
220-35	37882-37893	Approximate	_
220-36	37894-37905	Statistical	_
220-37	37906-37911	Tests	_
220-38	37912-37915	for	_
220-39	37916-37925	Comparing	_
220-40	37926-37936	Supervised	_
220-41	37937-37951	Classification	_
220-42	37952-37960	Learning	_
220-43	37961-37971	Algorithms	_
220-44	37971-37972	”	_
220-45	37973-37974	“	_
220-46	37974-37983	Clustring	_
220-47	37984-37992	Validity	_
220-48	37993-38003	Assessment	_
220-49	38004-38009	Using	_
220-50	38010-38015	Multi	_
220-51	38016-38031	Representatives	_
220-52	38031-38032	”	_
220-53	38033-38034	"	_
220-54	38034-38043	Automatic	_
220-55	38044-38051	Removal	_
220-56	38052-38054	of	_
220-57	38055-38058	the	_
220-58	38059-38062	Eye	_
220-59	38063-38068	Blink	_
220-60	38069-38077	Artifact	_
220-61	38078-38082	from	_
220-62	38083-38086	EEG	_
220-63	38087-38092	using	_
220-64	38093-38095	an	_
220-65	38096-38105	ICA-based	_
220-66	38106-38114	Template	_
220-67	38115-38123	Matching	_
220-68	38124-38132	Approach	_
220-69	38132-38133	,	_
220-70	38133-38134	"	_
220-71	38135-38136	“	_
220-72	38136-38144	Negative	_
220-73	38145-38148	and	_
220-74	38149-38157	positive	_
220-75	38158-38171	Schizophrenia	_
220-76	38171-38172	:	_
220-77	38173-38183	Definition	_
220-78	38184-38187	and	_
220-79	38188-38198	validation	_
220-80	38198-38199	.	_

#Text=Archives of General Psychiatry”
#Text=“Meta Analysis of P300 and Schizophrenia: Patients, Paradigms and Practical Implications”
#Text=“Contextual processing deficits in Parkinson´s disease: Role of the frontostriatal system”
#Text=“N300, P300 and the emotional processing of visual stimuli”
#Text=“EEG Spectral Analysis in Schizophrenia”
#Text=
#Text=“The P300 as a Possible Endophenotype for Schizophrenia and Bipolar Disorder: Evidence from twin and patient studies”
221-1	38200-38208	Archives	_
221-2	38209-38211	of	_
221-3	38212-38219	General	_
221-4	38220-38230	Psychiatry	_
221-5	38230-38231	”	_
221-6	38232-38233	“	_
221-7	38233-38237	Meta	_
221-8	38238-38246	Analysis	_
221-9	38247-38249	of	_
221-10	38250-38254	P300	_
221-11	38255-38258	and	_
221-12	38259-38272	Schizophrenia	_
221-13	38272-38273	:	_
221-14	38274-38282	Patients	_
221-15	38282-38283	,	_
221-16	38284-38293	Paradigms	_
221-17	38294-38297	and	_
221-18	38298-38307	Practical	_
221-19	38308-38320	Implications	_
221-20	38320-38321	”	_
221-21	38322-38323	“	_
221-22	38323-38333	Contextual	_
221-23	38334-38344	processing	_
221-24	38345-38353	deficits	_
221-25	38354-38356	in	_
221-26	38357-38366	Parkinson	_
221-27	38366-38367	´	_
221-28	38367-38368	s	_
221-29	38369-38376	disease	_
221-30	38376-38377	:	_
221-31	38378-38382	Role	_
221-32	38383-38385	of	_
221-33	38386-38389	the	_
221-34	38390-38404	frontostriatal	_
221-35	38405-38411	system	_
221-36	38411-38412	”	_
221-37	38413-38414	“	_
221-38	38414-38418	N300	_
221-39	38418-38419	,	_
221-40	38420-38424	P300	_
221-41	38425-38428	and	_
221-42	38429-38432	the	_
221-43	38433-38442	emotional	_
221-44	38443-38453	processing	_
221-45	38454-38456	of	_
221-46	38457-38463	visual	_
221-47	38464-38471	stimuli	_
221-48	38471-38472	”	_
221-49	38473-38474	“	_
221-50	38474-38477	EEG	_
221-51	38478-38486	Spectral	_
221-52	38487-38495	Analysis	_
221-53	38496-38498	in	_
221-54	38499-38512	Schizophrenia	_
221-55	38512-38513	”	_
221-56	38515-38516	“	_
221-57	38516-38519	The	_
221-58	38520-38524	P300	_
221-59	38525-38527	as	_
221-60	38528-38529	a	_
221-61	38530-38538	Possible	_
221-62	38539-38552	Endophenotype	_
221-63	38553-38556	for	_
221-64	38557-38570	Schizophrenia	_
221-65	38571-38574	and	_
221-66	38575-38582	Bipolar	_
221-67	38583-38591	Disorder	_
221-68	38591-38592	:	_
221-69	38593-38601	Evidence	_
221-70	38602-38606	from	_
221-71	38607-38611	twin	_
221-72	38612-38615	and	_
221-73	38616-38623	patient	_
221-74	38624-38631	studies	_
221-75	38631-38632	”	_
